<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Vaccines (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Vaccines (Basel)</journal-id><journal-id journal-id-type="publisher-id">vaccines</journal-id><journal-title-group><journal-title>Vaccines</journal-title></journal-title-group><issn pub-type="epub">2076-393X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7563161</article-id><article-id pub-id-type="pmid">32842641</article-id><article-id pub-id-type="doi">10.3390/vaccines8030468</article-id><article-id pub-id-type="publisher-id">vaccines-08-00468</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Plant-Derived Nutraceuticals and Immune System Modulation: An Evidence-Based Overview</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7467-1689</contrib-id><name><surname>Di Sotto</surname><given-names>Antonella</given-names></name><xref rid="c1-vaccines-08-00468" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2055-9755</contrib-id><name><surname>Vitalone</surname><given-names>Annabella</given-names></name><xref rid="c1-vaccines-08-00468" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3049-6644</contrib-id><name><surname>Di Giacomo</surname><given-names>Silvia</given-names></name></contrib></contrib-group><aff id="af1-vaccines-08-00468">Department of Physiology and Pharmacology, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy; <email>silvia.digiacomo@uniroma1.it</email></aff><author-notes><corresp id="c1-vaccines-08-00468"><label>*</label>Correspondence: <email>antonella.disotto@uniroma1.it</email> (A.D.S.); <email>annabella.vitalone@uniroma1.it</email> (A.V.); Tel.: +39-064-9912-497 (A.D.S.); +39-064-9912-904 (A.V.)</corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2020</year></pub-date><volume>8</volume><issue>3</issue><elocation-id>468</elocation-id><history><date date-type="received"><day>31</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>19</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Immunomodulators are agents able to affect the immune system, by boosting the immune defences to improve the body reaction against infectious or exogenous injuries, or suppressing the abnormal immune response occurring in immune disorders. Moreover, immunoadjuvants can support immune system acting on nonimmune targets, thus improving the immune response. The modulation of inflammatory pathways and microbiome can also contribute to control the immune function. Some plant-based nutraceuticals have been studied as possible immunomodulating agents due to their multiple and pleiotropic effects. Being usually more tolerable than pharmacological treatments, their adjuvant contribution is approached as a desirable nutraceutical strategy. In the present review, the up to date knowledge about the immunomodulating properties of polysaccharides, fatty acids and labdane diterpenes have been analyzed, in order to give scientific basic and clinical evidence to support their practical use. Since promising evidence in preclinical studies, limited and sometimes confusing results have been highlighted in clinical trials, likely due to low methodological quality and lacking standardization. More investigations of high quality and specificity are required to describe in depth the usefulness of these plant-derived nutraceuticals in the immune system modulation, for health promoting and disease preventing purposes.</p></abstract><kwd-group><kwd>immune system boosters</kwd><kwd>immunosuppressors</kwd><kwd>polysaccharides</kwd><kwd>fatty acids</kwd><kwd>labdane diterpenes</kwd><kwd>punicic acid</kwd><kwd>oleic acid</kwd><kwd>&#x003b3;-linolenic acid</kwd><kwd>&#x003b2;-glucans</kwd><kwd>andrographolide</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-vaccines-08-00468"><title>1. Introduction</title><p>Immunomodulators are defined as agents able to affect the immune response, which represents the set of reactions activated to protect the organism against infective agents, environmental injuries and illness; moreover, immune response can counteract the invasion of harmful native cells, such as precancerous and cancerous ones [<xref rid="B1-vaccines-08-00468" ref-type="bibr">1</xref>].</p><p>Immune response is mediated by a first line of defence, namely innate immunity (<xref ref-type="fig" rid="vaccines-08-00468-f001">Figure 1</xref>), which is characterized by physical and biochemical barriers, alongside a non-specific cell-mediated immune response, including granulocytes, macrophages, natural killer cells and humoral elements, which cooperate to counteract pathogen infection and malignant transformation [<xref rid="B2-vaccines-08-00468" ref-type="bibr">2</xref>]. Moreover, an adaptive immunity is activated as a second defense line after a macrophage-mediated presentation of antigens to B lymphocytes, with the help of T lymphocytes; then, B cells can mediate the humoral immunity through the production of high-affinity antibodies and establish immunological memory [<xref rid="B3-vaccines-08-00468" ref-type="bibr">3</xref>]. Moreover, T lymphocytes can mediate cellular immunity after activation by cytokines released from helper T cells [<xref rid="B2-vaccines-08-00468" ref-type="bibr">2</xref>].</p><p>Immunomodulating agents can affect immunity in a negative or positive manner, thus being categorized as suppressing or stimulant [<xref rid="B4-vaccines-08-00468" ref-type="bibr">4</xref>]. Particularly, immunosuppressors inhibit the activation of immune response or decrease the activity of its components, thus restoring normalcy. They are of interest in organ transplantations and in autoimmune disorders, wherein the immune system mistakenly activates an immune response against the own body tissues, leading to their destruction [<xref rid="B4-vaccines-08-00468" ref-type="bibr">4</xref>]. For instance, vitamin D has been shown to counteract the aberrant immune responses of systemic lupus erythematosus, without compromising the physiological defences and to produce benefits in atopic dermatitis too [<xref rid="B5-vaccines-08-00468" ref-type="bibr">5</xref>,<xref rid="B6-vaccines-08-00468" ref-type="bibr">6</xref>].</p><p>Conversely, immunostimulants boost the endogenous immune defences, thus allowing one to restore or maintain the body homeostasis [<xref rid="B4-vaccines-08-00468" ref-type="bibr">4</xref>]. They can be usefully exploited as immunotherapeutic agents by individuals with immunocompromised conditions; however, they can represent suitable prophylactic strategies for healthy individuals or more susceptible subjects against viral infections [<xref rid="B4-vaccines-08-00468" ref-type="bibr">4</xref>]. In support, during the current SARS-CoV-2 pandemic, the trained immunity by vaccines, which induce heterologous protection, have been proposed as a rational strategy to boost antiviral defences and reduce susceptibility to infection [<xref rid="B7-vaccines-08-00468" ref-type="bibr">7</xref>].</p><p>A further group of immunomodulators is represented by immunoadjuvants, able to enhance immune response to vaccines without producing specific antigenic effects, and more recently approached as adjuvant pharmacological treatments, especially for viral infections and cancers [<xref rid="B8-vaccines-08-00468" ref-type="bibr">8</xref>,<xref rid="B9-vaccines-08-00468" ref-type="bibr">9</xref>,<xref rid="B10-vaccines-08-00468" ref-type="bibr">10</xref>,<xref rid="B11-vaccines-08-00468" ref-type="bibr">11</xref>,<xref rid="B12-vaccines-08-00468" ref-type="bibr">12</xref>].</p><p>Immune-associated disorders, including autoimmune diseases, viral or bacterial infections, and chronic diseases, are usually associated with acute inflammation, which represents a key component for the activation of immune response [<xref rid="B13-vaccines-08-00468" ref-type="bibr">13</xref>]. On the other hand, the chronicity of inflammatory response can negatively influence the immune function, affecting both innate immune cells and T and B lymphocytes, thus suggesting a possible usefulness of anti-inflammatory immunomodulators [<xref rid="B13-vaccines-08-00468" ref-type="bibr">13</xref>]. Accordingly, immunomodulatory agents, with antioxidant and anti-inflammatory activity, have attracted great attention as possible chemopreventive agents, due to their ability to counteract chronic inflammation, which provides favorable conditions for the transition from normal to cancer cell [<xref rid="B14-vaccines-08-00468" ref-type="bibr">14</xref>].</p><p>Furthermore, immunostimulants can act as adjuvant anticancer treatments, to counteract their immunosuppressive side-effects [<xref rid="B14-vaccines-08-00468" ref-type="bibr">14</xref>].</p><p>Growing evidence highlighted an important role of gut microbiome in the maintenance of immune function, and the disruption of the microbiome seems to have a role in disease development [<xref rid="B15-vaccines-08-00468" ref-type="bibr">15</xref>]. This intimate microbiome&#x02013;immune system crosstalk suggests that boosting the resident microbiome, through pre/probiotic supplementations or suitable intervention for preventing disruption of microbial communities, can reinforce the immune defences, thus representing an alternative immunomodulatory strategy [<xref rid="B16-vaccines-08-00468" ref-type="bibr">16</xref>].</p><p>Several medicinal plants and phytochemicals are known since the ancient time for their ability to modulate the immune system function [<xref rid="B17-vaccines-08-00468" ref-type="bibr">17</xref>]. As major immunomodulatory mechanisms, they act especially as boosters of immune system, through the stimulation of both innate and adaptive humoral and cellular immunity (<xref rid="vaccines-08-00468-t001" ref-type="table">Table 1</xref>). However, further mechanisms, such as an interference with proinflammatory pathways and a modulation of the gut microbiome, have been reported [<xref rid="B18-vaccines-08-00468" ref-type="bibr">18</xref>,<xref rid="B19-vaccines-08-00468" ref-type="bibr">19</xref>,<xref rid="B20-vaccines-08-00468" ref-type="bibr">20</xref>].</p><p>The best known immunostimulant species is echinacea (<italic>Echinacea purpurea</italic> (L.) Moench, <italic>E. pallida</italic> Nutt. and <italic>E. angustifolia</italic> DC), characterized by immunostimulant properties on both innate and adaptive response, associated with antiviral, antinflammatory and antimicrobial effects [<xref rid="B42-vaccines-08-00468" ref-type="bibr">42</xref>]. More recently, its ability to indirectly boost the immune system, through the modulation of gut microbiome, has been highlighted [<xref rid="B18-vaccines-08-00468" ref-type="bibr">18</xref>]. All the phytocomplex seems to be involved in these properties, however, alkylamides and purified polysaccharides have been found to induce immunomodulatory effects [<xref rid="B42-vaccines-08-00468" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-08-00468" ref-type="bibr">43</xref>]. The immune boosting properties of echinacea, particularly as enhancers of macrophage and lymphocyte activation, have also been highlighted in clinical studies; however, further high-quality studies are required for better characterizing the possible usefulness of echinacea byproducts as immunomodulators [<xref rid="B44-vaccines-08-00468" ref-type="bibr">44</xref>]. </p><p>Several preclinical and clinical evidence also highlighted the ability of <italic>Curcuma longa</italic> L. to activate cellular immunity and to interfere with inflammation, thus acting as an immune booster [<xref rid="B42-vaccines-08-00468" ref-type="bibr">42</xref>]. </p><p>Furthermore, some adaptogenic plants, such as <italic>Panax ginseng</italic> C.A. Meyer, <italic>Astragalus membranaceous</italic> (Fisch.) Bge., and <italic>Withania somnifera</italic> (L.) Dunal can indirectly stimulate the immune system, through improving the resistance to stress [<xref rid="B35-vaccines-08-00468" ref-type="bibr">35</xref>,<xref rid="B45-vaccines-08-00468" ref-type="bibr">45</xref>]. Indeed, ginseng has been reported able to prevent several diseases through modulating the immune system and gut microbiome, thus suggesting its usefulness as an immunity boosting dietary supplement [<xref rid="B36-vaccines-08-00468" ref-type="bibr">36</xref>]. Similarly, the immunomodulatory properties of <italic>W. somnifera</italic> and its constituent withaferin A have been reported [<xref rid="B39-vaccines-08-00468" ref-type="bibr">39</xref>]. At last, preliminary studies have highlighted the immunomodulatory effects of other medicinal plants, such as <italic>Asparagus racemosus</italic> Willd., <italic>Azadirachta indica</italic> A. Juss., <italic>Artocarpus tonkinensis</italic> A. Chev. Ex Gagnep, <italic>Syzigium aromaticum</italic> (L.) Merr. and L.M. Perry and <italic>Hypoxis rooperi</italic> T. Moore [<xref rid="B26-vaccines-08-00468" ref-type="bibr">26</xref>,<xref rid="B33-vaccines-08-00468" ref-type="bibr">33</xref>,<xref rid="B37-vaccines-08-00468" ref-type="bibr">37</xref>,<xref rid="B46-vaccines-08-00468" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-08-00468" ref-type="bibr">47</xref>]. </p><p>Details about the bioactive constituents and the mechanisms of actions of medicinal plants known to modulate the immune function are reported in <xref rid="vaccines-08-00468-t001" ref-type="table">Table 1</xref>.</p><p>Several phytochemicals, especially alkaloids, phenolics, glycoproteins and saponins (<xref ref-type="fig" rid="vaccines-08-00468-f002">Figure 2</xref>), have been reported to possess antinflammatory and immune modulating properties [<xref rid="B48-vaccines-08-00468" ref-type="bibr">48</xref>]. Moreover, terpenoids, polysaccharides and fatty acids (<xref ref-type="fig" rid="vaccines-08-00468-f002">Figure 2</xref>) have received considerable attention as possible immunomodulatory agents for further application in immune disorders [<xref rid="B48-vaccines-08-00468" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-08-00468" ref-type="bibr">49</xref>]. </p><p>Particularly, aristolochic acid, an alkaloid from <italic>Aristolochia clematitis</italic> L., showed immunostimulatory properties, by enhancing the phagocytic activity of peritoneal macrophages and leukocytes; however, its potential cannot be exploited, because of its carcinogenic risk [<xref rid="B50-vaccines-08-00468" ref-type="bibr">50</xref>]. Likewise, vincristine and staurosporine act as immunostimulants at low doses, while as immunosuppressors at higher doses [<xref rid="B51-vaccines-08-00468" ref-type="bibr">51</xref>]. Among polyphenols, resveratrol stimulated both cellular and humoral immunity in preclinical models, thus preventing pathogen replication and inflammation, and promoted antitumor immune response too [<xref rid="B52-vaccines-08-00468" ref-type="bibr">52</xref>]. Furthermore, cichoric acid from echinacea promoted phagocytic activity, both <italic>in vitro</italic> and <italic>in vivo</italic> [<xref rid="B53-vaccines-08-00468" ref-type="bibr">53</xref>]. Anti-inflammatory and immune-modulatory effects has been highlighted for curcumin too, although the poor bioavailability limits its clinical application [<xref rid="B54-vaccines-08-00468" ref-type="bibr">54</xref>].</p><p>In the present review, up to date knowledge on the scientific basis for the immunomodulatory activity and clinical relevance of some emerging classes of plant-derived nutraceuticals, including polysaccharides, fatty acids and labdane diterpenes, has been reported. A comprehensive search was made using PubMed and SCOPUS electronic databases and selecting English as the preferred language, although no language limitations nor filters were applied. For more specific requirements, Google Scholar and ClinicalTrials.gov were considered too. The following searching keywords and their combinations through the Boolean logical operators were used: &#x0201c;herbal immunomodulators&#x0201d;, &#x0201c;phytochemicals&#x0201d;, &#x0201c;immune system&#x0201d;, &#x0201c;nutraceuticals&#x0201d;, &#x0201c;medicinal plants&#x0201d;, &#x0201c;immunomodulation&#x0201d;, &#x0201c;immune system boosters&#x0201d;, &#x0201c;immunosuppressors&#x0201d;, &#x0201c;immunoadjuvants&#x0201d;, &#x0201c;gut microbiome&#x0201d;, &#x0201c;natural occurrence&#x0201d;, &#x0201c;chemical features&#x0201d;, &#x0201c;preclinical studies&#x0201d;, &#x0201c;clinical trials&#x0201d;, &#x0201c;polysaccharides&#x0201d;, &#x0201c;echinacea&#x0201d;, &#x0201c;astragalus&#x0201d;, &#x0201c;&#x003b2;-glucan&#x0201d;, &#x0201c;fatty acids&#x0201d;, &#x0201c;PUFA&#x0201d;, &#x0201c;oleic acid&#x0201d;, &#x0201c;punicic acid&#x0201d;, &#x0201c;&#x003b3;-linolenic acid&#x0201d;, &#x0201c;linoleic acid&#x0201d;, &#x0201c;evening primrose oil&#x0201d;, &#x0201c;borage oil&#x0201d;, &#x0201c;flaxseed oils&#x0201d;, &#x0201c;labdane diterpenes&#x0201d; and &#x0201c;andrographolide&#x0201d;.</p><p>This overview allows one to identify novel immune system modulators to be usefully exploited for health promoting and disease preventing purposes.</p></sec><sec id="sec2-vaccines-08-00468"><title>2. Polysaccharides</title><sec id="sec2dot1-vaccines-08-00468"><title>2.1. Chemical Features</title><p>Polysaccharides are carbohydrate macromolecules containing at least 10 monosaccharide units, joined by glycosidic linkages to form long-chain molecules, which can be both linear and highly branched. They are called homopolysaccharides when constituted of the same monosaccharide unit, while heteropolysaccharides if different units are present. Some of them are also referred to as dietary fibres, meaning that these macromolecules are neither digested nor absorbed in the human small intestine [<xref rid="B55-vaccines-08-00468" ref-type="bibr">55</xref>].</p><p>Several polysaccharides have been found to modulate both innate and adaptive immune responses, among which, glucans, mannans, pectins, fucoidans, galactans, fructans, and xylans are the most studied (<xref ref-type="fig" rid="vaccines-08-00468-f003">Figure 3</xref>) [<xref rid="B56-vaccines-08-00468" ref-type="bibr">56</xref>].</p><p>Chemical structure, molecular weight, conformation, the presence of functional groups (i.e., acetyl and sulfate groups), and branching have been identified as structural features for the immunostimulatory properties of polysaccharides. The chemical structures of the polysaccharides associated with immunomodulatory properties are displayed in <xref ref-type="fig" rid="vaccines-08-00468-f004">Figure 4</xref>.</p><p>Glucans are based on the D-glucopyranosyl unit (homoglucans); the different glycosidic bonds, namely (&#x003b2;1&#x02192;4), (&#x003b2;1&#x02192;3), and (&#x003b2; 1&#x02192;6) or (&#x003b1;1&#x02192;3), (&#x003b1; 1&#x02192;4), and (&#x003b1; 1&#x02192;6), allow the production of linear and branched glucans. It seems that (&#x003b2;1&#x02192;3)-D-glucan moiety, triple helix conformations, sulfation and carboxymethylation of (&#x003b2; 1&#x02192;3)-D-glucans, and chain acetylation are involved in glucan immunostimulatory activity. Regarding (&#x003b1;1&#x02192;6) (&#x003b1;1&#x02192;4)-D-glucans, their structure activity relationship is less characterized [<xref rid="B56-vaccines-08-00468" ref-type="bibr">56</xref>].</p><p>Mannans consist of a D-mannose backbone, linked mainly by &#x003b2;1&#x02192;4 bonds, which can be ramified with other monosaccharide, so originating glucomannan, galactomannan, and galactoglucomannan [<xref rid="B57-vaccines-08-00468" ref-type="bibr">57</xref>]. Furthermore, (&#x003b2;1&#x02192;3)- or (&#x003b1;1&#x02192;3)-, (&#x003b2;1&#x02192;2)-, and (&#x003b2;1&#x02192;6)- or (&#x003b1;1&#x02192;6)-D-mannosidic bonds are reported [<xref rid="B56-vaccines-08-00468" ref-type="bibr">56</xref>]. The (&#x003b2;1&#x02192;6)-D-mannan moiety (e.g., galctoglucomannans), acetyl and sulfate group presence, and this kind of branching seems to confer a high immunostimulatory activity [<xref rid="B58-vaccines-08-00468" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-08-00468" ref-type="bibr">59</xref>,<xref rid="B60-vaccines-08-00468" ref-type="bibr">60</xref>].</p><p>Pectins are complex polysaccharides which contain a common galactopyranosyluronic acid. Homogalacturonans, xylogalacturonan, apiogalacturonan, rhamnogalacturonan, type I and II arabinogalactans belong to this class. Particularly, type I arabinogalactans (AG-I) possess an &#x003b1;-1-arabinofuranosyl and &#x003b2;-D-galactopyranosyl units linked via position 3 at the main chain, while type II arabinogalactans (AG-II) comprise highly branched polysaccharides with ramified chains of (&#x003b2;1&#x02192;3)- and (&#x003b2;1&#x02192;6)-D-galactopyranosyl units [<xref rid="B61-vaccines-08-00468" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-08-00468" ref-type="bibr">62</xref>], to which the arabinosyl units might be attached. The degree of branching, methyl esterification, acetylation, and the type of branched chains and molecular weight determine the structural diversity [<xref rid="B63-vaccines-08-00468" ref-type="bibr">63</xref>]. Moreover, flexible chain conformation and branched regions are the main ones responsible for the immunomodulatory properties [<xref rid="B64-vaccines-08-00468" ref-type="bibr">64</xref>,<xref rid="B65-vaccines-08-00468" ref-type="bibr">65</xref>].</p><p>Galactans are polysaccharides rich in galactose and include, beside type I and II arabinogalactans, carrageenans, chemically characterized by repeating disaccharide units of sulfated or unsulfated D-galactose, that are linked by (&#x003b2;1&#x02192;4)- and (&#x003b1;1&#x02192;3)-bonds. Low molecular weight (&#x0003c;20 kDa) and a high degree of sulfation have been reported as features that high influence their immunomodulatory properties [<xref rid="B66-vaccines-08-00468" ref-type="bibr">66</xref>,<xref rid="B67-vaccines-08-00468" ref-type="bibr">67</xref>].</p><p>Fucoidans are heteropolysaccharides rich in L-fucopyranosyl sulfated units linked by (&#x003b1;1&#x02192;2), (&#x003b1;1&#x02192;3) or (&#x003b1;1&#x02192;4) bonds. Other monosaccharides can be present, such as galactopyranosyl, mannopyranosyl, xylosepyranosyl and uronic acids [<xref rid="B68-vaccines-08-00468" ref-type="bibr">68</xref>]. The naturally higher content of sulfate groups and the presence of acetyl groups are associated with a higher stimulatory activity [<xref rid="B56-vaccines-08-00468" ref-type="bibr">56</xref>].</p><p>Fructans are polysaccharides which constitute up to 70 fructose units with a sucrolose terminal molecule. They are classified in inulin with a (&#x003b2;2&#x02192;1)-D-fructofuranosyl, levan with a (&#x003b2;2&#x02192;6)-D- fructofuranosyl, and mixed type, with both (&#x003b2;2&#x02192;1)- and (&#x003b2;2&#x02192;6)-linked d- fructofuranosyl moieties. A helical conformation has been associated with the modulatory activity on the immune system [<xref rid="B69-vaccines-08-00468" ref-type="bibr">69</xref>,<xref rid="B70-vaccines-08-00468" ref-type="bibr">70</xref>]. At last, xylans are polysaccharides containing predominantly a backbone of (&#x003b2;1&#x02192;4)-D- xylosepyranosyl units. Other monomers attached to their backbone include &#x003b1;-D- glucopyranosyl A units (glucuronoxylans) and &#x003b1;-L-arabinofuranosyl units (arabinoxylans). A correlation between their structure and activity has not been elucidated yet [<xref rid="B71-vaccines-08-00468" ref-type="bibr">71</xref>,<xref rid="B72-vaccines-08-00468" ref-type="bibr">72</xref>].</p></sec><sec id="sec2dot2-vaccines-08-00468"><title>2.2. Natural Occurrence</title><p>Polysaccharides are naturally occuring in animal body fluids, cell walls, bacteria, yeast and fungi, extra cellular fluids, and in plant seeds, stems and leaves, which represent the focus of the present review. The main advantage of plant polysaccharides seems to be the low toxicity with respect to immunomodulatory bacterial polysaccharides and synthetic compounds [<xref rid="B73-vaccines-08-00468" ref-type="bibr">73</xref>]. Thus, they represent an ideal alternative for immune modulation. A variety of polysaccharides with immunomodulatory properties have been discovered in different species of plants (<xref rid="vaccines-08-00468-t002" ref-type="table">Table 2</xref>). Among the most studied, there are type I and II arabinogalactans from <italic>Astragalus membranaceus</italic> (Fisch.) Bge., fructans from <italic>Allium sativum</italic> L. [<xref rid="B56-vaccines-08-00468" ref-type="bibr">56</xref>], fucogalactoxyloglucan and type II acidic arabinogalactan from <italic>Echinacea purpurea</italic> L. (Moench), ginsan and panaxanes from <italic>Panax ginseng</italic> C.A. Meyer, acemannan and aloeride from <italic>Aloe vera</italic> L. [<xref rid="B74-vaccines-08-00468" ref-type="bibr">74</xref>], and glucomannan from <italic>Amorphallus konjac</italic> Koch [<xref rid="B75-vaccines-08-00468" ref-type="bibr">75</xref>].</p></sec><sec id="sec2dot3-vaccines-08-00468"><title>2.3. Pharmacological Properties: Preclinical Evidence</title><p>Several studies have shown that polysaccharides from plants can modulate both innate and acquired intestinal immunity, by direct and indirect mechanisms. The former include the activation of immune cells (e.g., macrophages, dendritic cells, natural killer cells, T cells, B lymphocytes), while the latter the short-chain fatty acid (SCFA) formation (<xref ref-type="fig" rid="vaccines-08-00468-f005">Figure 5</xref>).</p><p>The immunomodulatory effects of plant polysaccharides on macrophages are mainly achieved through the generation of reactive oxygen and nitrogen species (ROS and NOS), and the stimulation of cytokines secretion, cell proliferation, and macrophage phagocytic activity [<xref rid="B101-vaccines-08-00468" ref-type="bibr">101</xref>]. For example, <italic>A. membranaceus</italic> polysaccharides have been shown to promote nitric oxide (NO) synthesis in macrophages, by inducing the gene expression of inducible nitric oxide synthase (iNOS), through the activation of nuclear factor kappa-B (NF-&#x003ba;B)/Rel [<xref rid="B102-vaccines-08-00468" ref-type="bibr">102</xref>,<xref rid="B103-vaccines-08-00468" ref-type="bibr">103</xref>]. Moreover, they were also able to increase the macrophage phagocytic activity, by enhancing their secretion of release factor and intracellular Ca<sup>2+</sup> concentration [<xref rid="B104-vaccines-08-00468" ref-type="bibr">104</xref>,<xref rid="B105-vaccines-08-00468" ref-type="bibr">105</xref>].</p><p>Pectic polysaccharides from <italic>Citrus unshiu</italic> Marc. have been shown to simultaneously regulate the expression of pro- and anti-inflammatory cytokines. Particularly, they increased the production of the pro-inflammatory cytokines tumor necrosis factor (TNF)-&#x003b1; and interleukin (IL)-6 and the anti-inflammatory cytokine IL-12 in macrophage RAW264.7, so showing a regulatory mechanism to maintain an equilibrium state [<xref rid="B106-vaccines-08-00468" ref-type="bibr">106</xref>]. Arabinogalactan from <italic>E. purpurea</italic> has been reported to increase macrophages activation and IL-1, TNF-&#x003b1; and interferon (IFN)-&#x003b2; production [<xref rid="B86-vaccines-08-00468" ref-type="bibr">86</xref>]. The activation of macrophages by plant polysaccharides seems to be due to specific receptors present on their surface, which initiates the immune response, and exerts an immunomodulatory effect. These receptors are called pattern recognition molecules, and include: Toll-like receptor 4 (TLR4), CD14, complement receptor 3 (CR3), scavenger receptor (SR), mannose receptor (MR), and Dectin-1. Their activation determines a series of intracellular signaling cascades, leading to the transcriptional activation and production of inflammation-related cytokines [<xref rid="B101-vaccines-08-00468" ref-type="bibr">101</xref>].</p><p>Immunity modulation by plant polysaccharides can be achieved also by modulating the cytokine release from intestinal dendritic cells. Indeed, pectin has been shown to reduce IL-6 and IL-10 release induced by the synthetic lipopeptide P3CSK4 [<xref rid="B107-vaccines-08-00468" ref-type="bibr">107</xref>]. Moreover, inulin, pectin, arabinoxylan and &#x003b2;-glucan have been found to elevate IL-10/IL-12 ratio and to reduce the release of IFN-&#x003b3;, IL-12, IL-1, IL-6, IL-8, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory proteins (MIP)-1&#x003b1;, RANTES and TNF-&#x003b1; by dendritic cells [<xref rid="B108-vaccines-08-00468" ref-type="bibr">108</xref>]. Polysaccharide enriched extracts of <italic>E. purpurea</italic> have been found to promote the phenotypic and functional maturation of dendritic cells by modulating c-Jun N-terminal kinase (JNK), p38 mitogen-activated protein kinase (MAPK) and NF-<italic>&#x003ba;</italic>B pathways [<xref rid="B109-vaccines-08-00468" ref-type="bibr">109</xref>].</p><p>The activation of natural killer (NK) cells also contributes to the immunity modulation by polysaccharides. Indeed, it has been shown that <italic>A. membranaceus</italic> polysaccharides can enhance the activity and killing effects of NK cells and promote their proliferation in rats with gastric cancer [<xref rid="B110-vaccines-08-00468" ref-type="bibr">110</xref>]. Moreover, they were able to increase CD3-CD4-CD8+ NKs in peripheral blood lymphocytes [<xref rid="B111-vaccines-08-00468" ref-type="bibr">111</xref>]. NKs activation is probably due to the polysaccharides interaction with the killer cell lectin-like receptor K1(KLRK1) of NKs [<xref rid="B112-vaccines-08-00468" ref-type="bibr">112</xref>]. Arabinoxylans extracted from wheat bran have been shown to inhibit the growth of transplantable tumors, and to promote the NK cell activity in S180 tumor-bearing mice [<xref rid="B113-vaccines-08-00468" ref-type="bibr">113</xref>]. Moreover, the MGN-3 rice bran arabinoxylan showed to enhance natural killer (NK) cell activity in aged C57BL/6 and C3H mice upon its intraperitoneal injection [<xref rid="B114-vaccines-08-00468" ref-type="bibr">114</xref>].</p><p>Adaptive immunity is also modulated by plant polysaccharides. Particularly, Fan et al. have shown that polysaccharides from <italic>A. membranaceus</italic> significantly up-regulated the proliferation of B lymphocytes, probably through the interaction with immunoglobulin on the surface of B cells [<xref rid="B115-vaccines-08-00468" ref-type="bibr">115</xref>,<xref rid="B116-vaccines-08-00468" ref-type="bibr">116</xref>,<xref rid="B117-vaccines-08-00468" ref-type="bibr">117</xref>]. <italic>A. membranaceus</italic> polysaccharides were also able to increase the number of CD3+CD4+CD8+ memory T helper (Th) cells and CD3+CD4-CD8+ cytotoxic T cells [<xref rid="B111-vaccines-08-00468" ref-type="bibr">111</xref>]. Moreover, they also enhance the CD4+/CD8+ T cell ratio [<xref rid="B118-vaccines-08-00468" ref-type="bibr">118</xref>]. Furthermore, arabinoxylan were found to increase the activation of T- and B-cells and humoral and cell-mediated immunity in tumor bearing mice [<xref rid="B71-vaccines-08-00468" ref-type="bibr">71</xref>].</p><p>At last, &#x003b2;-glucan microparticles enhanced T-cell activation and proliferation <italic>in vitro</italic> [<xref rid="B119-vaccines-08-00468" ref-type="bibr">119</xref>]. Their ability to affect the immune system by inducing Th1 and/or Th2 type immune response makes polysaccharides suitable adjuvants of the vaccine. Among them, inulin, chitosan, glucans and mannans have been most extensively studied. Particularly, the gamma and delta forms of inulin fructan have shown adjuvant activity against infectious pathogens by stimulating both Th1 and Th2 responses without inducing immunoglobulin E (IgE) production [<xref rid="B120-vaccines-08-00468" ref-type="bibr">120</xref>]. Moreover, Advax, a polysaccharide derived from delta inulin, has demonstrated to increase the immunization derived from influenza vaccine in mice. Particularly, an induction of neutralizing antibody and memory B-cell against influenza, an increase in CD4 and CD8 T-cell proliferation, and enhanced levels of IL-2, IFN-&#x003b3;, IL-5, IL-6 were highlighted [<xref rid="B121-vaccines-08-00468" ref-type="bibr">121</xref>].</p><p>Advax also enhanced the immunogenicity of hepatitis B surface antigen (HBs) in mice and guinea pigs, by increasing both anti-HBs antibody titers and anti-HBs CD4 and CD8 T-cells. Th1, Th2 and Th17 responses were increased too [<xref rid="B122-vaccines-08-00468" ref-type="bibr">122</xref>]. Astragalus polysaccharides were also used as adjuvants of Hepatitis B virus DNA vaccine in a mice model, showing increased HBsAg-specific antibody levels, higher activity of T cells, the production of IL-4, IL-2 and IFN-&#x003b3; by CD4+ T cells, and IFN-&#x003b3; expression of CD8+ T cells. Moreover, a stimulation of cytotoxic lymphocytes and dendritic cells maturation, and a reduction in the frequency of regulatory T cells were observed [<xref rid="B123-vaccines-08-00468" ref-type="bibr">123</xref>]. Mannans and fructooligosaccharide have also been shown to possess adjuvanticity [<xref rid="B124-vaccines-08-00468" ref-type="bibr">124</xref>,<xref rid="B125-vaccines-08-00468" ref-type="bibr">125</xref>].</p><p>Furthermore, indirect effects are involved in the immunomodulatory properties of polysaccharides. In particular, dietary fibers (e.g., inulin, mannan, &#x003b2;-glucan, pectin) are metabolized by intestinal bacteria in the anaerobic environment of the cecum and colon, so generating SCFA, such as acetate, propionate and butyrate [<xref rid="B126-vaccines-08-00468" ref-type="bibr">126</xref>]. These molecules are able to cross the gut epithelium and interact with surface receptors on the immune cells, such as the G-protein coupled receptors (GPRs) 41 and 43 [<xref rid="B127-vaccines-08-00468" ref-type="bibr">127</xref>]. The activation of GPRs by SCFA modulates inflammatory signalling pathways, such as NF-&#x003ba;B, ERK and p38 MAPK [<xref rid="B128-vaccines-08-00468" ref-type="bibr">128</xref>,<xref rid="B129-vaccines-08-00468" ref-type="bibr">129</xref>].</p><p>Moreover, it has been highlighted that SCFA can reach T lymphocyte nucleus, so modulating several functions through a histone deacetylase (HDAC) inhibition. Recently, SCFA have been reported able to induce T cells metabolic alterations by enhancing the mTOR complex activity. Particularly, after absorption into T cells, SCFA can stimulate the activity of mTOR complex, so increasing the conversion of pyruvate into acetyl-CoA. Moreover, the acetyl groups from SCFA can be link to CoA and enter the tricarboxylic acid cycle. The increased levels of citrate are exported from mitochondria into the cytoplasm, where the enzyme ATP citrate lyase converts it into acetyl-CoA, then used by histone acetyltransferases (HATs) for histone acetylation and the regulation of cytokine gene expression [<xref rid="B126-vaccines-08-00468" ref-type="bibr">126</xref>].</p></sec><sec id="sec2dot4-vaccines-08-00468"><title>2.4. Clinical Studies</title><p>Some clinical studies have been carried out on the potential immunomodulatory properties of polysaccharides, and <italic>A. membranaceus</italic>, <italic>E. purpurea</italic> and &#x003b2;-glucan have been most investigated.</p><p>In a clinical trial on <italic>A. membranaceus</italic> by Jiang et al. [<xref rid="B130-vaccines-08-00468" ref-type="bibr">130</xref>], twenthy-eight stable continuous ambulatory peritoneal dialysis patients were treated with peritoneal dialysis fluid containing astragalus (20 mL/2 L) for one week. An increase in the macrophage phagocytic capacity, NO and TNF-&#x003b1; contents were observed in patients compared to those before the treatment [<xref rid="B130-vaccines-08-00468" ref-type="bibr">130</xref>]. Furthermore, Ji et al. [<xref rid="B131-vaccines-08-00468" ref-type="bibr">131</xref>] investigated the effect of astragalus pre-operative treatment of colorectal cancer patients (<italic>n</italic> = 128) on immune function. Results showed that astragalus pre-operative treatment promoted the NK cell activity in postoperative patients. In addition, the possible immunomodulatory activity of astragalus in patients with acute exacerbations of bronchial asthma (n = 72) has been investigated [<xref rid="B132-vaccines-08-00468" ref-type="bibr">132</xref>]. Particularly, it was observed that the combination of conventional therapy with astragalus injection for 14 days improved the effects of routine treatment, by enhancing T lymphocyte and NK-cells immune function.</p><p>Results of clinical trials on the immune system modulation by <italic>E. purpurea</italic> are controversial. Particularly, a randomized blinded trial carried out on 108 patients revealed that there was no significant difference in the incidence and severity of colds and respiratory infection between echinacea treatment (8 weeks) and placebo groups. However, a small decrease of total lymphocyte counts was observed [<xref rid="B133-vaccines-08-00468" ref-type="bibr">133</xref>]. </p><p>Another randomized, placebo controlled, double-blind clinical trial investigated the effect of different echinacea preparations, namely Echinaforce<sup>&#x000ae;</sup> (<italic>E. purpurea</italic> preparation from 95% herba and 5% radix), <italic>E. purpurea</italic> concentrate (same preparation at 7 times higher concentration), special <italic>E. purpurea</italic> radix preparation (totally different from that of Echinaforce<sup>&#x000ae;</sup>) on the reduction of the complaint index, defined by 12 symptoms in healthy, adult volunteers who caught a common cold. The treatment continued until the enrolled patients felt healthy again, but not longer than 7 days. The supplementation with Echinaforce<sup>&#x000ae;</sup> and its concentrated preparation showed to be significantly more effective than the special echinacea extract or placebo. Moreover, all treatments were well tolerated [<xref rid="B134-vaccines-08-00468" ref-type="bibr">134</xref>]. Furthermore, prevention trials have been carried out, showing that echinacea products slightly reduce the risk of getting a cold in healthy individuals [<xref rid="B135-vaccines-08-00468" ref-type="bibr">135</xref>]. However, the heterogeneity (e.g., different species and part used) of preparations used in the trials makes the conclusions on the potential immunomodulatory properties of echinacea difficult.</p><p>Clinical trials concerning the &#x003b2;-glucan immunomodulatory properties have also been carried out, although in some cases, yeast-derived-glucan were used. Particularly, three randomized, double-blind, placebo-controlled studies have evaluated the effects of short-term &#x003b2;-glucan supplementation on children with chronic respiratory problems. After 30 days&#x02019; treatment, significant improvements in immunoglobulin, lysozyme, exhaled nitric oxide, and calprotectin production were found [<xref rid="B136-vaccines-08-00468" ref-type="bibr">136</xref>,<xref rid="B137-vaccines-08-00468" ref-type="bibr">137</xref>,<xref rid="B138-vaccines-08-00468" ref-type="bibr">138</xref>]. Furthermore, the combination of resveratrol plus carboxymethyl-&#x003b2;-glucan as a solution for aerosol has been tested in clinical trials. Particularly, the ability of the combination to prevent or treat recurrent respiratory infections in children was studied [<xref rid="B139-vaccines-08-00468" ref-type="bibr">139</xref>,<xref rid="B140-vaccines-08-00468" ref-type="bibr">140</xref>]. In both cases, resveratrol plus carboxymethyl-&#x003b2;-glucan had a positive impact on children clinical conditions. Indeed, nasal obstruction, rhinorrhea, sneezing, cough, fever, medication use, medical visits, and school absence were significantly reduced. Moreover, resveratrol plus carboxymethyl-&#x003b2;-glucan have also been shown to relief nasal symptoms in children with allergic rhinitis, due to pollen allergy [<xref rid="B141-vaccines-08-00468" ref-type="bibr">141</xref>]. </p><p>At last, mannans should be mentioned. They have been reported to possess adjuvant-vaccine properties in clinical studies, probably mediated by its interaction with mannose receptors. Particularly, it has been shown that oxidized mannan-mucin 1 can be useful as an adjuvant in the breast cancer immunotherapy. Indeed, a 12&#x02013;15 years follow-up has highlighted that it decreases the cancer recurrence rate and prolongs recurrence time, without inducing toxicity or adverse reactions [<xref rid="B124-vaccines-08-00468" ref-type="bibr">124</xref>]. </p></sec></sec><sec id="sec3-vaccines-08-00468"><title>3. Fatty Acids</title><sec id="sec3dot1-vaccines-08-00468"><title>3.1. Chemical Features</title><p>Fatty acids (FA) are a large group of lipids, characterized by a different number of carbons, arranged in a linear carbon chain skeleton of variable length with a terminal carboxylic group [<xref rid="B142-vaccines-08-00468" ref-type="bibr">142</xref>]. Based on the number of carbons in the chain, fatty acids can be classified as shortchain fatty acids (SCFA; aliphatic tails up to a maximum of six carbons), medium-chain fatty acids (MCFA; aliphatic tails of 7&#x02013;12 carbons), long-chain fatty acids (LCFA; aliphatic tails of 13 to 21 carbons) and very long-chain fatty acids (VLCFA; aliphatic tails of 22 and more carbons) [<xref rid="B143-vaccines-08-00468" ref-type="bibr">143</xref>].</p><p>Among them, SCFA, such as acetate, propionate, and butyrate, are produced by gut microbiota enzymes (i.e., propionate-CoA transferase and propionaldehyde dehydratase) during the metabolism of carbohydrates and peptides containing branched-chain amino acids [<xref rid="B144-vaccines-08-00468" ref-type="bibr">144</xref>]. <italic>Bacteroidetes</italic> are reported to be mainly responsible for the production of acetate and propionate, while <italic>Firmicutes</italic> are the primary contributors of butyrate; however, other bacteria such as <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic> spp. are involved too [<xref rid="B144-vaccines-08-00468" ref-type="bibr">144</xref>]. </p><p>Based on the presence of different double bonds in this structure, fatty acids can be distinguished in saturated fatty acids (SFA), lacking double bonds in their carbon backbone, and unsaturated FA (UFA), which may contain one or more double bonds, thus leading to monounsaturated (MUFA) and polyunsaturated FA (PUFA) [<xref rid="B143-vaccines-08-00468" ref-type="bibr">143</xref>]. SFA include palmitic acid (C16:0), lauric acid (C12:0), myristic acid (C14:0), and stearic acid (C18:0), whereas n-9 oleic acid (C18:1) is an example of MUFA. </p><p>Furthermore, PUFA class includes fatty acids such as &#x003b1;-linolenic acid (ALA; C18:3), linoleic acid (LA; C18:2) and further long-chain metabolites [<xref rid="B143-vaccines-08-00468" ref-type="bibr">143</xref>]. The number of carbon atoms and unsaturated bond position are used for the systematic nomenclature of FA. Moreover, the greek letters omega (&#x003c9;) and delta (&#x02206;) are included, to indicate how far a double bond is from the terminal methyl carbon and the presence and position of one or more double or triple bonds in the carbon backbone, respectively [<xref rid="B143-vaccines-08-00468" ref-type="bibr">143</xref>]. A further &#x0201c;&#x003c9;&#x0201d; or &#x0201c;n&#x0201d; classification designates the position of the first double bond in the skeleton from the end opposite to the carboxy group. Accordingly, oleic acid is classified as a &#x003c9;-9 (or n-9) fatty acid, while linoleic acid and <italic>&#x003b1;</italic>-linolenic acid are &#x003c9;-6 (or n-6) and &#x003c9;-3 (or n-3) fatty acids, as they contain the double bond nine, six and three carbons from the methyl end [<xref rid="B143-vaccines-08-00468" ref-type="bibr">143</xref>]. Nomenclature of the major representative fatty acids in the different FA classes is displayed in <xref rid="vaccines-08-00468-t003" ref-type="table">Table 3</xref>.</p><p>Unsaturated fatty acids can be characterized on the basis of the <italic>cis-</italic> or <italic>trans-</italic> orientation of the double bonds. Usually, natural fatty acids carry a <italic>cis-</italic> configuration, although some <italic>trans-</italic>fatty acids can also occur in foods as a consequence of the hydrogenation process, which can move double bonds from their naturally occurring position to a <italic>trans-</italic>configuration [<xref rid="B143-vaccines-08-00468" ref-type="bibr">143</xref>]. Trans-fatty acids are considered undesirable compounds in foods, as their intake is associated with an increased risk of cardiovascular and metabolic diseases [<xref rid="B145-vaccines-08-00468" ref-type="bibr">145</xref>]. </p><p>PUFA can be further classified depending on the relative positions of the double bonds, as conjugated (double-bonded carbon atoms alternate with single bonds) and unconjugated (double bonds separated by one or more single bonds) [<xref rid="B143-vaccines-08-00468" ref-type="bibr">143</xref>]. Unconjugated PUFA, especially &#x003c9;-3, &#x003c9;-6, and &#x003c9;-9 series, are the most occurring in nature. The most common conjugated PUFA are trienes, such as octadecatrienoic acids (e.g., punic acid, calendic acid). </p><p>Fatty acids within the series are biosynthetically related, being synthesized through enzymatic processes of desaturation, chain elongation, and chain shortening [<xref rid="B146-vaccines-08-00468" ref-type="bibr">146</xref>]. Particularly, the biosynthesis of &#x003c9;-3 and &#x003c9;-6 PUFA starts from &#x003b1;-linolenic acid (ALA or linolenate; 9,12,15&#x02013;18:2) and linoleic acid (LA or linoleate; 9,12&#x02013;18:2), respectively (<xref ref-type="fig" rid="vaccines-08-00468-f006">Figure 6</xref>). </p><p>These precursors cannot be synthetized by mammals, which lack the &#x02206;12 and &#x02206;15 desaturases responsible for the convertion of 18:1 &#x003c9;-9 FA to 18:2 &#x003c9;-6 and 18:3 &#x003c9;-3 PUFA, and must be supplied by the diet, thus being considered as essential fatty acids. </p><p>The initial rate-limiting step for the biosynthesis of &#x003c9;3 and &#x003c9;6 fatty acids is the insertion of a further double bond at the &#x02206;6 carbon into the carbon chain of ALA and LA, through the help of a &#x02206;6 desaturase enzyme: stearidonic acid (SA; 6,9,12,15&#x02013;18:4) and &#x003b3;-linolenic acid (GLA; 6,9,12&#x02013;18:3) are formed, respectively. These compounds are converted to eicosatetraenoic acid (ETA; 2,4,6,8&#x02013;20:4) and dihomo &#x003b3;-linolenic acid (DGLA; 8,11,14&#x02013;20:3) by the elongase 5, being further converted to eicosapentaenoic acid (EPA; 2,4,6,8,10&#x02013;20:5) and arachidonic acid (AA; 5,8,11,14&#x02013;20:4), by the addition of a double bond at the &#x02206;5 position, through a &#x02206;5 desaturase. Further elongations convert EPA and AA to docosapentaenoic acid (2,4,6,8,10&#x02013;22:5) and adrenic acid (7,10,13,16&#x02013;22:4); then, a desaturation by &#x02206;6 desaturase generates docosahexaenoic acid (DHA; 4,7,10,13,16,19&#x02013;22:6) [<xref rid="B146-vaccines-08-00468" ref-type="bibr">146</xref>]. Both series of fatty acids can be further metabolized by cyclooxygenase and lipoxygenase enzymes, to obtain eicosanoids, including prostaglandins, thromboxanes and leukotrienes, acting as central modulators of the inflammatory process [<xref rid="B146-vaccines-08-00468" ref-type="bibr">146</xref>]. </p><p>The byosynthetic pathways of &#x003c9;3 and &#x003c9;6 fatty acids are interconnected; indeed, it is known that long-chain derivatives from linolenic acid are accumulated in tissue only slightly when competing &#x003c9;6 analogues exceed their amounts. Therefore, suitable levels can be reasonably obtained through diet and when an optimum ratio of &#x003c9;3 and &#x003c9;6 series is maintained. </p></sec><sec id="sec3dot2-vaccines-08-00468"><title>3.2. Natural Occurrence</title><p>Fatty acids occur widely in nature, being identified in both animal tissue and plants. Particularly, short-chain saturated acids are components of milk fats: in bovine milk, butanoic acid along with other SCFA and MCFA have been reported [<xref rid="B147-vaccines-08-00468" ref-type="bibr">147</xref>]. Likewise, the MCFA lauric acid and myristic acid are the major components of the oils obtained from some Lauraceae and Myristiceae species [<xref rid="B148-vaccines-08-00468" ref-type="bibr">148</xref>]. Moreover, palmitic acid is the most representative SFA in vegetable oils, such as palm oil [<xref rid="B149-vaccines-08-00468" ref-type="bibr">149</xref>]. </p><p>Fatty acids with immune modulating properties mainly belong to the long-chain classes; among them, punicic acid is a peculiar conjugated triene, found to be a unique component of pomegranate seed oil [<xref rid="B150-vaccines-08-00468" ref-type="bibr">150</xref>], while oleic acid is one of the most widely distributed fatty acids: it represents 49% to 83% of total FA in olive oil, although it does occur in high amounts in other oils, such as those from grape seeds, canola and sufflower [<xref rid="B151-vaccines-08-00468" ref-type="bibr">151</xref>,<xref rid="B152-vaccines-08-00468" ref-type="bibr">152</xref>]. </p><p>Moreover, &#x003c9;3 and &#x003c9;6 fatty acids have been highlighted in several natural sources, wherein both series co-occur (<xref rid="vaccines-08-00468-t004" ref-type="table">Table 4</xref>), although in different amounts [<xref rid="B153-vaccines-08-00468" ref-type="bibr">153</xref>]. </p><p>Some vegetable oils, including rapseed, hemp seed, and sunflower oils, contain higher levels of LA (essential &#x003c9;6 PUFA), while ALA (essential &#x003c9;3 PUFA) is in lower proportion; a similar trend has also been reported for soybean, corn, and for dried black walnuts and brazilnuts; conversely, higher amounts of ALA respect to LA are reported in flaxseed oil and in the seeds of chia and perilla [<xref rid="B153-vaccines-08-00468" ref-type="bibr">153</xref>]. Likewise, green leafy vegetables seem to be an interesting source of ALA [<xref rid="B163-vaccines-08-00468" ref-type="bibr">163</xref>]. Fish oils are also sources of both EPA and DHA (&#x003c9;3 PUFA), with lower amounts of DPA (&#x003c9;6 PUFA) [<xref rid="B153-vaccines-08-00468" ref-type="bibr">153</xref>]. </p><p>Wild marine species showed to contain higher &#x003c9;3 PUFA levels compared to farmed ones, likely due to the feed composition [<xref rid="B153-vaccines-08-00468" ref-type="bibr">153</xref>]. Some vegetables can supply both the essential PUFA and some derivative fatty acids. Particularly, the oils obtained from the seeds of <italic>Borago</italic> spp., <italic>Echium</italic> spp., <italic>Ranunculus</italic> spp. and <italic>Oenothera biennis</italic> L. have been reported to contain high levels of both LA and &#x003b3;-linolenic acid (GLA) [<xref rid="B159-vaccines-08-00468" ref-type="bibr">159</xref>,<xref rid="B160-vaccines-08-00468" ref-type="bibr">160</xref>].</p></sec><sec id="sec3dot3-vaccines-08-00468"><title>3.3. Pharmacological Properties: Preclinical Evidence</title><p>Fatty acids play energetic, metabolic, and structural functions, being the main component of phospholipids, triglycerides, diglycerides and monoglycerides. A separate category is represented by SCFA, which act as metabolites of carbohydrates, produced by gut microbiota: their role in the modulation of immune function is described in <xref ref-type="sec" rid="sec2dot3-vaccines-08-00468">Section 2.3</xref>.</p><p>Long-chain fatty acids have been found involved in immune modulation, being able to affect both innate and adaptive response. Although specific profiles characterize each class of fatty acids, these effects are mainly ascribed to their ability to target the cell membrane, where they can be incorporated, thus changing membrane composition and fluidity and modulating membrane-protein interaction and signal transduction. Furthermore, a role in the control of inflammation has been reported. Epithelial growth factor receptors (a critical crossroad of multiple receptor pathways which is potentially implicated in the regulation of proliferation and possibly involved in atherogenesis) are considered possible targets for unsaturated fatty acids [<xref rid="B164-vaccines-08-00468" ref-type="bibr">164</xref>].</p><p>MUFA, especially oleic acid, have attracted great attention in the years as possible immunomodulating nutrients. Preclinical studies demonstrated the ability of oleic acid to modulate the immune system, through affecting both innate and adaptive immunity response [<xref rid="B164-vaccines-08-00468" ref-type="bibr">164</xref>]. Indeed, it diminished NK cell activity [<xref rid="B165-vaccines-08-00468" ref-type="bibr">165</xref>] and the expression of the leucocyte adhesion molecules, which have shown to be implicated in some pathophysiological conditions, such as rheumatoid arthritis [<xref rid="B165-vaccines-08-00468" ref-type="bibr">165</xref>]. Furthermore, it enhanced neutrophil aggregation and neutrophil-endothelial cell attachment, phagocytic and candidacidal capacities [<xref rid="B166-vaccines-08-00468" ref-type="bibr">166</xref>,<xref rid="B167-vaccines-08-00468" ref-type="bibr">167</xref>]. </p><p>In regard to adaptive response, it inhibited the proliferation of immune cells, such as Jurkat T cells and lymphocytes, likely through the regulation of the cell cycle, although the true mechanisms remain to be clarified [<xref rid="B164-vaccines-08-00468" ref-type="bibr">164</xref>]. Similar suppressive effects were also highlighted for its synthetic analogue minerval and confirmed in animal models [<xref rid="B164-vaccines-08-00468" ref-type="bibr">164</xref>,<xref rid="B168-vaccines-08-00468" ref-type="bibr">168</xref>]. Furthermore, the treatment with oleic acid and minerval induced proapoptotic effects in Jurkat (T lymphocyte) and Raji (B lymphocyte) cells, likely due to mitochondrial depolarization and ROS production [<xref rid="B168-vaccines-08-00468" ref-type="bibr">168</xref>,<xref rid="B169-vaccines-08-00468" ref-type="bibr">169</xref>,<xref rid="B170-vaccines-08-00468" ref-type="bibr">170</xref>]. </p><p>Recently, oleate has been reported to be able to protect macrophages from palmitate-induced lipotoxicity; moreover, it has been associated with an increase in the regulatory phenotype of the myeloid MSC-2 suppressor cells and suppression of activated T cells [<xref rid="B171-vaccines-08-00468" ref-type="bibr">171</xref>,<xref rid="B172-vaccines-08-00468" ref-type="bibr">172</xref>]. In the skin, oleic acid, along with other unsaturated FA, seems to be incorporated into the lipid moiety of <italic>Staphylococcus aureus</italic> Lpp, inducing an immune response against the pathogen [<xref rid="B173-vaccines-08-00468" ref-type="bibr">173</xref>]. </p><p>Regarding conjugated PUFA, punicic acid has been shown to improve the immune system development, stimulate the CD4+ and CD8+ lymphocyte-mediated immunity and increase the immune response against viruses [<xref rid="B174-vaccines-08-00468" ref-type="bibr">174</xref>]. These immune boosting effects are due to nuclear peroxisome proliferator-activated receptor (PPAR)&#x003b3;- and &#x003b4;-dependent mechanisms, as punicic acid is able to act as an agonist of these receptors; in support, the loss of PPAR&#x003b3; in immune cells impaired its effects [<xref rid="B174-vaccines-08-00468" ref-type="bibr">174</xref>,<xref rid="B175-vaccines-08-00468" ref-type="bibr">175</xref>]. Moreover, punicic acid inhibited the TNF-&#x003b1;-induced priming of ROS production by inhibiting the Ser345-p47phox phosphorylation and upstreaming kinase p38MAPK; likewise, it blocked the TNF-&#x003b1;-induced release of myeloperoxidase from neutrophils, and decreased neutrophil-activation and ROS/MPO-mediated tissue damage <italic>in vivo</italic> [<xref rid="B176-vaccines-08-00468" ref-type="bibr">176</xref>]. Antinflammatory properties were found to be related to the activation of PPAR&#x003b3; and the suppressed expression of inflammatory genes (encoding cytokines, chemokines, cyclooxygenase, NO synthase, and metalloproteinases) [<xref rid="B150-vaccines-08-00468" ref-type="bibr">150</xref>].</p><p>Immunomodulatory properties of &#x003c9;-6 and &#x003c9;-3 PUFA have been highlighted in different preclinical models and have been associated with their ability to modulate the inflammatory process [<xref rid="B177-vaccines-08-00468" ref-type="bibr">177</xref>]. These fatty acids share common biosynthetic enzymes which mediate the production of different series of eicosanoids, starting from typical precursors, including dihomo-&#x003b3;-linoleic acid (DGLA), arachidonic acid (AA) and eicosapentaenoic acid (EPA). Among prostanoids, three types of prostaglandins (PG), including PG1, PG2 and PG3, can be obtained. PG1 is associated with beneficial effects and lower inflammation, thus being considered as an antinflammatory prostanoid; conversely, PG2 has opposite behaviour, increasing inflammation, vasoconstriction and blood clotting. PG3 acts through a mixture of functions and is able to reduce the PG2-mediated inflammation [<xref rid="B177-vaccines-08-00468" ref-type="bibr">177</xref>].</p><p>Starting from DGLA, both anti-inflammatory PG1 and pro-inflammatory PG2, through the conversion into arachidonic acid, can be produced (<xref ref-type="fig" rid="vaccines-08-00468-f007">Figure 7</xref>). </p><p>This synthesis is controlled by the activity of &#x00394;5-desaturase and &#x00394;6-desaturase enzymes, which are often compromised during inflammatory conditions and diseases. It has been found that diets enriched in &#x003c9;-3 fatty acids are able to activate the conversion of DGLA into PG1, whereas low &#x003c9;-3 intake induces the conversion in AA with the synthesis of proinflammatory prostanoids [<xref rid="B178-vaccines-08-00468" ref-type="bibr">178</xref>].</p><p>AA can also be released by the cell membranes through the action of phospholipase A2 during cell injuries or changes in biomembrane composition, thus representing a physiological activator of inflammation as a defence response. AA and eicosapentaenoic acid (EPA) compete for the synthesis of different series of PG, mediated by cyclooxigenase, while 5-lipooxygenase (LOX) is involved in their conversion into thromboxanes and leukotrienes. Particularly, tromboxane A2 and leukotriene B4 are produced from AA, while tromboxane A3 and leukotriene B5 from EPA. EPA and DHA are also precursors of lipoxins, resolvins and protectins, which produced anti-inflammatory effects and regulate vascular tone and blood pressure [<xref rid="B178-vaccines-08-00468" ref-type="bibr">178</xref>]. Like punicic acid, the anti-inflammatory effects of EPA and DHA are mediated by the activation of the PPAR&#x003b1;/&#x003b3; [<xref rid="B179-vaccines-08-00468" ref-type="bibr">179</xref>]. </p><p>Despite the antinflammatory role of &#x003c9;-3 and &#x003c9;-6-based diets, AA increases the plasmatic levels of proinflammatory eicosanoids, associated with an increased incidence of allergic and inflammatory disorders and with excessive cell proliferation. </p><p>Anyhow, it is not clear the usefulness to select &#x003c9;-3 with respect to &#x003c9;-6 in the diet: a balance between &#x003c9;-3 and &#x003c9;-6 PUFA seems to be essential for mantaining ahealth status.</p><p>The ability of fatty acids to be incorporated in the cell membrane seems to represent a key mechanism accounting for the immunomodulating properties of &#x003c9;-3 and &#x003c9;-6 PUFA. Indeed, immune cells (i.e., T cells and neutrophils) can incorporate exogenous fatty acids into membrane with a lateration in the function of cell surface pattern recognition receptors [<xref rid="B180-vaccines-08-00468" ref-type="bibr">180</xref>]. </p><p>Dietary &#x003c9;-3 PUFA has been shown able to modulate the macrophage function, through the activation of G protein coupled receptors (GPR) and to induce a shift to an anti-inflammatory phenotype [<xref rid="B49-vaccines-08-00468" ref-type="bibr">49</xref>]. Modulating signalings through the GPR receptor activation can also affect leukocyte function. Likewise, an inhibition of the pro-inflammatory phenotype of dendritic cells and of the T cell responses has been reported [<xref rid="B49-vaccines-08-00468" ref-type="bibr">49</xref>]. They are also able to inhibit neutrophil and monocyte adhesion, depending on the activation of PPAR-<italic>&#x003b1;</italic> [<xref rid="B49-vaccines-08-00468" ref-type="bibr">49</xref>]. </p><p>Conversely, &#x003c9;-6 PUFAs seem to promote inflammation, associated with incresead ROS levels, in neutrophils [<xref rid="B49-vaccines-08-00468" ref-type="bibr">49</xref>]. Particularly, linoleic acid increased the marginated pool of neutrophils in tissues by the induced expression of adhesion molecules; it also complexed with the anti-inflammatory molecule 1-antitrypsin, thus reducing LPS-induced IL-1 secretion in neutrophils [<xref rid="B49-vaccines-08-00468" ref-type="bibr">49</xref>]. On the whole, preclinical evidence highlighted that these fatty acids could increase neutrophil function, thus promoting innate immunity. </p><p>Regarding adaptive immunity, &#x003c9;-3 PUFA have been reported able to improve the mitogen-mediated activation of immune cells and to promote the development of a TH2-type immune response [<xref rid="B180-vaccines-08-00468" ref-type="bibr">180</xref>]. Moreover, an increased production of associated anti-inflammatory cytokines like IL-4, in spite of a reduction of pro-inflammatory TNF-&#x003b1;, was found [<xref rid="B180-vaccines-08-00468" ref-type="bibr">180</xref>]. Similar effects were highlighted with both fish oil-enriched diets and the purified EPA and DHA [<xref rid="B49-vaccines-08-00468" ref-type="bibr">49</xref>].</p><p>The beneficial influence of &#x003c9;-3 PUFA has been highlighted also on epithelial cells during inflammation, being able to restore impaired barrier function and reduce the production of pro-inflammatory mediators [<xref rid="B49-vaccines-08-00468" ref-type="bibr">49</xref>]. Moreover, a strictly interplay between omega-3 fatty acids, immunity and gut microbiota has been reported and seems to be an essential factor to maintain the intestinal wall integrity. These effects have been ascribed to the ability of &#x003c9;-3 PUFA to positively affect the microbiota composition and increase the production of anti-inflammatory compounds, like short-chain fatty acids [<xref rid="B181-vaccines-08-00468" ref-type="bibr">181</xref>]. </p><p>Although a major interest over the years has been focused on marine sources of &#x003c9;-3-enriched oils or on pure compounds, some plant species have been studied for their immunomodulating and anti-inflammatory properties, likely ascribable to &#x003c9;-3 and/or &#x003c9;-6 PUFA, although the major evidence has been highlighted for <italic>Linum usitatissimun</italic> L., <italic>Oenothera biennis</italic> L. and <italic>Borago officinalis</italic> L. [<xref rid="B160-vaccines-08-00468" ref-type="bibr">160</xref>,<xref rid="B182-vaccines-08-00468" ref-type="bibr">182</xref>,<xref rid="B183-vaccines-08-00468" ref-type="bibr">183</xref>].</p><p>The seed oil from <italic>L. usitatissimum</italic>, also known as flaxseed oil, has been reported to induce immunomodulating effects, likely through suppressing cell mediated immunity, without the involvement of humoral immunity. Being a rich source of ALA, its effects are mainly ascribed to this compound, although further studies suggested a possible contribution of bioactive phenolics [<xref rid="B184-vaccines-08-00468" ref-type="bibr">184</xref>]. Flaxseed oil was found to be effective in reducing skin inflammatory responses, although with a lower immunosuppressive power with respect to fish oil [<xref rid="B185-vaccines-08-00468" ref-type="bibr">185</xref>]. Moreover, it improved systemic and gut immunity, in a piglet model with intrauterine growth retardation: increased plasma concentration of immunoglobulin G, decreased CD3+CD8+ T lymphocytes, and the downregulation of genes expression for proinflammatory factors have been reported [<xref rid="B186-vaccines-08-00468" ref-type="bibr">186</xref>].</p><p>Regarding <italic>O. biennis</italic>, the administration of the seed oil (namely, evening primrose oil) in animal models enhanced PGE1 synthesis in peritoneal macrophages, decreased PGE2 amounts in granulocytes, and suppressed the natural killer (NK) cell activity and lymphocyte proliferation; moreover, it decreased the serum levels of interferon &#x003b3; (IFN-&#x003b3;) and MCP-1, while stimulating TNF-&#x003b1; [<xref rid="B187-vaccines-08-00468" ref-type="bibr">187</xref>,<xref rid="B188-vaccines-08-00468" ref-type="bibr">188</xref>,<xref rid="B189-vaccines-08-00468" ref-type="bibr">189</xref>,<xref rid="B190-vaccines-08-00468" ref-type="bibr">190</xref>,<xref rid="B191-vaccines-08-00468" ref-type="bibr">191</xref>]. Furthermore, anti-inflammatory effects have been found to be involved in the immunomodulation by evening primrose oil [<xref rid="B160-vaccines-08-00468" ref-type="bibr">160</xref>]. </p><p>These effects were ascribed to the content of GLA, whose T-regulatory cell activity in autoimmune disease models was highlighted [<xref rid="B192-vaccines-08-00468" ref-type="bibr">192</xref>]. However, a contribution of LA to the antinflammatory effects seems to be likely; indeed, LA can itself modulate inflammation as it is metabolized by LOX to hydroxyoctadecadienoic acids (HODEs) and oxo-HODEs, characterized by antinflammatory properties [<xref rid="B193-vaccines-08-00468" ref-type="bibr">193</xref>]. </p><p>Similarly, the seed oil from <italic>B. officinalis</italic> seeds produced immonomodulating and antinflammatory effects, likely through its GLA content [<xref rid="B183-vaccines-08-00468" ref-type="bibr">183</xref>]. A chemotactic migration of monocytes to necrotic site that differentiate into macrophages is associated with the administration of this product. Moreover, it is known to reduce the levels of proinflammatory cytokines, such as TNF-&#x003b1;, and to promote PGE1 generation; a reduced expression of inflammatory genes, especially those of macrophages involved in atherosclerosis, has been reported too [<xref rid="B183-vaccines-08-00468" ref-type="bibr">183</xref>,<xref rid="B184-vaccines-08-00468" ref-type="bibr">184</xref>,<xref rid="B185-vaccines-08-00468" ref-type="bibr">185</xref>,<xref rid="B186-vaccines-08-00468" ref-type="bibr">186</xref>,<xref rid="B187-vaccines-08-00468" ref-type="bibr">187</xref>,<xref rid="B188-vaccines-08-00468" ref-type="bibr">188</xref>,<xref rid="B189-vaccines-08-00468" ref-type="bibr">189</xref>,<xref rid="B190-vaccines-08-00468" ref-type="bibr">190</xref>,<xref rid="B191-vaccines-08-00468" ref-type="bibr">191</xref>,<xref rid="B192-vaccines-08-00468" ref-type="bibr">192</xref>,<xref rid="B193-vaccines-08-00468" ref-type="bibr">193</xref>,<xref rid="B194-vaccines-08-00468" ref-type="bibr">194</xref>]. </p></sec><sec id="sec3dot4-vaccines-08-00468"><title>3.4. Clinical Studies</title><p>Clinical studies mainly focused on the effects of fatty acid-enriched diet on inflammation, although specific immune-based pathological conditions associated with inflammation were assessed too. Regarding MUFA, few studies are available, and results differ from those in animal models. Indeed, a MUFA-rich diet (with highly refined olive oil for 8 weeks) did not alter the immune function in healthy subjects; such effects could be due to the high amounts administered in animal models [<xref rid="B164-vaccines-08-00468" ref-type="bibr">164</xref>]. Conversely, clinical evidence about the immunomodulatory power of punicic acid in healthy or sick subjects is lacking [<xref rid="B150-vaccines-08-00468" ref-type="bibr">150</xref>].</p><p>The &#x003c9;-3 PUFA series and the relative enriched fish oils have been mainly evaluated for their immunomodulating and antinflammatory effects in humans. Although preclinical evidence highlighted their ability to influence both innate and adaptive immunity, the clinical relevance of these results remains to be clarified, due to lacking or inconclusive data [<xref rid="B49-vaccines-08-00468" ref-type="bibr">49</xref>]. </p><p>Inadequacy of clinical results should be due to the different doses used in preclinical studies, wherein often high fatty acids levels were administered; moreover, other factors such as genetic and epigenetic heterogeneity of the recruited subjects, diet diversity, nutritional habits and microbiome can be considered as additional confounding factors [<xref rid="B49-vaccines-08-00468" ref-type="bibr">49</xref>]. </p><p>Although limitations of clinical studies require further confirmation, &#x003c9;-3 PUFA intake produced significant clinical benefits and reduction of the symptoms in patients with autoimmune disorders, especially rheumatic diseases and systemic lupus erythematosus [<xref rid="B195-vaccines-08-00468" ref-type="bibr">195</xref>,<xref rid="B196-vaccines-08-00468" ref-type="bibr">196</xref>,<xref rid="B197-vaccines-08-00468" ref-type="bibr">197</xref>]. In support, low levels of PUFAs have been found in the serum of patients with rheumatic diseases [<xref rid="B198-vaccines-08-00468" ref-type="bibr">198</xref>]. Conversely, inconsistent results are reported for multiple sclerosis, thus the possible usefulness of these fatty acids as supportive therapy requires more clinical trials [<xref rid="B199-vaccines-08-00468" ref-type="bibr">199</xref>]. </p><p>Regarding &#x003c9;-6 PUFA, although they are associated with possible increased inflammatory conditions, being arachidonic acid a presursor of proinflammatory prostanoids, such a risk is not confirmed by clinical evidence [<xref rid="B200-vaccines-08-00468" ref-type="bibr">200</xref>]. Indeed, studies in healthy human adults highlighted that an increased intake of these fatty acids did not induce inflammation; conversely, epidemiological evidence reported reduced inflammatory conditions [<xref rid="B200-vaccines-08-00468" ref-type="bibr">200</xref>]. The antinflammatory effects of LA have been reported too [<xref rid="B193-vaccines-08-00468" ref-type="bibr">193</xref>]. Similarly, increased LA intake was found to be not related to increased amounts of ARA and proinflammatory factors; however, an inverse correlation with EPA and DHA was reported [<xref rid="B201-vaccines-08-00468" ref-type="bibr">201</xref>]. This suggests that the interaction between &#x003c9;-e and &#x003c9;-6 series is regulated by complex mechanisms that requires further clarifications.</p><p>Major clinical studies have been performed using evening primrose oil (from the seeds of <italic>O. biennis</italic>), as a source of LA and GLA, in inflammatory diseases associated with immune system disorders, including atopic dermatitis, psoriasis, multiple sclerosis and rheumatoid arthritis. Standardized oils for the content in LA and ALA (for instance, Efamol is titred to contain 72% LA and 9% GLA) were usually used [<xref rid="B202-vaccines-08-00468" ref-type="bibr">202</xref>]. </p><p>The treatment with evening primrose oil (4 and 7 weeks) produced clinical improvements in patients with atopic dermatitis, as revealed by measuring the SCORing atopic dermatitis [<xref rid="B203-vaccines-08-00468" ref-type="bibr">203</xref>]. Some beneficial effects were also reported in multiple schlerosis patients, although the few available studies limited the evidence in this disorder. </p><p>Conversely, evening primrose oil in combination with fish oil and vitamin E (Efamol Marine) failed to improve the symptoms of psoriasiac patients but produced antinflammatory effects [<xref rid="B204-vaccines-08-00468" ref-type="bibr">204</xref>]. Similarly, in association with &#x003c9;-3 fatty acids, it did not induce improvements in patients with rheumatoid arthritis [<xref rid="B205-vaccines-08-00468" ref-type="bibr">205</xref>]. A Cochrane revision highlighted moderate evidence for oils containing GLA (i.e., evening primrose, borage, or blackcurrant seed oil) to produce benefit in rheumatoid arthritis [<xref rid="B205-vaccines-08-00468" ref-type="bibr">205</xref>,<xref rid="B206-vaccines-08-00468" ref-type="bibr">206</xref>]. Evening primrose oil along with borage oil were not effective to treat eczema too [<xref rid="B207-vaccines-08-00468" ref-type="bibr">207</xref>]. Highly variable results were also obtained for borage oil in the treatment of atopic dermatitis, although, in all the studies, a moderate efficacy degree was displayed [<xref rid="B208-vaccines-08-00468" ref-type="bibr">208</xref>]. </p><p>Regarding flaxseed oils, some clinical trials higlighted a significant improvement of inflammatory parameters in subjects with cardiovascular diseases non-associated with the immune system [<xref rid="B209-vaccines-08-00468" ref-type="bibr">209</xref>].</p><p>Reported studies, although performed in pathological conditions associated with immune system disfunction, did not give a direct measure of the immunomodulatory effects of the treatments. Furthermore, specific and high-quality studies are required for better characterizing the possible usefuleness of these PUFA-enriched oils as anti-inflammatory and immunomodulating treatments.</p></sec></sec><sec id="sec4-vaccines-08-00468"><title>4. Labdane Diterpenes</title><sec id="sec4dot1-vaccines-08-00468"><title>4.1. Chemical Features</title><p>Labdane compounds have a molecular formula C<sub>20</sub>H<sub>38</sub> with an average mass of 278.516 Da (<xref ref-type="fig" rid="vaccines-08-00468-f008">Figure 8</xref>). Labdane-related molecules have a hydrocarbon skeleton, originated from dual biosynthetic cyclization and/or rearrangement reactions, produced through the biosynthetic pathway of gibberellin phytohormones by the diterpene cyclases. The labane diterpenoids belong to a superfamily of natural products, in which the hydrocarbon skeleton might serve as privileged scaffolds for their biological activity [<xref rid="B210-vaccines-08-00468" ref-type="bibr">210</xref>].</p></sec><sec id="sec4dot2-vaccines-08-00468"><title>4.2. Natural Occurrence</title><p>Labdane diterpenes have been found in the various matrix of vegetal origin (leaves, rizomes, fruits, etc.) of different plants. In <xref rid="vaccines-08-00468-t001" ref-type="table">Table 1</xref>, some of them (where diterpenes have been found), their botanical family (in parentheses) and the part of plant of biological interest are reported. </p><p>Some labdane diterpenoids, isolated from plant matrix, include the following: andrographolide (<xref ref-type="fig" rid="vaccines-08-00468-f009">Figure 9</xref>) (from <italic>Andrographis paniculata</italic> (Burm.f.) Nees) [<xref rid="B211-vaccines-08-00468" ref-type="bibr">211</xref>], labda-8(17), 12-diene-15, 16-dial (from <italic>Curcuma amada</italic> Roxb) [<xref rid="B212-vaccines-08-00468" ref-type="bibr">212</xref>], podoimbricatin C (a 12,17-cyclo-labdane diterpenoid from <italic>Dacrycarpus imbricatus</italic> (Blume) de Laub) [<xref rid="B213-vaccines-08-00468" ref-type="bibr">213</xref>] chapecoderins A-C (from <italic>Echinodorus macrophyllus</italic> (Kunth) Micheli), [<xref rid="B214-vaccines-08-00468" ref-type="bibr">214</xref>], (4R,5S,9S,10R)-13-des-ethyl-13-oxolabda-8(17),11E-dien-19-oic acid (from <italic>Juniperus oblonga</italic> M. Bieb) [<xref rid="B215-vaccines-08-00468" ref-type="bibr">215</xref>], leoheteronin D and leojaponin A (from <italic>Leonurus japonicus</italic> Houtt) [<xref rid="B216-vaccines-08-00468" ref-type="bibr">216</xref>], marrubasch A-F and marrubenol (from <italic>Marrubium aschersonii</italic> P.Magnus), marrulibanoside (from <italic>Marrubium globosum</italic> Boiss. and Balansa) [<xref rid="B217-vaccines-08-00468" ref-type="bibr">217</xref>], vitexlimolides A&#x02013;C (from <italic>Vitex limonifolia</italic> Wall. ex C.B. Clarke) [<xref rid="B218-vaccines-08-00468" ref-type="bibr">218</xref>].</p></sec><sec id="sec4dot3-vaccines-08-00468"><title>4.3. Pharmacological Properties: Preclinical Studies</title><p>The body&#x02019;s defense responses can be improved through various properties induced by plants. Some of them, referring to the plants in <xref rid="vaccines-08-00468-t005" ref-type="table">Table 5</xref>, are shown below. For each plants and plant-derived nutraceutical, only properties potentially attributable to the labdane skeleton and useful to improve the immune system are reported. </p><p>As both inflammation (biological response of body tissues to harmful stimuli) and oxidative stress (imbalance between reactive oxygen species and a biological system&#x02019;s ability to detoxify/repair the resulting damage of the reactive intermediates) are the main self-defend methods to eliminate pathogens and protect living bodies, plants with antinflammatory and/or radical scavenger properties are considered too [<xref rid="B211-vaccines-08-00468" ref-type="bibr">211</xref>]. Indeed, labdane diterpenoids have recently gained greater attention from the scientific point of view, due to a wide range of biological activities, including the anti-inflammatory modulation of immune cell functions [<xref rid="B217-vaccines-08-00468" ref-type="bibr">217</xref>].</p><p><italic>A. paniculata</italic> exhibited, <italic>in vitro</italic> and <italic>in vivo</italic>, various pharmacological activities, including antihyperglycemic, antiplatelet aggregation, anti-microbial, anti-inflammatory, anti-HIV, anti-cancer, anti-nociceptive activity, etc. It has also been used for autoimmune encephalomyelitis and, in Indian and Chinese medicine, for respiratory tract infections [<xref rid="B217-vaccines-08-00468" ref-type="bibr">217</xref>,<xref rid="B219-vaccines-08-00468" ref-type="bibr">219</xref>]. </p><p>More recently, <italic>A. paniculata</italic> has been used to stimulate the immune system and treat myocardial ischemia [<xref rid="B211-vaccines-08-00468" ref-type="bibr">211</xref>]. <italic>A. paniculata</italic> inhibited interleukin (IL)-6, TNF-&#x003b1; mRNA, LPS-induced expression, and suppressed levels of TNF-&#x003b1;, IL-1&#x003b2;, JNK, C-reactive protein, and NF-&#x003ba;B [<xref rid="B211-vaccines-08-00468" ref-type="bibr">211</xref>]. Many labdane diterpenoids compounds have been found to act on the latter. The activation of the NF-&#x003ba;B pathway leads to several physiological responses, including inflammatory or innate immune response [<xref rid="B217-vaccines-08-00468" ref-type="bibr">217</xref>]. </p><p><italic>In vitro</italic>, andrographolide (the main phytoconstituent of <italic>A. paniculata</italic>) can inhibit inflammation, by regulating protein expression (cytokines, chemokines) and by reducing immune cell infiltration. Andrographolide was shown to inhibit also oxidative stress by binding to adenosine A2A receptor, by inducing nuclear factor (erthroid-derived 2)-like 2 (Nrf2) translocation, and by increasing the expression of superoxide dismutase, catalase, glutathione reductase, glutathione peroxidase-2 [<xref rid="B211-vaccines-08-00468" ref-type="bibr">211</xref>]. These effects can contribute to the immunoregulatory activity of this plant-derived nutraceutical, as it can modulate the innate and adaptive immune responses by regulating macrophage phenotypic polarization and antibody productions [<xref rid="B25-vaccines-08-00468" ref-type="bibr">25</xref>]. Moreover, it was found to exert cytotoxic/anticancer effects on almost all types of tumour cell lines (human leukemia, renal tubular epithelial cells, breast cancer cells, etc.), mainly by cell cycle arrest, autophagy, cell death, anti-inflammatory and immune system mediated effects [<xref rid="B220-vaccines-08-00468" ref-type="bibr">220</xref>].</p><p>Other preclinical studies have highlighted pharmacological properties of labdane diterpenoids-containing plants. Data are limited, and consequently also their preclinical evidence. Some examples are reported below.</p><p><italic>C. amada</italic>, also known as mango ginger, and its labdane-diterpenoids have shown antiflammatory, antibacterial, insecticidal, antifungal, antipyretic, antioxidant, anticancer, and antitubercolar properties in preclinical trials [<xref rid="B212-vaccines-08-00468" ref-type="bibr">212</xref>].</p><p><italic>D. imbricatus</italic> displayed cytotoxic and anti-neuroinflammatory activities, but it had no cytotoxic activity against human tumour cell lines [<xref rid="B213-vaccines-08-00468" ref-type="bibr">213</xref>].</p><p><italic>E. macrophyllus</italic>, Brazilian plant, also known as &#x0201c;leather hat&#x0201d;, is used as a methanolic (which contains mainly labane diterpenoids, steroids, alcaloids, etc.) or aqueous extract (rich in flavonoids) of the aerial parts, leaves in particular. In folk medicine, <italic>E. macrophyllus</italic> is used for various illnesses (respiratoy and urinary diseases, rheumatoid arthritis, atherosclerosis, etc.), as it has been shown to possess tissues protective activity and immunosuppressive effects (impaired secretion and function of B and/or T cells), on humoral or cellular immune responses and on autoimmune rheumatic diseases [<xref rid="B221-vaccines-08-00468" ref-type="bibr">221</xref>]. </p><p>In <italic>in vitro/vivo</italic> studies, the aqueous extract of <italic>E. macrophyllus</italic> exhibited strong antinflammatory activities by decreasing rats paw edema, inflammatory exudates, infiltrate tissues, NO production, LTB4 release, and neutrophil migration [<xref rid="B222-vaccines-08-00468" ref-type="bibr">222</xref>]. In preclinical studies, the methanolic extract of <italic>E. macrophyllus</italic> was not cytotoxic, genotoxic, mutagenic, and no acute toxicity (up to the maximum dose of 2000 mg/kg b.w.) has been observed in tested animals [<xref rid="B221-vaccines-08-00468" ref-type="bibr">221</xref>]. However, the extrapolation of animal experiments to clinical practice must be done with caution [<xref rid="B223-vaccines-08-00468" ref-type="bibr">223</xref>].</p><p>Compounds from <italic>J. oblonga</italic> have shown anti-tumor effects, through moderate cytotoxicity against human tumor cell lines obtained from various human tissues, including: hepatocellular carcinoma (HepG2), breast cancer (MCF-7), and cervical carcinoma cancer (HeLa) [<xref rid="B215-vaccines-08-00468" ref-type="bibr">215</xref>]. The berries from <italic>J. oblonga</italic> also have antimicrobial activity and anti-inflammatory effects. </p><p>Labdane diterpenoid (e.g., leonurine), extracted from <italic>L. japonicus</italic>, exhibited cytotoxicity and cell cicle arrest against cancer cell lines and presented immunomodulatory and antinflammatory activities (suppresses TNF-<italic>&#x003b1;</italic>, NF-&#x003ba;B, and down-regulated expression of iNOS, COX2, and conseguently PEG2 and NO levels) [<xref rid="B216-vaccines-08-00468" ref-type="bibr">216</xref>].</p><p><italic>Marrubium</italic> spp. (<italic>aschersonii</italic>, <italic>globosum</italic>, etc.) have multiple actions, including antimicrobial and anti-inflammatory activities. Marrubasch A-F and marrubenol, isolated from the ethanolic extract of <italic>M. aschersonii</italic>, exhibited weak reduction in iNOS activity and, consequentely, NO production [<xref rid="B217-vaccines-08-00468" ref-type="bibr">217</xref>]. Marrulibanoside, obtained from the aerial parts of <italic>M. globosum</italic>, inhibited catalytic activity of iNOS and COX-2enzymes, and consequentely, the PEG2 and NO production.</p><p><italic>V. limonifolia</italic>, in preclinical trial, have shown a strong antiviral activity against coxsackievirus B3, human rhinovirus 1B, and enterovirus 71 (EV71). All of them could be responsible for various illnesses, ranging from common cold, hand, foot, and mouth diseases, to acute flaccid paralysis [<xref rid="B218-vaccines-08-00468" ref-type="bibr">218</xref>].</p></sec><sec id="sec4dot4-vaccines-08-00468"><title>4.4. Clinical Studies</title><p>The clinical efficacy of the medicinal plants, and plant-derived nutraceuticals discussed above are almost totally lacking. Only for <italic>A. paniculata</italic> there are some evidence in humans. </p><p>Andrographis extract (various and not standardized), andrographolide, and its derivatives have been studied in the treatment of various disease (multiple sclerosis, infection disease, gastro-intestinal upsets, respiratory ailments, pain), and in the maintenance of immune function. In this last context, it seemed to improve the response to cough and sore throat, shortening the sick leave/time to resolution [<xref rid="B219-vaccines-08-00468" ref-type="bibr">219</xref>]. The most interesting activity is the increase of CD4+ lymphocyte levels, in HIV-positive patients [<xref rid="B211-vaccines-08-00468" ref-type="bibr">211</xref>]. The increase in these lymphocytes testifies an improvement in the state of the immune system. Moreover, a Chinese product containing andrographolide improved the efficacy of glucocorticoids and immunoglobulin in patients with severe hand, food, and mouth disease. </p><p>However, andrographolide is considered a hazard, as it is irritating, and its injectable use is limited because it could induce allergic reactions (erythema, pruritus, etc.), which are sometimes life-threatening [<xref rid="B211-vaccines-08-00468" ref-type="bibr">211</xref>]. </p><p>Preclinical data suggested that andrographolide could be responsible of pharmacokinetics interactions, as it induced CYP1A2 [<xref rid="B219-vaccines-08-00468" ref-type="bibr">219</xref>]. The European Medicines Agency (EMA) reports a possibility of causing reproductive toxicity of Andrographis extracts (decreases in sperm motility and counts) [<xref rid="B219-vaccines-08-00468" ref-type="bibr">219</xref>]. On the other hand, no major adverse effects have been reported for <italic>A. paniculata</italic>; only minor side effects, mainly gastrointestinal, are known [<xref rid="B219-vaccines-08-00468" ref-type="bibr">219</xref>]. </p><p>Notably, even if <italic>A. paniculata</italic> presents numerous pharmacological properties, andrographolide possess poor solubility (principally in DMSO), which severely limits the possibility of achieving a therapeutic effect (if not properly formulated). Its better absorption could be achieved by nano-formulations (e.g., nano-emulsion, nano-capsules).</p></sec></sec><sec id="sec5-vaccines-08-00468"><title>5. Further Research</title><p>Immunomodulation by plant-based nutraceuticals represents an interesting tool to be exploited for the treatment and preventing purposes of immune system disorders, due to their multiple bioactivities, well tolerability and good patient compliance. However, as often reported for several herbal medicinal products, some points require being underlined to improve the research in the field and provide solid evidence to support their rational use. </p><p>According to previous stated critical issues [<xref rid="B224-vaccines-08-00468" ref-type="bibr">224</xref>,<xref rid="B225-vaccines-08-00468" ref-type="bibr">225</xref>], herbal products under study must be characterized for the phytochemical composition, using validated analytical methodologies, and for the extraction procedures; moreover, the starting material should be fully defined in terms of origin (country and region), cultivation conditions, botanical identity and plant part. The content of specific compounds, used as analytical or active markers, should be determined too. These requirements are needed to ensure reproducible pharmacological/clinical activity and to compare different studies. Indeed, using nonstandardized phytocomplexes increases variability of the biological response, thus limiting the reliability and validity of the studies. </p><p>Furthermore, to assess the pharmacological activity of specific compounds, purity (at least 95%) and identity should be characterized. Indeed, when assessed as mixtures, the subtle interactions which can be established among phytochemicals make it difficult to understand whether the observed benefits are attributable to a specific class or to the whole phytocomplex. For instance, both fatty acids and polyphenols can be involved in the immunomodulating effects of PUFA-enriched plant oils. Moreover, as found for both polysaccharides and fatty acids, among the same class, different subclasses can co-occur, thus contributing to the whole effects. </p><p>Regarding preclinical studies, detailed methodologies, including information about specific extraction process, the choice of the tested concentrations and experimental procedures, vehicle effects, and comparison with standard effective compounds (positive controls) should be reported. </p><p>In order to validate the &#x0201c;goodness&#x0201d; of the treatment, promising results in preclinical studies should be confirmed by clinical evidence of efficacy and lack of toxicological concerns for both the isolated compounds and the whole phytocomplex. At last, possible interactions with diet constituents or possible pharmacological treatments, as reported for andrographolide, which is a CYP1A2 inducer, should be considered.</p><p>As highlighted for a number of natural products, clinical evidence is a major challenge for plant-based immunomodulating nutraceuticals too, due to limited specific studies.</p><p>Moreover, methodological quality of the available trials was overall poor, the studies often being not blinded, protocol unavailable and lacking the standardization of tested products, thus making the claimed effect difficult to be reproduced. </p><p>At last, standardized methodologies for systematic reviews and meta-analyses, such as the PRISMA guidelines [<xref rid="B226-vaccines-08-00468" ref-type="bibr">226</xref>], would allow a rational interpretation of the results and suggestions for future research.</p></sec><sec sec-type="conclusions" id="sec6-vaccines-08-00468"><title>6. Conclusions</title><p>Medicinal plants are rich sources of bioactive phytochemicals, characterized by multiple and often pleiotropic activities, which can be exploited both therapeutically and as nutraceutical strategies for preventive purposes. Among plant-based nutraceuticals, immunomodulators have been highlighted to be of interest as boosters of the immune system, to counteract infectious or exogenous injuries, immunosuppressor, to control the abnormal immune response occurring during autoimmune diseases, or as adjuvants, which contribute by modulating nonimmune targets. </p><p>In this review, we highlighted the scientific evidence about the immunomodulating properties of three emerging classes of nutraceuticals, including polysaccharides, fatty acids and labdane diterpenes. Some of them, especially polysaccharides and labdane diterpenes, act as immune system booster, while fatty acids (MUFA and PUFA) mainly act as immunosuppressor, although punicic acid (a conjugate PUFA) exhibited immunostimulant properties. To date, these products are mainly used as well-tolerated food supplements, although the clinical evidence about their modulation of the immune functions is still limited. More investigations of better quality and specificity could strengthen the validity of using these plant-derived nutraceuticals in the immune system modulation.</p></sec></body><back><ack><title>Acknowledgments</title><p>A.D.S. and S.D.G. fellowships were funded by grants from Sapienza University (Ateneo 2019) and Regione Lazio. The Authors thank &#x0201c;Enrico and Enrica Sovena&#x0201d; Foundation (Italy) for supporting the study. </p></ack><notes><title>Author Contributions</title><p>Conceptualization, A.D.S., A.V. and S.D.G.; supervision, A.D.S., A.V. and S.D.G.; Writing&#x02014;original draft, A.D.S., A.V. and S.D.G.; Writing&#x02014;review and editing, A.D.S. All authors have read and agreed to the published version of the manuscript. </p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-vaccines-08-00468"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maggini</surname><given-names>S.</given-names></name><name><surname>Pierre</surname><given-names>A.</given-names></name><name><surname>Calder</surname><given-names>P.C.</given-names></name></person-group><article-title>Immune Function and Micronutrient Requirements Change over the Life Course</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><elocation-id>1531</elocation-id><pub-id pub-id-type="doi">10.3390/nu10101531</pub-id></element-citation></ref><ref id="B2-vaccines-08-00468"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>M.</given-names></name><name><surname>Leo</surname><given-names>O.</given-names></name></person-group><article-title>Key concepts in immunology</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><fpage>C2</fpage><lpage>C13</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2010.07.022</pub-id><pub-id pub-id-type="pmid">20713253</pub-id></element-citation></ref><ref id="B3-vaccines-08-00468"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>D.</given-names></name><name><surname>Romero</surname><given-names>Y.</given-names></name><name><surname>Schuck</surname><given-names>K.N.</given-names></name><name><surname>Smalley</surname><given-names>H.</given-names></name><name><surname>Subedi</surname><given-names>B.</given-names></name><name><surname>Fleming</surname><given-names>S.D.</given-names></name></person-group><article-title>Drivers and regulators of humoral innate immune responses to infection and cancer</article-title><source>Mol. Immunol.</source><year>2020</year><volume>121</volume><fpage>99</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2020.03.005</pub-id><pub-id pub-id-type="pmid">32199212</pub-id></element-citation></ref><ref id="B4-vaccines-08-00468"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>C.C.</given-names></name><name><surname>Chen</surname><given-names>H.M.</given-names></name><name><surname>Yang</surname><given-names>N.S.</given-names></name></person-group><article-title>Developing Phytocompounds from Medicinal Plants as Immunomodulators</article-title><source>Adv. Bot. Res.</source><year>2012</year><volume>62</volume><fpage>197</fpage><lpage>272</lpage><?supplied-pmid 32300254?><pub-id pub-id-type="pmid">32300254</pub-id></element-citation></ref><ref id="B5-vaccines-08-00468"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durcan</surname><given-names>L.</given-names></name><name><surname>Petri</surname><given-names>M.</given-names></name></person-group><article-title>Immunomodulators in SLE: Clinical evidence and immunologic actions</article-title><source>J. Autoimmun.</source><year>2016</year><volume>74</volume><fpage>73</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.jaut.2016.06.010</pub-id><?supplied-pmid 27371107?><pub-id pub-id-type="pmid">27371107</pub-id></element-citation></ref><ref id="B6-vaccines-08-00468"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutgi</surname><given-names>K.</given-names></name><name><surname>Koo</surname><given-names>J.</given-names></name></person-group><article-title>Update on the role of systemic vitamin D in atopic dermatitis</article-title><source>Pediatr. Dermatol.</source><year>2013</year><volume>30</volume><fpage>303</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1111/j.1525-1470.2012.01850.x</pub-id><?supplied-pmid 22957498?><pub-id pub-id-type="pmid">22957498</pub-id></element-citation></ref><ref id="B7-vaccines-08-00468"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>M.G.</given-names></name><name><surname>Giamarellos-Bourboulis</surname><given-names>E.J.</given-names></name><name><surname>Dom&#x000ed;nguez-Andr&#x000e9;s</surname><given-names>J.</given-names></name></person-group><article-title>Trained Immunity: A Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection</article-title><source>Cell</source><year>2020</year><volume>181</volume><fpage>969</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.042</pub-id><pub-id pub-id-type="pmid">32437659</pub-id></element-citation></ref><ref id="B8-vaccines-08-00468"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Pasquale</surname><given-names>A.</given-names></name><name><surname>Preiss</surname><given-names>S.</given-names></name><name><surname>Tavares Da Silva</surname><given-names>F.</given-names></name><name><surname>Gar&#x000e7;on</surname><given-names>N.</given-names></name></person-group><article-title>Vaccine Adjuvants: From 1920 to 2015 and beyond</article-title><source>Vaccines</source><year>2015</year><volume>3</volume><fpage>320</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.3390/vaccines3020320</pub-id><pub-id pub-id-type="pmid">26343190</pub-id></element-citation></ref><ref id="B9-vaccines-08-00468"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coffman</surname><given-names>R.L.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name><name><surname>Seder</surname><given-names>R.A.</given-names></name></person-group><article-title>Vaccine adjuvants: Putting innate immunity to work</article-title><source>Immunity</source><year>2010</year><volume>33</volume><fpage>492</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.10.002</pub-id><pub-id pub-id-type="pmid">21029960</pub-id></element-citation></ref><ref id="B10-vaccines-08-00468"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>D.S.</given-names></name><name><surname>Lee</surname><given-names>N.</given-names></name><name><surname>Chan</surname><given-names>P.K.</given-names></name><name><surname>Beigel</surname><given-names>J.H.</given-names></name></person-group><article-title>The role of adjuvant immunomodulatory agents for treatment of severe influenza</article-title><source>Antiviral Res.</source><year>2018</year><volume>150</volume><fpage>202</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2018.01.002</pub-id><pub-id pub-id-type="pmid">29325970</pub-id></element-citation></ref><ref id="B11-vaccines-08-00468"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temizoz</surname><given-names>B.</given-names></name><name><surname>Kuroda</surname><given-names>E.</given-names></name><name><surname>Ishii</surname><given-names>K.J.</given-names></name></person-group><article-title>Vaccine adjuvants as potential cancer immunotherapeutics</article-title><source>Int. Immunol.</source><year>2016</year><volume>28</volume><fpage>329</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxw015</pub-id><?supplied-pmid 27006304?><pub-id pub-id-type="pmid">27006304</pub-id></element-citation></ref><ref id="B12-vaccines-08-00468"><label>12.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dougan</surname><given-names>M.</given-names></name><name><surname>Dranoff</surname><given-names>G.</given-names></name></person-group><article-title>Immunotherapy of Cancer</article-title><source>Innate Immune Regulation and Cancer Immunotherapy</source><person-group person-group-type="editor"><name><surname>Wang</surname><given-names>R.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2012</year></element-citation></ref><ref id="B13-vaccines-08-00468"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawelec</surname><given-names>G.</given-names></name><name><surname>Gupta</surname><given-names>S.</given-names></name></person-group><article-title>Editorial: Immunology of Aging</article-title><source>Front. Immunol.</source><year>2019</year><volume>10</volume><fpage>1614</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.01614</pub-id><pub-id pub-id-type="pmid">31354744</pub-id></element-citation></ref><ref id="B14-vaccines-08-00468"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>S.I.A.</given-names></name><name><surname>Jantan</surname><given-names>I.</given-names></name><name><surname>Haque</surname><given-names>M.A.</given-names></name></person-group><article-title>Naturally occurring immunomodulators with antitumor activity: An insight on their mechanisms of action</article-title><source>Int. Immunopharmacol.</source><year>2017</year><volume>50</volume><fpage>291</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2017.07.010</pub-id><?supplied-pmid 28734166?><pub-id pub-id-type="pmid">28734166</pub-id></element-citation></ref><ref id="B15-vaccines-08-00468"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>D.</given-names></name><name><surname>Liwinski</surname><given-names>T.</given-names></name><name><surname>Elinav</surname><given-names>E.</given-names></name></person-group><article-title>Interaction between microbiota and immunity in health and disease</article-title><source>Cell Res.</source><year>2020</year><volume>30</volume><fpage>492</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1038/s41422-020-0332-7</pub-id><?supplied-pmid 32433595?><pub-id pub-id-type="pmid">32433595</pub-id></element-citation></ref><ref id="B16-vaccines-08-00468"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>J.</given-names></name><name><surname>Mezouar</surname><given-names>S.</given-names></name><name><surname>Sereme</surname><given-names>Y.</given-names></name><name><surname>Chanez</surname><given-names>P.</given-names></name><name><surname>Vitte</surname><given-names>J.</given-names></name><name><surname>Dubus</surname><given-names>J.C.</given-names></name><name><surname>Chantran</surname><given-names>Y.</given-names></name><name><surname>Leone</surname><given-names>M.</given-names></name><name><surname>M&#x000e8;ge</surname><given-names>J.L.</given-names></name><name><surname>Fabre</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Microbiome and the immune system: From a healthy steady-state to allergy associated disruption</article-title><source>Hum. Microbiome J.</source><year>2018</year><volume>10</volume><fpage>11</fpage><lpage>20</lpage></element-citation></ref><ref id="B17-vaccines-08-00468"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>P.K.</given-names></name><name><surname>Nema</surname><given-names>N.K.</given-names></name><name><surname>Venkatesh</surname><given-names>P.</given-names></name><name><surname>Debnath</surname><given-names>P.K.</given-names></name></person-group><article-title>Changing scenario for promotion and development of Ayurveda&#x02014;Way forward</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>143</volume><fpage>424434</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.07.036</pub-id></element-citation></ref><ref id="B18-vaccines-08-00468"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Lv</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Jia</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title><italic>Echinacea purpurea</italic> Extract Affects the Immune System, Global Metabolome, and Gut Microbiome in Wistar Rats</article-title><source>J. Agric. Sci.</source><year>2017</year><volume>9</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.5539/jas.v9n4p1</pub-id></element-citation></ref><ref id="B19-vaccines-08-00468"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Wei</surname><given-names>R.</given-names></name><name><surname>Xei</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Fan</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Jia</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Metabolome and gut microbiota variation with long-term intake of <italic>Panax ginseng</italic> extracts on rats</article-title><source>Food Funct.</source><year>2018</year><volume>9</volume><fpage>3547</fpage><lpage>3556</lpage><pub-id pub-id-type="doi">10.1039/C8FO00025E</pub-id><pub-id pub-id-type="pmid">29896600</pub-id></element-citation></ref><ref id="B20-vaccines-08-00468"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Wan</surname><given-names>P.</given-names></name><name><surname>Peng</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Ye</surname><given-names>H.</given-names></name><name><surname>Zeng</surname><given-names>X.</given-names></name><name><surname>Ran</surname><given-names>L.</given-names></name></person-group><article-title>Polysaccharides from the flowers of tea (<italic>Camellia sinensis</italic> L.) modulate gut health and ameliorate cyclophosphamide-induced immunosuppression</article-title><source>J. Funct. Food</source><year>2019</year><volume>61</volume><fpage>103470</fpage><pub-id pub-id-type="doi">10.1016/j.jff.2019.103470</pub-id></element-citation></ref><ref id="B21-vaccines-08-00468"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stohs</surname><given-names>S.J.</given-names></name><name><surname>Bagchi</surname><given-names>D.</given-names></name></person-group><article-title>Antioxidant, Anti-inflammatory, and Chemoprotective Properties of <italic>Acacia catechu</italic> Heartwood Extracts</article-title><source>Phytother. Res.</source><year>2015</year><volume>29</volume><fpage>818</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1002/ptr.5335</pub-id><pub-id pub-id-type="pmid">25802170</pub-id></element-citation></ref><ref id="B22-vaccines-08-00468"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.F.</given-names></name><name><surname>Wang</surname><given-names>H.M.</given-names></name><name><surname>Song</surname><given-names>Y.L.</given-names></name><name><surname>Nie</surname><given-names>L.H.</given-names></name><name><surname>Wang</surname><given-names>L.F.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Shen</surname><given-names>P.P.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group><article-title>Isolation, structure elucidation, antioxidative and immunomodulatory properties of two novel dihydrocoumarins from <italic>Aloe vera</italic></article-title><source>Bioorg. Med. Chem. Lett.</source><year>2016</year><volume>16</volume><fpage>949</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2005.10.096</pub-id><?supplied-pmid 16297615?><pub-id pub-id-type="pmid">16297615</pub-id></element-citation></ref><ref id="B23-vaccines-08-00468"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Cui</surname><given-names>Y.</given-names></name><name><surname>Pi</surname><given-names>F.</given-names></name><name><surname>Cheng</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Qian</surname><given-names>H.</given-names></name></person-group><article-title>Extraction, Purification, Structural Characteristics, Biological Activities and Pharmacological Applications of Acemannan, a Polysaccharide from <italic>Aloe vera</italic>: A Review</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1554</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24081554</pub-id><?supplied-pmid 31010204?><pub-id pub-id-type="pmid">31010204</pub-id></element-citation></ref><ref id="B24-vaccines-08-00468"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pugh</surname><given-names>N.</given-names></name><name><surname>Ross</surname><given-names>S.A.</given-names></name><name><surname>El Sohly</surname><given-names>M.A.</given-names></name><name><surname>Pasco</surname><given-names>D.S.</given-names></name></person-group><article-title>Characterization of Aloeride, a new high-molecular-weight polysaccharide from Aloe vera with potent immunostimulatory activity</article-title><source>J. Agric. Food Chem.</source><year>2001</year><volume>49</volume><fpage>1030</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1021/jf001036d</pub-id><?supplied-pmid 11262067?><pub-id pub-id-type="pmid">11262067</pub-id></element-citation></ref><ref id="B25-vaccines-08-00468"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>S.F.</given-names></name><name><surname>Liu</surname><given-names>C.H.</given-names></name><name><surname>Italiani</surname><given-names>P.</given-names></name><name><surname>Sun</surname><given-names>S.H.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Boraschi</surname><given-names>D.</given-names></name><name><surname>Ma</surname><given-names>S.P.</given-names></name><name><surname>Qu</surname><given-names>D.</given-names></name></person-group><article-title>Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response</article-title><source>Acta Pharmacol. Sin.</source><year>2010</year><volume>31</volume><fpage>191</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1038/aps.2009.205</pub-id><?supplied-pmid 20139902?><pub-id pub-id-type="pmid">20139902</pub-id></element-citation></ref><ref id="B26-vaccines-08-00468"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adorisio</surname><given-names>S.</given-names></name><name><surname>Fierabracci</surname><given-names>A.</given-names></name><name><surname>Muscari</surname><given-names>I.</given-names></name></person-group><article-title><italic>Artocarpus tonkinensis</italic> Protects Mice Against Collagen-Induced Arthritis and Decreases Th17 Cell Function</article-title><source>Front. Pharmacol.</source><year>2019</year><volume>10</volume><fpage>503</fpage><pub-id pub-id-type="doi">10.3389/fphar.2019.00503</pub-id><?supplied-pmid 31214019?><pub-id pub-id-type="pmid">31214019</pub-id></element-citation></ref><ref id="B27-vaccines-08-00468"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Ren</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group><article-title>A Review of the Pharmacological Action of Astragalus Polysaccharide</article-title><source>Front. Pharmacol.</source><year>2020</year><volume>11</volume><fpage>349</fpage><pub-id pub-id-type="doi">10.3389/fphar.2020.00349</pub-id><pub-id pub-id-type="pmid">32265719</pub-id></element-citation></ref><ref id="B28-vaccines-08-00468"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>M.L.</given-names></name><name><surname>Kaul</surname><given-names>A.</given-names></name><name><surname>Khajuria</surname><given-names>A.</given-names></name></person-group><article-title>Immunomodulatory activity of Boswellic acids (Pentacyclic Triterpene Acids) from <italic>Boswellia serrata</italic></article-title><source>Phytother. Res</source><year>1996</year><volume>10</volume><fpage>107</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-1573(199603)10:2&#x0003c;107::AID-PTR780&#x0003e;3.0.CO;2-3</pub-id></element-citation></ref><ref id="B29-vaccines-08-00468"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahayu</surname><given-names>R.P.</given-names></name><name><surname>Prasetyo</surname><given-names>R.A.</given-names></name><name><surname>Purwanto</surname><given-names>D.A.</given-names></name><name><surname>Kresnoadi</surname><given-names>U.</given-names></name><name><surname>Iskandar</surname><given-names>R.P.D.</given-names></name><name><surname>Rubianto</surname><given-names>M.</given-names></name></person-group><article-title>The immunomodulatory effect of green tea (Camellia sinensis) leaves extract on immunocompromised Wistar rats infected by <italic>Candida albicans</italic></article-title><source>Vet. World</source><year>2018</year><volume>11</volume><fpage>765</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.14202/vetworld.2018.765-770</pub-id><pub-id pub-id-type="pmid">30034167</pub-id></element-citation></ref><ref id="B30-vaccines-08-00468"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gohil</surname><given-names>K.J.</given-names></name><name><surname>Patel</surname><given-names>J.A.</given-names></name><name><surname>Gajjar</surname><given-names>A.K.</given-names></name></person-group><article-title>Pharmacological Review on <italic>Centella asiatica</italic>: A Potential Herbal Cure-all</article-title><source>Ind. J. Pharm. Sci.</source><year>2010</year><volume>72</volume><fpage>546</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.4103/0250-474X.78519</pub-id></element-citation></ref><ref id="B31-vaccines-08-00468"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollazadeh</surname><given-names>H.</given-names></name><name><surname>Cicero</surname><given-names>A.F.G.</given-names></name><name><surname>Blesso</surname><given-names>C.N.</given-names></name><name><surname>Pirro</surname><given-names>M.</given-names></name><name><surname>Majeed</surname><given-names>M.</given-names></name><name><surname>Sahebkar</surname><given-names>A.</given-names></name></person-group><article-title>Immune modulation by curcumin: The role of interleukin-10</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2019</year><volume>59</volume><fpage>89</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1080/10408398.2017.1358139</pub-id><pub-id pub-id-type="pmid">28799796</pub-id></element-citation></ref><ref id="B32-vaccines-08-00468"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>A.</given-names></name><name><surname>He</surname><given-names>D.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Geng</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name></person-group><article-title>Promotion of regulatory T cell induction by immunomodulatory herbal medicine licorice and its two constituents</article-title><source>Sci. Rep.</source><year>2016</year><volume>5</volume><fpage>14046</fpage><pub-id pub-id-type="doi">10.1038/srep14046</pub-id><?supplied-pmid 26370586?><pub-id pub-id-type="pmid">26370586</pub-id></element-citation></ref><ref id="B33-vaccines-08-00468"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matyanga</surname><given-names>C.M.J.</given-names></name><name><surname>Morse</surname><given-names>G.D.</given-names></name><name><surname>Gundidza</surname><given-names>M.</given-names></name><name><surname>Nbachi</surname><given-names>C.F.B.</given-names></name></person-group><article-title>African potato (<italic>Hypoxis hemerocallidea</italic>): A systematic review of its chemistry, pharmacology and ethno medicinal properties</article-title><source>BMC Complement. Med. Ther.</source><year>2020</year><volume>20</volume><elocation-id>182</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-020-02956-x</pub-id><?supplied-pmid 32527245?><pub-id pub-id-type="pmid">32527245</pub-id></element-citation></ref><ref id="B34-vaccines-08-00468"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeba</surname><given-names>R.C.</given-names></name><name><surname>Vaidyanathan</surname><given-names>R.A.M.A.</given-names></name><name><surname>Rameshkumar</surname><given-names>G.</given-names></name></person-group><article-title>Efficacy of <italic>Ocimum basilicum</italic> for immunomodulatory activity in Wistar albino rat</article-title><source>Int. J. Pharm. Pharm. Sci.</source><year>2011</year><volume>3</volume><fpage>199</fpage><lpage>203</lpage></element-citation></ref><ref id="B35-vaccines-08-00468"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>H.</given-names></name><name><surname>N&#x000f6;rr</surname><given-names>H.</given-names></name><name><surname>Winterhoff</surname><given-names>H.</given-names></name></person-group><article-title>Plant daptogens</article-title><source>Phytomedicine</source><year>1994</year><volume>1</volume><fpage>63</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/S0944-7113(11)80025-5</pub-id><pub-id pub-id-type="pmid">23195818</pub-id></element-citation></ref><ref id="B36-vaccines-08-00468"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riaz</surname><given-names>M.</given-names></name><name><surname>Rahman</surname><given-names>N.U.</given-names></name><name><surname>Zia-Ul-Haq</surname><given-names>M.</given-names></name><name><surname>Jaffar</surname><given-names>H.Z.E.</given-names></name><name><surname>Manea</surname><given-names>R.</given-names></name></person-group><article-title>Ginseng: A dietary supplement as immune-modulator in various diseases</article-title><source>Trends Food Sci. Tech.</source><year>2019</year><volume>83</volume><fpage>12</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.tifs.2018.11.008</pub-id></element-citation></ref><ref id="B37-vaccines-08-00468"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wael</surname><given-names>S.</given-names></name><name><surname>Watuguly</surname><given-names>T.W.</given-names></name><name><surname>Arini</surname><given-names>I.</given-names></name><name><surname>Smit</surname><given-names>A.</given-names></name><name><surname>Matdoan</surname><given-names>N.</given-names></name><name><surname>Prihati</surname><given-names>D.R.</given-names></name><name><surname>Sari</surname><given-names>A.B.</given-names></name><name><surname>Wahyudi</surname><given-names>D.</given-names></name><name><surname>Nuringtyas</surname><given-names>T.R.</given-names></name><name><surname>Wijayanti</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Potential of <italic>Syzygium aromaticum</italic> (Clove) Leaf Extract on Immune Proliferation Response in Balb/c Mice Infected with <italic>Salmonella typhimurium</italic></article-title><source>Clin. Med. Case Rep.</source><year>2018</year><volume>7</volume><fpage>613</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.4236/crcm.2018.712057</pub-id></element-citation></ref><ref id="B38-vaccines-08-00468"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haque</surname><given-names>M.A.</given-names></name><name><surname>Jantan</surname><given-names>I.</given-names></name><name><surname>Abbas Bukhari</surname><given-names>S.N.</given-names></name></person-group><article-title><italic>Tinospora</italic> species: An overview of their modulating effects on the immune system</article-title><source>J. Ethnopharmacol.</source><year>2017</year><volume>207</volume><fpage>67</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2017.06.013</pub-id><pub-id pub-id-type="pmid">28629816</pub-id></element-citation></ref><ref id="B39-vaccines-08-00468"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandran</surname><given-names>U.</given-names></name><name><surname>Patwardhan</surname><given-names>B.</given-names></name></person-group><article-title>Network ethnopharmacological evaluation of the immunomodulatory activity of <italic>Withania somnifera</italic></article-title><source>J. Ethnopharmacol.</source><year>2017</year><volume>197</volume><fpage>250</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.07.080</pub-id><pub-id pub-id-type="pmid">27487266</pub-id></element-citation></ref><ref id="B40-vaccines-08-00468"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalra</surname><given-names>R.</given-names></name><name><surname>Kaushik</surname><given-names>N.</given-names></name></person-group><article-title><italic>Withania somnifera</italic> (Linn.) Dunal: A review of chemical and pharmacological diversity</article-title><source>Phytochem. Rev.</source><year>2017</year><volume>16</volume><fpage>953</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1007/s11101-017-9504-6</pub-id></element-citation></ref><ref id="B41-vaccines-08-00468"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>B.H.</given-names></name><name><surname>Blunden</surname><given-names>G.</given-names></name><name><surname>Tanira</surname><given-names>M.O.</given-names></name><name><surname>Nemmar</surname><given-names>A.</given-names></name></person-group><article-title>Some phytochemical, pharmacological and toxicological properties of ginger (<italic>Zingiber officinale</italic> Roscoe): A review of recent research</article-title><source>Food Chem. Toxicol.</source><year>2008</year><volume>46</volume><fpage>409</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2007.09.085</pub-id><pub-id pub-id-type="pmid">17950516</pub-id></element-citation></ref><ref id="B42-vaccines-08-00468"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catanzaro</surname><given-names>M.</given-names></name><name><surname>Corsini</surname><given-names>E.</given-names></name><name><surname>Rosini</surname><given-names>M.</given-names></name><name><surname>Racchi</surname><given-names>M.</given-names></name><name><surname>Lanni</surname><given-names>C.</given-names></name></person-group><article-title>Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>2778</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23112778</pub-id></element-citation></ref><ref id="B43-vaccines-08-00468"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillai</surname><given-names>S.</given-names></name><name><surname>Pillai</surname><given-names>C.</given-names></name><name><surname>Mitscher</surname><given-names>L.A.</given-names></name><name><surname>Cooper</surname><given-names>R.</given-names></name></person-group><article-title>Use of quantitative flow cytometry to measure <italic>ex vivo</italic> immunostimulant activity of Echinacea: The case for polysaccharides</article-title><source>J. Altern. Complement. Med.</source><year>2007</year><volume>13</volume><fpage>625</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1089/acm.2006.6361</pub-id><?supplied-pmid 17718645?><pub-id pub-id-type="pmid">17718645</pub-id></element-citation></ref><ref id="B44-vaccines-08-00468"><label>44.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>European Medicines Agency</collab></person-group><source>Assessment Report on Echinacea purpurea (L.) Moench, Radix</source><comment>EMA/HMPC/424584/2016</comment><publisher-name>European Medicines Agency</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2017</year></element-citation></ref><ref id="B45-vaccines-08-00468"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>P.</given-names></name><name><surname>Makanjuola</surname><given-names>V.O.</given-names></name><name><surname>Arora</surname><given-names>R.</given-names></name><name><surname>Singh</surname><given-names>B.</given-names></name><name><surname>Arora</surname><given-names>S.</given-names></name></person-group><article-title>Immunopotentiating significance of conventionally used plant adaptogens as modulators in biochemical and molecular signalling pathways in cell mediated processes</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>95</volume><fpage>1815</fpage><lpage>1829</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.09.081</pub-id><?supplied-pmid 28968926?><pub-id pub-id-type="pmid">28968926</pub-id></element-citation></ref><ref id="B46-vaccines-08-00468"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachiega</surname><given-names>T.F.</given-names></name><name><surname>Orsatti</surname><given-names>C.L.</given-names></name><name><surname>Pagliarona</surname><given-names>A.C.</given-names></name><name><surname>Missima</surname><given-names>F.</given-names></name><name><surname>Sousa</surname><given-names>J.P.B.</given-names></name><name><surname>Bastos</surname><given-names>J.K.</given-names></name><name><surname>Sforcin</surname><given-names>J.M.</given-names></name></person-group><article-title>Th1/Th2 Cytokine Production by Clove-Treated Mice</article-title><source>Nat. Prod. Res.</source><year>2009</year><volume>23</volume><fpage>1552</fpage><lpage>1558</lpage><pub-id pub-id-type="doi">10.1080/14786410902809328</pub-id><?supplied-pmid 19844828?><pub-id pub-id-type="pmid">19844828</pub-id></element-citation></ref><ref id="B47-vaccines-08-00468"><label>47.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Akbar</surname><given-names>S.</given-names></name></person-group><article-title><italic>Azadirachta indica</italic> A. Juss. (Meliaceae)</article-title><source>Handbook of 200 Medicinal Plants</source><person-group person-group-type="editor"><name><surname>Akbar</surname><given-names>S.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2020</year></element-citation></ref><ref id="B48-vaccines-08-00468"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cundell</surname><given-names>R.D.</given-names></name></person-group><article-title>Herbal Phytochemicals as Immunomodulators</article-title><source>Curr. Immunol. Rev.</source><year>2014</year><volume>10</volume><fpage>64</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.2174/1573395510666140915213156</pub-id></element-citation></ref><ref id="B49-vaccines-08-00468"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radzikowska</surname><given-names>U.</given-names></name><name><surname>Rinaldi</surname><given-names>A.O.</given-names></name><name><surname>&#x000c7;elebi S&#x000f6;zener</surname><given-names>Z.</given-names></name><name><surname>Karaguzel</surname><given-names>D.</given-names></name><name><surname>Wojcik</surname><given-names>M.</given-names></name><name><surname>Cypryk</surname><given-names>K.</given-names></name><name><surname>Akdis</surname><given-names>M.</given-names></name><name><surname>Akdis</surname><given-names>C.A.</given-names></name><name><surname>Sokolowska</surname><given-names>M.</given-names></name></person-group><article-title>The Influence of Dietary Fatty Acids on Immune Responses</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>2990</elocation-id><pub-id pub-id-type="doi">10.3390/nu11122990</pub-id></element-citation></ref><ref id="B50-vaccines-08-00468"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoang</surname><given-names>M.L.</given-names></name><name><surname>Chen</surname><given-names>C.H.</given-names></name><name><surname>Chen</surname><given-names>P.C.</given-names></name><name><surname>Roberts</surname><given-names>N.J.</given-names></name><name><surname>Dickman</surname><given-names>K.G.</given-names></name><name><surname>Yun</surname><given-names>B.H.</given-names></name><name><surname>Turesky</surname><given-names>R.J.</given-names></name><name><surname>Pu</surname><given-names>Y.S.</given-names></name><name><surname>Vogelstein</surname><given-names>B.</given-names></name><name><surname>Papadopoulus</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Aristolochic acid in the etiology of renal cell carcinoma</article-title><source>Cancer Epidemiol. Prev. Biomarkers</source><year>2016</year><volume>25</volume><fpage>1600</fpage><lpage>1608</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-16-0219</pub-id></element-citation></ref><ref id="B51-vaccines-08-00468"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantan</surname><given-names>I.</given-names></name><name><surname>Ahmad</surname><given-names>W.</given-names></name><name><surname>Bukhari</surname><given-names>S.N.A.</given-names></name></person-group><article-title>Plant-derived immunomodulators: An insight on their preclinical evaluation and clinical trials</article-title><source>Front. Plant Sci.</source><year>2015</year><volume>25</volume><fpage>655</fpage><pub-id pub-id-type="doi">10.3389/fpls.2015.00655</pub-id></element-citation></ref><ref id="B52-vaccines-08-00468"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>C.N.</given-names></name><name><surname>Gan</surname><given-names>R.Y.</given-names></name><name><surname>Li</surname><given-names>H.B.</given-names></name></person-group><article-title>Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review</article-title><source>Foods</source><year>2020</year><volume>9</volume><elocation-id>340</elocation-id><pub-id pub-id-type="doi">10.3390/foods9030340</pub-id></element-citation></ref><ref id="B53-vaccines-08-00468"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuban-Jankowska</surname><given-names>A.</given-names></name><name><surname>Sahu</surname><given-names>K.K.</given-names></name><name><surname>Gorska</surname><given-names>M.</given-names></name><name><surname>Tuszynski</surname><given-names>J.A.</given-names></name><name><surname>Wozniak</surname><given-names>M.</given-names></name></person-group><article-title>Chicoric acid binds to two sites and decreases the activity of the YopH bacterial virulence factor</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>2229</fpage><lpage>2238</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.6812</pub-id><pub-id pub-id-type="pmid">26735581</pub-id></element-citation></ref><ref id="B54-vaccines-08-00468"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuyaerts</surname><given-names>S.</given-names></name><name><surname>Rombauts</surname><given-names>K.</given-names></name><name><surname>Everaert</surname><given-names>T.</given-names></name><name><surname>Van Nuffel</surname><given-names>A.M.T.</given-names></name><name><surname>Amant</surname><given-names>F.</given-names></name></person-group><article-title>A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer</article-title><source>Front. Nutr.</source><year>2019</year><volume>5</volume><fpage>138</fpage><pub-id pub-id-type="doi">10.3389/fnut.2018.00138</pub-id><?supplied-pmid 30687714?><pub-id pub-id-type="pmid">30687714</pub-id></element-citation></ref><ref id="B55-vaccines-08-00468"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>J.M.</given-names></name></person-group><article-title>CODEX-aligned dietary fiber definitions help to bridge the &#x02018;fiber gap&#x02019;</article-title><source>Nutr. J.</source><year>2014</year><volume>13</volume><fpage>34</fpage><pub-id pub-id-type="doi">10.1186/1475-2891-13-34</pub-id><?supplied-pmid 24725724?><pub-id pub-id-type="pmid">24725724</pub-id></element-citation></ref><ref id="B56-vaccines-08-00468"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>S.S.</given-names></name><name><surname>Passos</surname><given-names>C.P.</given-names></name><name><surname>Madureira</surname><given-names>P.</given-names></name><name><surname>Vilanova</surname><given-names>M.</given-names></name><name><surname>Coimbra</surname><given-names>M.A.</given-names></name></person-group><article-title>Structure-function relationships of immunostimulatory polysaccharides: A review</article-title><source>Carbohydr. Polym.</source><year>2015</year><volume>132</volume><fpage>378</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2015.05.079</pub-id><?supplied-pmid 26256362?><pub-id pub-id-type="pmid">26256362</pub-id></element-citation></ref><ref id="B57-vaccines-08-00468"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>G.</given-names></name><name><surname>Arya</surname><given-names>S.K.</given-names></name></person-group><article-title>Mannans: An overview of properties and application in food products</article-title><source>Int. J. Biol. Macromol.</source><year>2018</year><volume>119</volume><fpage>79</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2018.07.130</pub-id><pub-id pub-id-type="pmid">30048723</pub-id></element-citation></ref><ref id="B58-vaccines-08-00468"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.S.</given-names></name><name><surname>Kwon</surname><given-names>J.S.</given-names></name><name><surname>Yun</surname><given-names>J.S.</given-names></name><name><surname>Pahk</surname><given-names>J.W.</given-names></name><name><surname>Shin</surname><given-names>W.C.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Hong</surname><given-names>E.K.</given-names></name></person-group><article-title>Structural characterization of immunostimulating polysaccharide from cultured mycelia of <italic>Cordyceps militaris</italic></article-title><source>Carbohyd. Polym.</source><year>2010</year><volume>80</volume><fpage>1011</fpage><lpage>1017</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2010.01.017</pub-id></element-citation></ref><ref id="B59-vaccines-08-00468"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim&#x000f5;es</surname><given-names>J.</given-names></name><name><surname>Madureira</surname><given-names>P.</given-names></name><name><surname>Nunes</surname><given-names>F.M.</given-names></name><name><surname>Domingues</surname><given-names>M.D.R.</given-names></name><name><surname>Vilanova</surname><given-names>M.</given-names></name><name><surname>Coimbra</surname><given-names>M.A.</given-names></name></person-group><article-title>Immunostimulatory properties of coffee mannans</article-title><source>Mol. Nutr. Food Res.</source><year>2009</year><volume>53</volume><fpage>1036</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1002/mnfr.200800385</pub-id><pub-id pub-id-type="pmid">19603397</pub-id></element-citation></ref><ref id="B60-vaccines-08-00468"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.K.</given-names></name><name><surname>Kim</surname><given-names>Z.-H.</given-names></name><name><surname>Lee</surname><given-names>C.G.</given-names></name><name><surname>Synytsya</surname><given-names>A.</given-names></name><name><surname>Jo</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>S.O.</given-names></name><name><surname>Park</surname><given-names>J.W.</given-names></name><name><surname>Park</surname><given-names>Y.I.</given-names></name></person-group><article-title>Characterization and immunostimulating activity of a water-soluble polysaccharide isolated from <italic>Haematococcus lacustris</italic></article-title><source>Biotechnol. Bioproc. E</source><year>2011</year><volume>16</volume><fpage>1090</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1007/s12257-011-0173-9</pub-id></element-citation></ref><ref id="B61-vaccines-08-00468"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohta</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>J.B.</given-names></name><name><surname>Hayashi</surname><given-names>K.</given-names></name><name><surname>Fujita</surname><given-names>A.</given-names></name><name><surname>Park</surname><given-names>D.K.</given-names></name><name><surname>Hayashi</surname><given-names>T.</given-names></name></person-group><article-title><italic>In vivo</italic> anti influenza virus activity of an immunomodulatory acidic polysaccharide isolated from <italic>Cordyceps militaris</italic> grown on germinated soybeans</article-title><source>J. Agric. Food Chem.</source><year>2007</year><volume>55</volume><fpage>10194</fpage><lpage>10199</lpage><pub-id pub-id-type="doi">10.1021/jf0721287</pub-id><pub-id pub-id-type="pmid">17988090</pub-id></element-citation></ref><ref id="B62-vaccines-08-00468"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>G.</given-names></name><name><surname>Schepetkin</surname><given-names>I.A.</given-names></name><name><surname>Siemsen</surname><given-names>D.W.</given-names></name><name><surname>Kirpotina</surname><given-names>L.N.</given-names></name><name><surname>Wiley</surname><given-names>J.A.</given-names></name><name><surname>Quinn</surname><given-names>M.T.</given-names></name></person-group><article-title>Fractionation and characterization of biologically-active polysaccharides from <italic>Artemisia tripartita</italic></article-title><source>Phytochemistry</source><year>2008</year><volume>69</volume><fpage>1359</fpage><lpage>1371</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2008.01.009</pub-id><pub-id pub-id-type="pmid">18325553</pub-id></element-citation></ref><ref id="B63-vaccines-08-00468"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popov</surname><given-names>S.V.</given-names></name><name><surname>Ovodov</surname><given-names>Y.S.</given-names></name></person-group><article-title>Polypotency of the immunomodulatory effect of pectins</article-title><source>Biochemistry</source><year>2013</year><volume>78</volume><fpage>823</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1134/S0006297913070134</pub-id><pub-id pub-id-type="pmid">24010844</pub-id></element-citation></ref><ref id="B64-vaccines-08-00468"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>J.Y.</given-names></name><name><surname>Chan</surname><given-names>B.C.L.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Lau</surname><given-names>I.Y.K.</given-names></name><name><surname>Han</surname><given-names>X.Q.</given-names></name><name><surname>Cheng</surname><given-names>S.W.</given-names></name><name><surname>Wong</surname><given-names>C.K.</given-names></name><name><surname>Lau</surname><given-names>C.B.S.</given-names></name><name><surname>Xie</surname><given-names>M.Y.</given-names></name><name><surname>Fung</surname><given-names>K.P.</given-names></name><etal/></person-group><article-title>Separation, structure characterization, conformation and immunomodulating effect of a hyperbranched heteroglycan from Radix Astragali</article-title><source>Carbohydr. Polym.</source><year>2012</year><volume>87</volume><fpage>667</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2011.08.045</pub-id></element-citation></ref><ref id="B65-vaccines-08-00468"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>Structure elucidation and immunological activity of a novel pectic polysaccharide from the stems of Avicennia marina</article-title><source>Eur. Food Res. Technol.</source><year>2013</year><volume>236</volume><fpage>243</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1007/s00217-012-1877-6</pub-id></element-citation></ref><ref id="B66-vaccines-08-00468"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephanie</surname><given-names>B.</given-names></name><name><surname>Eric</surname><given-names>D.</given-names></name><name><surname>Sophie</surname><given-names>F.M.</given-names></name><name><surname>Christian</surname><given-names>B.</given-names></name><name><surname>Yu</surname><given-names>G.</given-names></name></person-group><article-title>Carrageenan from <italic>Solieria chordalis</italic> (Gigartinales): Structural analysis and immunological activities of the low molecular weight fractions</article-title><source>Carbohydr. Polym.</source><year>2010</year><volume>81</volume><fpage>448</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2010.02.046</pub-id></element-citation></ref><ref id="B67-vaccines-08-00468"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatia</surname><given-names>S.</given-names></name><name><surname>Rathee</surname><given-names>P.</given-names></name><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Chaugule</surname><given-names>B.B.</given-names></name><name><surname>Kar</surname><given-names>N.</given-names></name><name><surname>Bera</surname><given-names>T.</given-names></name></person-group><article-title>Immunomodulation effect of sulphated polysaccharide (porphyran) from <italic>Porphyra vietnamensis</italic></article-title><source>Int. J. Biol. Macromol.</source><year>2013</year><volume>57</volume><fpage>50</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2013.03.012</pub-id><?supplied-pmid 23500431?><pub-id pub-id-type="pmid">23500431</pub-id></element-citation></ref><ref id="B68-vaccines-08-00468"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chlubnov&#x000e1;</surname><given-names>I.</given-names></name><name><surname>Sylla</surname><given-names>B.</given-names></name><name><surname>Nugier-Chauvin</surname><given-names>C.</given-names></name><name><surname>Daniellou</surname><given-names>R.</given-names></name><name><surname>Legentil</surname><given-names>L.</given-names></name><name><surname>Kralov&#x000e1;</surname><given-names>B.</given-names></name><name><surname>Ferri&#x000e8;res</surname><given-names>V.</given-names></name></person-group><article-title>Natural glycans and glycoconjugates as immunomodulating agents</article-title><source>Nat. Prod. Rep.</source><year>2011</year><volume>28</volume><fpage>937</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.1039/c1np00005e</pub-id><?supplied-pmid 21380417?><pub-id pub-id-type="pmid">21380417</pub-id></element-citation></ref><ref id="B69-vaccines-08-00468"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benkeblia</surname><given-names>N.</given-names></name></person-group><article-title>Fructooligosaccharides and fructans analysis in plants and food crops</article-title><source>J. Chromatogr. A</source><year>2013</year><volume>1313</volume><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2013.08.013</pub-id><?supplied-pmid 23988013?><pub-id pub-id-type="pmid">23988013</pub-id></element-citation></ref><ref id="B70-vaccines-08-00468"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Dai</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Tsim</surname><given-names>K.W.K.</given-names></name><name><surname>Tu</surname><given-names>P.</given-names></name></person-group><article-title>A fructan, from Radix ophiopogonis, stimulates the proliferation of cultured lymphocytes: Structural and functional analyses</article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>1257</fpage><lpage>1260</lpage><pub-id pub-id-type="doi">10.1021/np060033d</pub-id><pub-id pub-id-type="pmid">16989515</pub-id></element-citation></ref><ref id="B71-vaccines-08-00468"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhtar</surname><given-names>M.</given-names></name><name><surname>Tariq</surname><given-names>A.F.</given-names></name><name><surname>Awais</surname><given-names>M.M.</given-names></name><name><surname>Iqbal</surname><given-names>Z.</given-names></name><name><surname>Muhammad</surname><given-names>F.</given-names></name><name><surname>Shahid</surname><given-names>M.</given-names></name><name><surname>Hiszczynska-Sawicka</surname><given-names>E.</given-names></name></person-group><article-title>Studies on wheat bran Arabinoxylan for its immunostimulatory and protective effects against avian coccidiosis</article-title><source>Carbohydr. Polym.</source><year>2012</year><volume>90</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2012.05.048</pub-id><pub-id pub-id-type="pmid">24751049</pub-id></element-citation></ref><ref id="B72-vaccines-08-00468"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Peng</surname><given-names>D.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name></person-group><article-title>Comparison of the immunological activities of arabinoxylans from wheat bran with alkali and xylanase-aided extraction</article-title><source>Carbohydr. Polym.</source><year>2010</year><volume>81</volume><fpage>784</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2010.03.040</pub-id></element-citation></ref><ref id="B73-vaccines-08-00468"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albuquerque</surname><given-names>P.B.S.</given-names></name><name><surname>de Oliveira</surname><given-names>W.F.</given-names></name><name><surname>Dos Santos Silva</surname><given-names>P.M.</given-names></name><name><surname>Dos Santos Correia</surname><given-names>M.T.</given-names></name><name><surname>Kennedy</surname><given-names>J.F.</given-names></name><name><surname>Coelho</surname><given-names>L.C.B.B.</given-names></name></person-group><article-title>Epiphanies of well-known and newly discovered macromolecular carbohydrates&#x02014;A review</article-title><source>Int. J. Biol. Macromol.</source><year>2020</year><volume>156</volume><fpage>51</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.04.046</pub-id><pub-id pub-id-type="pmid">32289406</pub-id></element-citation></ref><ref id="B74-vaccines-08-00468"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schepetkin</surname><given-names>I.A.</given-names></name><name><surname>Quinn</surname><given-names>M.T.</given-names></name></person-group><article-title>Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential</article-title><source>Int. Immunopharmacol.</source><year>2006</year><volume>6</volume><fpage>317</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2005.10.005</pub-id><?supplied-pmid 16428067?><pub-id pub-id-type="pmid">16428067</pub-id></element-citation></ref><ref id="B75-vaccines-08-00468"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korolenko</surname><given-names>T.A.</given-names></name><name><surname>Bgatova</surname><given-names>N.P.</given-names></name><name><surname>Vetvicka</surname><given-names>V.</given-names></name></person-group><article-title>Glucan and Mannan-Two Peas in a Pod</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>3189</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20133189</pub-id><?supplied-pmid 31261851?><pub-id pub-id-type="pmid">31261851</pub-id></element-citation></ref><ref id="B76-vaccines-08-00468"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name></person-group><article-title>Isolation and structural characterization of an immunostimulating polysaccharide from fuzi, <italic>Aconitum carmichaeli</italic></article-title><source>Carbohydr. Res.</source><year>2006</year><volume>341</volume><fpage>485</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1016/j.carres.2005.11.032</pub-id><?supplied-pmid 16406277?><pub-id pub-id-type="pmid">16406277</pub-id></element-citation></ref><ref id="B77-vaccines-08-00468"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrashekar</surname><given-names>P.M.</given-names></name><name><surname>Prashanth</surname><given-names>K.V.H.</given-names></name><name><surname>Venkatesh</surname><given-names>Y.P.</given-names></name></person-group><article-title>Isolation, structural elucidation and immunomodulatory activity of fructans from aged garlic extract</article-title><source>Phytochemistry</source><year>2011</year><volume>72</volume><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2010.11.015</pub-id><pub-id pub-id-type="pmid">21168173</pub-id></element-citation></ref><ref id="B78-vaccines-08-00468"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simoes</surname><given-names>J.</given-names></name><name><surname>Nunes</surname><given-names>F.M.</given-names></name><name><surname>Domingues</surname><given-names>P.</given-names></name><name><surname>Coimbra</surname><given-names>M.A.</given-names></name><name><surname>Domingues</surname><given-names>M.R.</given-names></name></person-group><article-title>Mass spectrometry characterization of an <italic>Aloe vera</italic> mannan presentin immunostimulatory activity</article-title><source>Carbohydr. Polym.</source><year>2012</year><volume>90</volume><fpage>229</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2012.05.029</pub-id><pub-id pub-id-type="pmid">24751035</pub-id></element-citation></ref><ref id="B79-vaccines-08-00468"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikkonen</surname><given-names>K.S.</given-names></name><name><surname>Tenkanen</surname><given-names>M.</given-names></name></person-group><article-title>Sustainable food packaging materials based on future biorefinery products: Xylans and mannans</article-title><source>Trends Food. Sci. Technol.</source><year>2012</year><volume>28</volume><fpage>90</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.tifs.2012.06.012</pub-id></element-citation></ref><ref id="B80-vaccines-08-00468"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moret&#x000e3;o</surname><given-names>M.P.</given-names></name><name><surname>Zampronio</surname><given-names>A.R.</given-names></name><name><surname>Gorin</surname><given-names>P.A.J.</given-names></name><name><surname>Iacomini</surname><given-names>M.</given-names></name><name><surname>Oliveira</surname><given-names>M.B.M.</given-names></name></person-group><article-title>Induction of secretory and tumoricidal activities in peritoneal macrophages activated by an acidic heteropolysaccharide (ARAGAL) from the gum of <italic>Anadenanthera colubrina</italic> (Angico branco)</article-title><source>Immunol. Lett.</source><year>2004</year><volume>93</volume><fpage>189</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2004.03.021</pub-id><pub-id pub-id-type="pmid">15158616</pub-id></element-citation></ref><ref id="B81-vaccines-08-00468"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petkowicz</surname><given-names>C.D.O.</given-names></name><name><surname>Reicher</surname><given-names>F.</given-names></name><name><surname>Chanzy</surname><given-names>H.</given-names></name><name><surname>Taravel</surname><given-names>F.R.</given-names></name><name><surname>Vuong</surname><given-names>R.</given-names></name></person-group><article-title>Linear mannan in the endosperm of Schizolobium amazonicum</article-title><source>Carbohydr. Polym.</source><year>2001</year><volume>44</volume><fpage>107</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/S0144-8617(00)00212-5</pub-id></element-citation></ref><ref id="B82-vaccines-08-00468"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.S.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Fang</surname><given-names>J.N.</given-names></name></person-group><article-title>Immunological activities and structure of pectin from <italic>Centella asiatica</italic></article-title><source>Carbohydr. Polym.</source><year>2005</year><volume>60</volume><fpage>95</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2004.11.031</pub-id></element-citation></ref><ref id="B83-vaccines-08-00468"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sachslehner</surname><given-names>A.</given-names></name><name><surname>Foidl</surname><given-names>G.</given-names></name><name><surname>Foidl</surname><given-names>N.</given-names></name><name><surname>G&#x000fc;bitz</surname><given-names>G.</given-names></name><name><surname>Haltrich</surname><given-names>D.</given-names></name></person-group><article-title>Hydrolysis of isolated coffee mannan and coffee extract by mannanases of Sclerotium rolfsii</article-title><source>J. Biotechnol.</source><year>2000</year><volume>80</volume><fpage>127</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/S0168-1656(00)00253-4</pub-id><pub-id pub-id-type="pmid">10908793</pub-id></element-citation></ref><ref id="B84-vaccines-08-00468"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikkonen</surname><given-names>K.S.</given-names></name><name><surname>Tenkanen</surname><given-names>M.</given-names></name><name><surname>Cooke</surname><given-names>P.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Rita</surname><given-names>H.</given-names></name><name><surname>Willf&#x000f6;r</surname><given-names>S.</given-names></name><name><surname>Holmbom</surname><given-names>B.</given-names></name><name><surname>Hicks</surname><given-names>K.B.</given-names></name><name><surname>Yadav</surname><given-names>M.P.</given-names></name></person-group><article-title>Mannans as stabilizers of oil-in-water beverage emulsions</article-title><source>LWT Food Sci. Technol.</source><year>2009</year><volume>42</volume><fpage>849</fpage><lpage>855</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2008.11.010</pub-id></element-citation></ref><ref id="B85-vaccines-08-00468"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zha</surname><given-names>X.Q.</given-names></name><name><surname>Luo</surname><given-names>J.P.</given-names></name><name><surname>Luo</surname><given-names>S.Z.</given-names></name><name><surname>Jiang</surname><given-names>S.T.</given-names></name></person-group><article-title>Structure identification of a new immunostimulating polysaccharide from the stems of <italic>Dendrobium huoshanense</italic></article-title><source>Carbohydr. Polym.</source><year>2007</year><volume>69</volume><fpage>86</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2006.09.005</pub-id></element-citation></ref><ref id="B86-vaccines-08-00468"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luettig</surname><given-names>B.</given-names></name><name><surname>Steinmuller</surname><given-names>C.</given-names></name><name><surname>Gifford</surname><given-names>G.E.</given-names></name><name><surname>Wagner</surname><given-names>H.</given-names></name><name><surname>Lohmann-Matthes</surname><given-names>M.-L.</given-names></name></person-group><article-title>Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of <italic>Echinacea purpurea</italic></article-title><source>J. Natl. Cancer Inst.</source><year>1989</year><volume>81</volume><fpage>669</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1093/jnci/81.9.669</pub-id><?supplied-pmid 2785214?><pub-id pub-id-type="pmid">2785214</pub-id></element-citation></ref><ref id="B87-vaccines-08-00468"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>H.</given-names></name><name><surname>Stuppner</surname><given-names>H.</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>W.</given-names></name><name><surname>Zenk</surname><given-names>M.</given-names></name></person-group><article-title>Immunologically active polysaccharides of Echinacea purpurea cell cultures</article-title><source>Phytochemistry</source><year>1988</year><volume>27</volume><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(88)80601-0</pub-id></element-citation></ref><ref id="B88-vaccines-08-00468"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holderness</surname><given-names>J.</given-names></name><name><surname>Schepetkin</surname><given-names>I.A.</given-names></name><name><surname>Freedman</surname><given-names>B.</given-names></name><name><surname>Kirpotina</surname><given-names>L.N.</given-names></name><name><surname>Quinn</surname><given-names>M.T.</given-names></name><name><surname>Hedges</surname><given-names>J.F.</given-names></name><name><surname>Jutila</surname><given-names>M.A.</given-names></name></person-group><article-title>Polysaccharides isolated from aca&#x000ed; fruit induce innate immune responses</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e17301</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0017301</pub-id><?supplied-pmid 21386979?><pub-id pub-id-type="pmid">21386979</pub-id></element-citation></ref><ref id="B89-vaccines-08-00468"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skyberg</surname><given-names>J.A.</given-names></name><name><surname>Rollins</surname><given-names>M.F.</given-names></name><name><surname>Holderness</surname><given-names>J.S.</given-names></name><name><surname>Marlenee</surname><given-names>N.L.</given-names></name><name><surname>Schepetkin</surname><given-names>I.A.</given-names></name><name><surname>Goodyear</surname><given-names>A.</given-names></name><name><surname>Dow</surname><given-names>S.W.</given-names></name><name><surname>Jutila</surname><given-names>M.A.</given-names></name><name><surname>Pascual</surname><given-names>D.W.</given-names></name></person-group><article-title>Nasal acai polysaccharides potentiate innate immunity to protect against pulmonary <italic>Francisella tularensis</italic> and <italic>Burkholderia pseudomallei</italic> infections</article-title><source>PLoS Pathog.</source><year>2012</year><volume>8</volume><elocation-id>e1002587</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002587</pub-id><?supplied-pmid 22438809?><pub-id pub-id-type="pmid">22438809</pub-id></element-citation></ref><ref id="B90-vaccines-08-00468"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuelsen</surname><given-names>A.B.</given-names></name><name><surname>Rieder</surname><given-names>A.</given-names></name><name><surname>Grimmer</surname><given-names>S.</given-names></name><name><surname>Michaelsen</surname><given-names>T.E.</given-names></name><name><surname>Knutsen</surname><given-names>S.H.</given-names></name></person-group><article-title>Immunomodulatory activity of dietary fiber: Arabinoxylan and mixed-linked Beta-glucan isolated from barley show modest activities <italic>in vitro</italic></article-title><source>Int. J. Mol. Sci.</source><year>2011</year><volume>12</volume><fpage>570</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.3390/ijms12010570</pub-id><pub-id pub-id-type="pmid">21340001</pub-id></element-citation></ref><ref id="B91-vaccines-08-00468"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>G.H.</given-names></name><name><surname>Kan</surname><given-names>J.Q.</given-names></name><name><surname>Li</surname><given-names>Z.X.</given-names></name><name><surname>Chen</surname><given-names>Z.D.</given-names></name></person-group><article-title>Characterization and immunostimulatory activity of an (1&#x02192;6)- &#x003b1;-d-glucan from the root of <italic>Ipomoea batatas</italic></article-title><source>Int. Immunopharmacol.</source><year>2005</year><volume>5</volume><fpage>1436</fpage><lpage>1445</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2005.03.012</pub-id><pub-id pub-id-type="pmid">15953570</pub-id></element-citation></ref><ref id="B92-vaccines-08-00468"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schepetkin</surname><given-names>I.A.</given-names></name><name><surname>Faulkner</surname><given-names>C.L.</given-names></name><name><surname>Nelson-Overton</surname><given-names>L.K.</given-names></name><name><surname>Wiley</surname><given-names>J.A.</given-names></name><name><surname>Quinn</surname><given-names>M.T.</given-names></name></person-group><article-title>Macrophage immunomodulatory activity of polysaccharides isolated from <italic>Juniperus scopolorum</italic></article-title><source>Int. Immunopharmacol.</source><year>2005</year><volume>5</volume><fpage>1783</fpage><lpage>1799</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2005.05.009</pub-id><pub-id pub-id-type="pmid">16275615</pub-id></element-citation></ref><ref id="B93-vaccines-08-00468"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>X.M.</given-names></name><name><surname>Huang</surname><given-names>L.J.</given-names></name><name><surname>Qi</surname><given-names>C.H.</given-names></name><name><surname>Zhang</surname><given-names>Y.X.</given-names></name><name><surname>Tian</surname><given-names>G.Y.</given-names></name></person-group><article-title>Studies on chemistry and immunomodulating mechanism of aglycoconjugate from <italic>Lycium barbarum</italic> L</article-title><source>Chin. J. Chem.</source><year>2001</year><volume>19</volume><fpage>1190</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1002/cjoc.20010191206</pub-id></element-citation></ref><ref id="B94-vaccines-08-00468"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Peng</surname><given-names>X.X.</given-names></name><name><surname>Sun</surname><given-names>P.</given-names></name><name><surname>Shi</surname><given-names>J.H.</given-names></name><name><surname>Yuan</surname><given-names>X.W.</given-names></name><name><surname>Zhu</surname><given-names>J.J.</given-names></name><name><surname>Tai</surname><given-names>G.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name></person-group><article-title>Structural characterization and immunostimulatory activity of a novel linear &#x003b1;-(1&#x02192;6)- d-glucan isolated from <italic>Panax ginseng</italic> C. A. Meyer</article-title><source>Glycoconj. J.</source><year>2012</year><volume>29</volume><fpage>357</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1007/s10719-012-9403-4</pub-id><?supplied-pmid 22684214?><pub-id pub-id-type="pmid">22684214</pub-id></element-citation></ref><ref id="B95-vaccines-08-00468"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willf&#x000f6;r</surname><given-names>S.</given-names></name><name><surname>Sundberg</surname><given-names>K.</given-names></name><name><surname>Tenkanen</surname><given-names>M.</given-names></name><name><surname>Holmbom</surname><given-names>B.</given-names></name></person-group><article-title>Spruce-derived mannans&#x02014;A potential raw material for hydrocolloids and novel advanced natural materials</article-title><source>Carbohydr. Polym.</source><year>2008</year><volume>72</volume><fpage>197</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2007.08.006</pub-id></element-citation></ref><ref id="B96-vaccines-08-00468"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dourado</surname><given-names>F.</given-names></name><name><surname>Madureira</surname><given-names>P.</given-names></name><name><surname>Carvalho</surname><given-names>V.</given-names></name><name><surname>Coelho</surname><given-names>R.</given-names></name><name><surname>Coimbra</surname><given-names>M.A.</given-names></name><name><surname>Vilanova</surname><given-names>M.</given-names></name><name><surname>Mota</surname><given-names>M.</given-names></name><name><surname>Gama</surname><given-names>F.M.</given-names></name></person-group><article-title>Purification, structure and immunobiological activity of an arabinan-rich pectic polysaccharide from the cell walls of <italic>Prunus dulcis</italic> seeds</article-title><source>Carbohydr. Res.</source><year>2004</year><volume>339</volume><fpage>2555</fpage><lpage>2566</lpage><pub-id pub-id-type="doi">10.1016/j.carres.2004.07.024</pub-id><?supplied-pmid 15476717?><pub-id pub-id-type="pmid">15476717</pub-id></element-citation></ref><ref id="B97-vaccines-08-00468"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>R.</given-names></name><name><surname>Ai</surname><given-names>L.</given-names></name><name><surname>Cao</surname><given-names>N.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name></person-group><article-title>Physicochemical properties and structural characterization of a galactomannan from <italic>Sophora alopecuroides</italic> L. seeds</article-title><source>Carbohydr. Polym.</source><year>2016</year><volume>140</volume><fpage>451</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2015.12.058</pub-id><?supplied-pmid 26876873?><pub-id pub-id-type="pmid">26876873</pub-id></element-citation></ref><ref id="B98-vaccines-08-00468"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>G.</given-names></name><name><surname>Schepetkin</surname><given-names>I.A.</given-names></name><name><surname>Quinn</surname><given-names>M.T.</given-names></name></person-group><article-title>Immunomodulatory activity of acidic polysaccharides isolated from <italic>Tanacetum vulgare</italic> L</article-title><source>Int. Immunopharmacol.</source><year>2007</year><volume>7</volume><fpage>1639</fpage><lpage>1650</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2007.08.013</pub-id><?supplied-pmid 17996673?><pub-id pub-id-type="pmid">17996673</pub-id></element-citation></ref><ref id="B99-vaccines-08-00468"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>P.K.R.</given-names></name><name><surname>Rodriguez</surname><given-names>S.</given-names></name><name><surname>Ramachandran</surname><given-names>R.</given-names></name><name><surname>Alamo</surname><given-names>A.</given-names></name><name><surname>Melnick</surname><given-names>S.J.</given-names></name><name><surname>Escalon</surname><given-names>E.</given-names></name><name><surname>Garcia</surname><given-names>P.I.</given-names><suffix>Jr.</suffix></name><name><surname>Wnuk</surname><given-names>S.F.</given-names></name><name><surname>Ramachandran</surname><given-names>C.</given-names></name></person-group><article-title>Immune stimulating properties of a novel polysaccharide from the medicinal plant Tinospora cordifolia</article-title><source>Int. Immunopharmacol.</source><year>2004</year><volume>4</volume><fpage>1645</fpage><lpage>1659</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2004.07.024</pub-id><pub-id pub-id-type="pmid">15454117</pub-id></element-citation></ref><ref id="B100-vaccines-08-00468"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramesh</surname><given-names>H.P.</given-names></name><name><surname>Yamaki</surname><given-names>K.</given-names></name><name><surname>Tsushida</surname><given-names>T.</given-names></name></person-group><article-title>Effect of fenugreek (<italic>Trigonella foenum-graecum</italic> L.) galactomannan fractions on phagocytosis in rat macrophages and on proliferation and IgM secretion in HB4C5 cells</article-title><source>Carbohydr. Polym.</source><year>2002</year><volume>50</volume><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/S0144-8617(01)00377-0</pub-id></element-citation></ref><ref id="B101-vaccines-08-00468"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name></person-group><article-title>Advances in Research on Immunoregulation of Macrophages by Plant Polysaccharides</article-title><source>Front. Immunol.</source><year>2019</year><volume>10</volume><fpage>145</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.00145</pub-id><pub-id pub-id-type="pmid">30804942</pub-id></element-citation></ref><ref id="B102-vaccines-08-00468"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>J.F.</given-names></name><name><surname>Wang</surname><given-names>Z.X.</given-names></name><name><surname>Zhang</surname><given-names>X.Y.</given-names></name><name><surname>Zhang</surname><given-names>R.F.</given-names></name></person-group><article-title>Study on immunomodulatory effect of Astragalus Polysaccharide on mice peritoneal macrophage</article-title><source>J. Henan Univ.</source><year>2005</year><volume>24</volume><fpage>34</fpage><lpage>36</lpage></element-citation></ref><ref id="B103-vaccines-08-00468"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K.Y.</given-names></name><name><surname>Jeon</surname><given-names>Y.J.</given-names></name></person-group><article-title>Macrophage activation by polysaccharide isolated from <italic>Astragalus membranaceus</italic></article-title><source>Int. Immunopharm.</source><year>2005</year><volume>5</volume><fpage>1225</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2005.02.020</pub-id></element-citation></ref><ref id="B104-vaccines-08-00468"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eman</surname><given-names>Z.</given-names></name><name><surname>Engy</surname><given-names>R.</given-names></name><name><surname>Fatma</surname><given-names>A.</given-names></name><name><surname>Hebata</surname><given-names>A.M.</given-names></name><name><surname>Tarek</surname><given-names>I.</given-names></name></person-group><article-title>Effects of dietary Astragalus polysaccharides (APS) on growth performance, immunological parameters, digestive enzymes, and intestinal morphology of Nile tilapia (Oreochromis niloticus)</article-title><source>Fish Shellfish Immunol.</source><year>2014</year><volume>38</volume><fpage>149</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">24657260</pub-id></element-citation></ref><ref id="B105-vaccines-08-00468"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>Q.</given-names></name><name><surname>Niu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Qiao</surname><given-names>Z.</given-names></name><name><surname>Gu</surname><given-names>Y.</given-names></name></person-group><article-title><italic>Astragalus membranaceus</italic> extract activates immune response in macrophages via heparanase</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>7232</fpage><lpage>7240</lpage><pub-id pub-id-type="doi">10.3390/molecules17067232</pub-id><?supplied-pmid 22695229?><pub-id pub-id-type="pmid">22695229</pub-id></element-citation></ref><ref id="B106-vaccines-08-00468"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>M.S.</given-names></name><name><surname>Park</surname><given-names>S.B.</given-names></name><name><surname>Shin</surname><given-names>K.S.</given-names></name></person-group><article-title>Molecular mechanisms of immunomodulatory activity by polysaccharide isolated from the peels of <italic>Citrus unshiu</italic></article-title><source>Int. J. Biol. Macromol.</source><year>2018</year><volume>112</volume><fpage>576</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2018.02.006</pub-id><?supplied-pmid 29410270?><pub-id pub-id-type="pmid">29410270</pub-id></element-citation></ref><ref id="B107-vaccines-08-00468"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahasrabudhe</surname><given-names>N.M.</given-names></name><name><surname>Beukema</surname><given-names>M.</given-names></name><name><surname>Tian</surname><given-names>L.</given-names></name><name><surname>Troost</surname><given-names>B.</given-names></name><name><surname>Scholte</surname><given-names>J.</given-names></name><name><surname>Bruininx</surname><given-names>E.</given-names></name><name><surname>Bruggeman</surname><given-names>G.</given-names></name><name><surname>van den Berg</surname><given-names>M.</given-names></name><name><surname>Scheurink</surname><given-names>A.</given-names></name><name><surname>Schols</surname><given-names>H.A.</given-names></name><etal/></person-group><article-title>Dietary fiber pectin directly blocks toll-like receptor 2-1 and prevents doxorubicin-induced ileitis</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><fpage>383</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00383</pub-id><?supplied-pmid 29545800?><pub-id pub-id-type="pmid">29545800</pub-id></element-citation></ref><ref id="B108-vaccines-08-00468"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Folkerts</surname><given-names>J.</given-names></name><name><surname>Folkerts</surname><given-names>G.</given-names></name><name><surname>Maurer</surname><given-names>M.</given-names></name><name><surname>Braber</surname><given-names>S.</given-names></name></person-group><article-title>Microbiota-dependent and -independent effects of dietary fibre on human health</article-title><source>Br. J. Pharmacol.</source><year>2020</year><volume>177</volume><fpage>1363</fpage><lpage>1381</lpage><pub-id pub-id-type="doi">10.1111/bph.14871</pub-id><?supplied-pmid 31663129?><pub-id pub-id-type="pmid">31663129</pub-id></element-citation></ref><ref id="B109-vaccines-08-00468"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name></person-group><article-title><italic>Echinacea purpurea</italic> extracts promote murine dendritic cell maturation by activation of JNK, p38 MAPK and NF-&#x003ba;B pathways</article-title><source>Dev. Comp. Immunol.</source><year>2017</year><volume>73</volume><fpage>21</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2017.03.002</pub-id><pub-id pub-id-type="pmid">28263837</pub-id></element-citation></ref><ref id="B110-vaccines-08-00468"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Tian</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name></person-group><article-title>Extraction, characterization of Astragalus polysaccharides and its immune modulating activities in rats with gastric cancer</article-title><source>Carbohydr. Polym.</source><year>2009</year><volume>78</volume><fpage>738</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2009.06.005</pub-id></element-citation></ref><ref id="B111-vaccines-08-00468"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Ma</surname><given-names>W.</given-names></name><name><surname>Cheng</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name></person-group><article-title>Enhancement of Astragalus polysaccharide on the immune responses in pigs inoculated with foot-and-mouth disease virus vaccine</article-title><source>Int. J. Biol. Macromol.</source><year>2011</year><volume>49</volume><fpage>362</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2011.05.015</pub-id><pub-id pub-id-type="pmid">21640133</pub-id></element-citation></ref><ref id="B112-vaccines-08-00468"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.H.</given-names></name><name><surname>Zhang</surname><given-names>J.Z.</given-names></name><name><surname>Liu</surname><given-names>S.J.</given-names></name><name><surname>Qiu</surname><given-names>H.N.</given-names></name><name><surname>Guo</surname><given-names>J.X.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name></person-group><article-title>Effect of radix astragali drug serum on NK cell activity and expression of KLRK1</article-title><source>Prog. Mod. Biomed.</source><year>2014</year><volume>14</volume><fpage>4637</fpage><lpage>4640</lpage></element-citation></ref><ref id="B113-vaccines-08-00468"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Qian</surname><given-names>T.</given-names></name><name><surname>Sun</surname><given-names>G.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Chang</surname><given-names>F.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name></person-group><article-title>Antitumor andimmunomodulatory activity of arabinoxylans: A major constituent of wheatbran</article-title><source>Int. J. Biol. Macromol.</source><year>2011</year><volume>48</volume><fpage>160</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2010.10.014</pub-id><pub-id pub-id-type="pmid">21087621</pub-id></element-citation></ref><ref id="B114-vaccines-08-00468"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghoneum</surname><given-names>M.</given-names></name><name><surname>Abedi</surname><given-names>S.</given-names></name></person-group><article-title>Enhancement of natural killer cell activity of agedmice by modified arabinoxylan rice bran (MGN-3/Biobran)</article-title><source>J. Pharm. Pharmacol.</source><year>2004</year><volume>56</volume><fpage>1581</fpage><lpage>1588</lpage><pub-id pub-id-type="doi">10.1211/0022357044922</pub-id><?supplied-pmid 15563765?><pub-id pub-id-type="pmid">15563765</pub-id></element-citation></ref><ref id="B115-vaccines-08-00468"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>B.M.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Dai</surname><given-names>H.</given-names></name><name><surname>Tu</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Gao</surname><given-names>X.M.</given-names></name></person-group><article-title>A study on the immune receptors for polysaccharides from the roots of <italic>Astragalus membranaceus</italic>, a Chinese medicinal herb</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2004</year><volume>320</volume><fpage>1103</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.06.065</pub-id><?supplied-pmid 15249203?><pub-id pub-id-type="pmid">15249203</pub-id></element-citation></ref><ref id="B116-vaccines-08-00468"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name><name><surname>Ruan</surname><given-names>S.</given-names></name></person-group><article-title>Effects of Astragalus polysaccharide liposome on lymphocyte proliferation <italic>in vitro</italic> and adjuvanticity <italic>in vivo</italic></article-title><source>Carbohydr. Polym.</source><year>2012</year><volume>88</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2011.11.067</pub-id></element-citation></ref><ref id="B117-vaccines-08-00468"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Lim</surname><given-names>T.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Cho</surname><given-names>C.</given-names></name><name><surname>Jang</surname><given-names>M.</given-names></name></person-group><article-title>Mixing ratio optimization for functional complex extracts of Rhodiola crenulata, Panax quinquefolius, and <italic>Astragalus membranaceus</italic> using mixture design and verification of immune functional efficacy in animal models</article-title><source>J. Funct. Foods</source><year>2018</year><volume>40</volume><fpage>447</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2017.11.038</pub-id><?supplied-pmid 32288793?><pub-id pub-id-type="pmid">32288793</pub-id></element-citation></ref><ref id="B118-vaccines-08-00468"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abuelsaad</surname><given-names>A.S.</given-names></name></person-group><article-title>Supplementation with Astragalus polysaccharides alters <italic>Aeromonas</italic>-induced tissue-specific cellular immune response</article-title><source>Microb. Pathog.</source><year>2014</year><volume>66</volume><fpage>48</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2013.12.005</pub-id><pub-id pub-id-type="pmid">24456824</pub-id></element-citation></ref><ref id="B119-vaccines-08-00468"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novak</surname><given-names>M.</given-names></name><name><surname>Vetvicka</surname><given-names>V.</given-names></name></person-group><article-title>Beta-glucans, history, and the present: Immunomodulatory aspects and mechanisms of action</article-title><source>J. Immunotoxicol.</source><year>2008</year><volume>5</volume><fpage>47</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1080/15476910802019045</pub-id><pub-id pub-id-type="pmid">18382858</pub-id></element-citation></ref><ref id="B120-vaccines-08-00468"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar</surname><given-names>J.C.</given-names></name><name><surname>Rodriguez</surname><given-names>E.G.</given-names></name></person-group><article-title>Vaccine adjuvants revisited</article-title><source>Vaccine</source><year>2007</year><volume>25</volume><fpage>3752</fpage><lpage>3762</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2007.01.111</pub-id><pub-id pub-id-type="pmid">17336431</pub-id></element-citation></ref><ref id="B121-vaccines-08-00468"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda-Okubo</surname><given-names>Y.</given-names></name><name><surname>Saade</surname><given-names>F.</given-names></name><name><surname>Petrovsky</surname><given-names>N.</given-names></name></person-group><article-title>AdvaxTM, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses</article-title><source>Vaccine</source><year>2012</year><volume>30</volume><fpage>5373</fpage><lpage>5381</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2012.06.021</pub-id><pub-id pub-id-type="pmid">22728225</pub-id></element-citation></ref><ref id="B122-vaccines-08-00468"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saade</surname><given-names>F.</given-names></name><name><surname>Honda-Okubo</surname><given-names>Y.</given-names></name><name><surname>Trec</surname><given-names>S.</given-names></name><name><surname>Petrovsky</surname><given-names>N.</given-names></name></person-group><article-title>A novel hepatitis B vaccine containing AdvaxTM, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing</article-title><source>Vaccine</source><year>2013</year><volume>31</volume><fpage>1999</fpage><lpage>2007</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2012.12.077</pub-id><pub-id pub-id-type="pmid">23306367</pub-id></element-citation></ref><ref id="B123-vaccines-08-00468"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name><name><surname>Diao</surname><given-names>M.</given-names></name><name><surname>Feng</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Zeng</surname><given-names>X.</given-names></name></person-group><article-title>Astragalus polysaccharides enhance immune responses of HBV DNA vaccination via promoting the dendritic cell maturation and suppressing Treg frequency in mice</article-title><source>Int. Immunopharmacol.</source><year>2012</year><volume>14</volume><fpage>463</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2012.09.006</pub-id><pub-id pub-id-type="pmid">23006659</pub-id></element-citation></ref><ref id="B124-vaccines-08-00468"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vassilaros</surname><given-names>S.</given-names></name><name><surname>Tsibanis</surname><given-names>A.</given-names></name><name><surname>Tsikkinis</surname><given-names>A.</given-names></name><name><surname>Pietersz</surname><given-names>G.A.</given-names></name><name><surname>McKenzie</surname><given-names>I.F.</given-names></name><name><surname>Apostolopoulos</surname><given-names>V.</given-names></name></person-group><article-title>Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1</article-title><source>Immunotherapy</source><year>2013</year><volume>5</volume><fpage>1177</fpage><lpage>1182</lpage><pub-id pub-id-type="doi">10.2217/imt.13.126</pub-id><?supplied-pmid 24188672?><pub-id pub-id-type="pmid">24188672</pub-id></element-citation></ref><ref id="B125-vaccines-08-00468"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kjaerup</surname><given-names>R.M.</given-names></name><name><surname>Dalgaard</surname><given-names>T.S.</given-names></name><name><surname>Norup</surname><given-names>L.R.</given-names></name><name><surname>Bergman</surname><given-names>I.M.</given-names></name><name><surname>S&#x000f8;rensen</surname><given-names>P.</given-names></name><name><surname>Juul-Madsen</surname><given-names>H.R.</given-names></name></person-group><article-title>Adjuvant effects of mannose-binding lectin ligands on the immune response to infectious bronchitis vaccine in chickens with high or low serum mannose-binding lectin concentrations</article-title><source>Immunobiology</source><year>2014</year><volume>219</volume><fpage>263</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/j.imbio.2013.10.013</pub-id><?supplied-pmid 24305086?><pub-id pub-id-type="pmid">24305086</pub-id></element-citation></ref><ref id="B126-vaccines-08-00468"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luu</surname><given-names>M.</given-names></name><name><surname>Visekruna</surname><given-names>A.</given-names></name></person-group><article-title>Short-chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells</article-title><source>Eur. J. Immunol.</source><year>2019</year><volume>9</volume><fpage>842</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1002/eji.201848009</pub-id><?supplied-pmid 31054154?><pub-id pub-id-type="pmid">31054154</pub-id></element-citation></ref><ref id="B127-vaccines-08-00468"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>A.</given-names></name><name><surname>De Vadder</surname><given-names>F.</given-names></name><name><surname>Kovatcheva-Datchary</surname><given-names>P.</given-names></name><name><surname>Backhed</surname><given-names>F.</given-names></name></person-group><article-title>From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites</article-title><source>Cell</source><year>2016</year><volume>165</volume><fpage>1332</fpage><lpage>1345</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.041</pub-id><?supplied-pmid 27259147?><pub-id pub-id-type="pmid">27259147</pub-id></element-citation></ref><ref id="B128-vaccines-08-00468"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segain</surname><given-names>J.P.</given-names></name><name><surname>Raingeard de la Bletiere</surname><given-names>D.</given-names></name><name><surname>Bourreille</surname><given-names>A.</given-names></name><name><surname>Leray</surname><given-names>V.</given-names></name><name><surname>Gervois</surname><given-names>N.</given-names></name><name><surname>Rosales</surname><given-names>C.</given-names></name><name><surname>Ferrier</surname><given-names>L.</given-names></name><name><surname>Bonnet</surname><given-names>C.</given-names></name><name><surname>Blotti&#x000e8;re</surname><given-names>H.M.</given-names></name><name><surname>Galmiche</surname><given-names>J.P.</given-names></name></person-group><article-title>Butyrate inhibits inflammatory responses through NFkappaB inhibition: Implications for Crohn&#x02019;s disease</article-title><source>Gut</source><year>2000</year><volume>47</volume><fpage>397</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1136/gut.47.3.397</pub-id><pub-id pub-id-type="pmid">10940278</pub-id></element-citation></ref><ref id="B129-vaccines-08-00468"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M.H.</given-names></name><name><surname>Kang</surname><given-names>S.G.</given-names></name><name><surname>Park</surname><given-names>J.H.</given-names></name><name><surname>Yanagisawa</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>C.H.</given-names></name></person-group><article-title>Shortchain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice</article-title><source>Gastroenterology</source><year>2013</year><volume>145</volume><fpage>396</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2013.04.056</pub-id><pub-id pub-id-type="pmid">23665276</pub-id></element-citation></ref><ref id="B130-vaccines-08-00468"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>C.M.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>Z.</given-names></name></person-group><article-title>Addition of astragalus into peritoneal dialysate improve peritoneal macrophages function in CAPD patients</article-title><source>J. Med. Postgrad.</source><year>2005</year><volume>18</volume><fpage>135</fpage><lpage>138</lpage></element-citation></ref><ref id="B131-vaccines-08-00468"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>X.Q.</given-names></name><name><surname>Du</surname><given-names>J.F.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name></person-group><article-title>Comparison of perioperative immune function status in colorectal cancer patients and immune regulatory function of drugs</article-title><source>Pract. J. Cancer</source><year>2011</year><volume>26</volume><fpage>331</fpage><lpage>334</lpage></element-citation></ref><ref id="B132-vaccines-08-00468"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>X.S.</given-names></name><name><surname>Sun</surname><given-names>Z.X.</given-names></name></person-group><article-title>Influences of astragalus Injection on clinical efficacy and cellular immune function in patients of bronchial asthma with acute exacerbation</article-title><source>Chin. J. Exp. Trad. Med. Form.</source><year>2012</year><volume>18</volume><fpage>293</fpage><lpage>296</lpage></element-citation></ref><ref id="B133-vaccines-08-00468"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>E.</given-names></name><name><surname>Parlesak</surname><given-names>A.</given-names></name><name><surname>Henneicke-von Zepelin</surname><given-names>H.H.</given-names></name><name><surname>Bode</surname><given-names>J.C.</given-names></name><name><surname>Bode</surname><given-names>C.</given-names></name></person-group><article-title>Effect of oral administration of freshly pressed juice of <italic>Echinacea purpurea</italic> on the number of various subpopulations of B- and T-lymphocytes in healthy volunteers: Results of a double-blind, placebo-controlled cross-over study</article-title><source>Phytomedicine</source><year>2005</year><volume>12</volume><fpage>625</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2005.04.001</pub-id><pub-id pub-id-type="pmid">16194048</pub-id></element-citation></ref><ref id="B134-vaccines-08-00468"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinkeborn</surname><given-names>R.M.</given-names></name><name><surname>Shah</surname><given-names>D.V.</given-names></name><name><surname>Degenring</surname><given-names>F.H.</given-names></name></person-group><article-title>Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial</article-title><source>Phytomedicine</source><year>1999</year><volume>6</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/S0944-7113(99)80027-0</pub-id><pub-id pub-id-type="pmid">10228604</pub-id></element-citation></ref><ref id="B135-vaccines-08-00468"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karsch-V&#x000f6;lk</surname><given-names>M.</given-names></name><name><surname>Barrett</surname><given-names>B.</given-names></name><name><surname>Kiefer</surname><given-names>D.</given-names></name><name><surname>Bauer</surname><given-names>R.</given-names></name><name><surname>Ardjomand-Woelkart</surname><given-names>K.</given-names></name><name><surname>Linde</surname><given-names>K.</given-names></name></person-group><article-title>Echinacea for preventing and treating the common cold</article-title><source>Cochrane Database Syst. Rev.</source><year>2014</year><volume>2</volume><pub-id pub-id-type="doi">10.1002/14651858.CD000530.pub3</pub-id><?supplied-pmid 24554461?><pub-id pub-id-type="pmid">24554461</pub-id></element-citation></ref><ref id="B136-vaccines-08-00468"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>J.</given-names></name><name><surname>Svozil</surname><given-names>V.</given-names></name><name><surname>Kral</surname><given-names>V.</given-names></name><name><surname>Rajnohova Dobiasova</surname><given-names>L.</given-names></name><name><surname>Stiborova</surname><given-names>I.</given-names></name><name><surname>Vetvicka</surname><given-names>V.</given-names></name></person-group><article-title>Clinical trials of yeast-derived beta-(1,3) glucan in children: Effects on innate immunity</article-title><source>Ann. Transl. Med.</source><year>2014</year><volume>2</volume><fpage>15</fpage><?supplied-pmid 25332991?><pub-id pub-id-type="pmid">25332991</pub-id></element-citation></ref><ref id="B137-vaccines-08-00468"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>J.</given-names></name><name><surname>Svozil</surname><given-names>V.</given-names></name><name><surname>Kral</surname><given-names>V.</given-names></name><name><surname>Rajnohova Dobiasova</surname><given-names>L.</given-names></name><name><surname>Vetvicka</surname><given-names>V.</given-names></name></person-group><article-title>beta-glucan affects mucosal immunity in children with chronic respiratory problems under physical stress: Clinical trials</article-title><source>Ann. Transl. Med.</source><year>2015</year><volume>3</volume><fpage>52</fpage><pub-id pub-id-type="pmid">25861607</pub-id></element-citation></ref><ref id="B138-vaccines-08-00468"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vetvicka</surname><given-names>V.</given-names></name><name><surname>Richter</surname><given-names>J.</given-names></name><name><surname>Svozil</surname><given-names>V.</given-names></name><name><surname>Rajnohova Dobiasova</surname><given-names>L.</given-names></name><name><surname>Kral</surname><given-names>V.</given-names></name></person-group><article-title>Placebo-driven clinical trials of yeast-derived beta-(1-3) glucan in children with chronic respiratory problems</article-title><source>Ann. Transl. Med.</source><year>2013</year><volume>1</volume><fpage>26</fpage><pub-id pub-id-type="pmid">25332970</pub-id></element-citation></ref><ref id="B139-vaccines-08-00468"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varricchio</surname><given-names>A.M.</given-names></name><name><surname>Capasso</surname><given-names>M.</given-names></name><name><surname>Della Volpe</surname><given-names>A.</given-names></name><name><surname>Malafronte</surname><given-names>L.</given-names></name><name><surname>Mansi</surname><given-names>N.</given-names></name><name><surname>Varricchio</surname><given-names>A.</given-names></name><name><surname>Ciprandi</surname><given-names>G.</given-names></name></person-group><article-title>Resveratrol plus carboxymethyl-&#x003b2;-glucan in children with recurrent respiratory infections: A preliminary and real-life experience</article-title><source>Ital. J. Pediatr.</source><year>2014</year><volume>40</volume><fpage>93</fpage><pub-id pub-id-type="doi">10.1186/s13052-014-0093-3</pub-id><pub-id pub-id-type="pmid">25416925</pub-id></element-citation></ref><ref id="B140-vaccines-08-00468"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldassarre</surname><given-names>M.E.</given-names></name><name><surname>Di Mauro</surname><given-names>A.</given-names></name><name><surname>Labellarte</surname><given-names>G.</given-names></name><name><surname>Pignatelli</surname><given-names>M.</given-names></name><name><surname>Fanelli</surname><given-names>M.</given-names></name><name><surname>Schiavi</surname><given-names>E.</given-names></name><name><surname>Mastromarino</surname><given-names>P.</given-names></name><name><surname>Capozza</surname><given-names>M.</given-names></name><name><surname>Panza</surname><given-names>R.</given-names></name><name><surname>Laforgia</surname><given-names>N.</given-names></name></person-group><article-title>Resveratrol plus carboxymethyl-&#x003b2;-glucan in infants with common cold: A randomized double-blind trial</article-title><source>Heliyon</source><year>2020</year><volume>6</volume><fpage>e03814</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e03814</pub-id><pub-id pub-id-type="pmid">32322697</pub-id></element-citation></ref><ref id="B141-vaccines-08-00468"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miraglia Del Giudice</surname><given-names>M.</given-names></name><name><surname>Maiello</surname><given-names>N.</given-names></name><name><surname>Capristo</surname><given-names>C.</given-names></name><name><surname>Alterio</surname><given-names>E.</given-names></name><name><surname>Capasso</surname><given-names>M.</given-names></name><name><surname>Perrone</surname><given-names>L.</given-names></name><name><surname>Ciprandi</surname><given-names>G.</given-names></name></person-group><article-title>Resveratrol plus carboxymethyl-&#x003b2;-glucan reduces nasal symptoms in children with pollen-induced allergic rhinitis</article-title><source>Curr. Med. Res. Opin.</source><year>2014</year><volume>30</volume><fpage>1931</fpage><lpage>1935</lpage><pub-id pub-id-type="doi">10.1185/03007995.2014.938731</pub-id><pub-id pub-id-type="pmid">24983742</pub-id></element-citation></ref><ref id="B142-vaccines-08-00468"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahy</surname><given-names>E.</given-names></name><name><surname>Subramaniam</surname><given-names>S.</given-names></name><name><surname>Murphy</surname><given-names>R.C.</given-names></name><name><surname>Nishijima</surname><given-names>M.</given-names></name><name><surname>Raetz</surname><given-names>C.R.</given-names></name><name><surname>Shimizu</surname><given-names>T.</given-names></name><name><surname>Spener</surname><given-names>F.</given-names></name><name><surname>van Meer</surname><given-names>G.</given-names></name><name><surname>Wakelam</surname><given-names>M.J.</given-names></name><name><surname>Dennis</surname><given-names>E.A.</given-names></name></person-group><article-title>Update of the LIPID MAPS comprehensive classification system for lipids</article-title><source>J. Lipid Res.</source><year>2009</year><volume>50</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1194/jlr.R800095-JLR200</pub-id></element-citation></ref><ref id="B143-vaccines-08-00468"><label>143.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>C.</given-names></name></person-group><source>Fatty Acids in Foods and Their Health Implications</source><edition>3rd ed.</edition><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2007</year><fpage>1</fpage><lpage>17</lpage></element-citation></ref><ref id="B144-vaccines-08-00468"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>W.</given-names></name><name><surname>Ao</surname><given-names>H.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name></person-group><article-title>Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines</article-title><source>Front. Pharmacol.</source><year>2018</year><volume>9</volume><fpage>1354</fpage><pub-id pub-id-type="doi">10.3389/fphar.2018.01354</pub-id><pub-id pub-id-type="pmid">30532706</pub-id></element-citation></ref><ref id="B145-vaccines-08-00468"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oteng</surname><given-names>A.B.</given-names></name><name><surname>Kersten</surname><given-names>S.</given-names></name></person-group><article-title>Mechanisms of Action of trans Fatty Acids</article-title><source>Adv. Nutr.</source><year>2020</year><volume>11</volume><fpage>697</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1093/advances/nmz125</pub-id><?supplied-pmid 31782488?><pub-id pub-id-type="pmid">31782488</pub-id></element-citation></ref><ref id="B146-vaccines-08-00468"><label>146.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Burdge</surname><given-names>G.C.</given-names></name></person-group><article-title>Polyunsaturated fatty acid biosynthesis and metabolism in adult mammals</article-title><source>Polyunsaturated Fatty Acid Metabolism</source><edition>1st ed.</edition><person-group person-group-type="editor"><name><surname>Burdge</surname><given-names>G.C.</given-names></name></person-group><publisher-name>Elsevier Inc.</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2018</year><fpage>15</fpage><lpage>30</lpage></element-citation></ref><ref id="B147-vaccines-08-00468"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hageman</surname><given-names>J.H.</given-names></name><name><surname>Danielsen</surname><given-names>M.</given-names></name><name><surname>Nieuwenhuizen</surname><given-names>A.G.</given-names></name><name><surname>Feitsma</surname><given-names>A.L.</given-names></name><name><surname>Dalsgaard</surname><given-names>T.K.</given-names></name></person-group><article-title>Comparison of bovine milk fat and vegetable fat for infant formula: Implications for infant health</article-title><source>Int. Dairy J.</source><year>2019</year><volume>92</volume><fpage>37</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.idairyj.2019.01.005</pub-id></element-citation></ref><ref id="B148-vaccines-08-00468"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arkcoll</surname><given-names>D.</given-names></name></person-group><article-title>Laurie oil resources</article-title><source>Econ. Bot.</source><year>1988</year><volume>42</volume><fpage>195</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1007/BF02858920</pub-id></element-citation></ref><ref id="B149-vaccines-08-00468"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fattore</surname><given-names>E.</given-names></name><name><surname>Fanelli</surname><given-names>R.</given-names></name></person-group><article-title>Palm oil and palmitic acid: A review on cardiovascular effects and carcinogenicity</article-title><source>Int. J. Food Sci. Nutr.</source><year>2013</year><volume>64</volume><fpage>648</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.3109/09637486.2013.768213</pub-id><?supplied-pmid 23406428?><pub-id pub-id-type="pmid">23406428</pub-id></element-citation></ref><ref id="B150-vaccines-08-00468"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aruna</surname><given-names>P.</given-names></name><name><surname>Venkataramanamma</surname><given-names>D.</given-names></name><name><surname>Singh</surname><given-names>A.K.</given-names></name><name><surname>Singh</surname><given-names>R.P.</given-names></name></person-group><article-title>Health benefits of punicic acid: A review</article-title><source>Compr. Rev. Food Sci. Food Saf.</source><year>2016</year><volume>15</volume><fpage>16</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1111/1541-4337.12171</pub-id></element-citation></ref><ref id="B151-vaccines-08-00468"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Servili</surname><given-names>M.</given-names></name><name><surname>Sordini</surname><given-names>B.</given-names></name><name><surname>Esposto</surname><given-names>S.</given-names></name><name><surname>Urbani</surname><given-names>S.</given-names></name><name><surname>Veneziani</surname><given-names>G.</given-names></name><name><surname>Di Maio</surname><given-names>I.</given-names></name><name><surname>Selvaggini</surname><given-names>R.</given-names></name><name><surname>Taticchi</surname><given-names>A.</given-names></name></person-group><article-title>Biological Activities of Phenolic Compounds of Extra Virgin Olive Oil</article-title><source>Antioxidants</source><year>2013</year><volume>3</volume><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.3390/antiox3010001</pub-id><pub-id pub-id-type="pmid">26784660</pub-id></element-citation></ref><ref id="B152-vaccines-08-00468"><label>152.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>S.G.</given-names></name><name><surname>Won</surname><given-names>S.R.</given-names></name><name><surname>Rhee</surname><given-names>H.I.</given-names></name></person-group><article-title>Oleic Acid and Inhibition of Glucosyltransferase</article-title><source>Olives and Olive Oil in Health and Disease Prevention</source><edition>1st ed.</edition><person-group person-group-type="editor"><name><surname>Preedy</surname><given-names>V.R.</given-names></name><name><surname>Watson</surname><given-names>R.R.</given-names></name></person-group><publisher-name>Academic Press</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2010</year><fpage>1375</fpage><lpage>1383</lpage></element-citation></ref><ref id="B153-vaccines-08-00468"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>R.K.</given-names></name><name><surname>Keum</surname><given-names>Y.S.</given-names></name></person-group><article-title>Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance&#x02014;A review</article-title><source>Life Sci.</source><year>2018</year><volume>203</volume><fpage>255</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2018.04.049</pub-id><pub-id pub-id-type="pmid">29715470</pub-id></element-citation></ref><ref id="B154-vaccines-08-00468"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachman</surname><given-names>J.</given-names></name><name><surname>Hejtm&#x000e1;nkov&#x000e1;</surname><given-names>A.</given-names></name><name><surname>Taborsky</surname><given-names>J.</given-names></name><name><surname>Kot&#x000ed;kov&#x000e1;</surname><given-names>Z.</given-names></name><name><surname>Pivec</surname><given-names>V.</given-names></name><name><surname>St&#x00159;alkov&#x000e1;</surname><given-names>R.</given-names></name><name><surname>Vollmannov&#x000e1;</surname><given-names>A.</given-names></name><name><surname>Boj&#x00148;ansk&#x000e1;</surname><given-names>T.</given-names></name><name><surname>D&#x0011b;dina</surname><given-names>M.</given-names></name></person-group><article-title>Evaluation of oil content and fatty acid composition in the seed of grapevine varieties</article-title><source>LWT Food Sci.Technol.</source><year>2015</year><volume>63</volume><fpage>620</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2015.03.044</pub-id></element-citation></ref><ref id="B155-vaccines-08-00468"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nath</surname><given-names>U.K.</given-names></name><name><surname>Kim</surname><given-names>H.-T.</given-names></name><name><surname>Khatun</surname><given-names>K.</given-names></name><name><surname>Park</surname><given-names>J.I.</given-names></name><name><surname>Kang</surname><given-names>K.K.</given-names></name><name><surname>Nou</surname><given-names>I.S.</given-names></name></person-group><article-title>Modification of fatty acid profiles of rapeseed (Brassica napus L.) oil for using as food, industrial feed-stock and biodiesel</article-title><source>Plant Breed. Biotechnol.</source><year>2016</year><volume>4</volume><fpage>123</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.9787/PBB.2016.4.2.123</pub-id></element-citation></ref><ref id="B156-vaccines-08-00468"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshime</surname><given-names>L.T.</given-names></name><name><surname>de Melo</surname><given-names>I.L.P.</given-names></name><name><surname>Sattler</surname><given-names>J.A.G.</given-names></name><name><surname>de Carvalho</surname><given-names>E.B.T.</given-names></name><name><surname>Mancini-Filho</surname><given-names>J.</given-names></name></person-group><article-title>Bitter gourd (<italic>Momordica charantia</italic> L.) seed oil as a naturally rich source of bioactive compounds for nutraceutical purposes</article-title><source>Nutrire</source><year>2016</year><volume>41</volume><fpage>12</fpage><pub-id pub-id-type="doi">10.1186/s41110-016-0013-y</pub-id></element-citation></ref><ref id="B157-vaccines-08-00468"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikh</surname><given-names>M.</given-names></name><name><surname>Netticadan</surname><given-names>T.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>Flaxseed: Its bioactive components and their cardiovascular benefits</article-title><source>Am. J. Physiol. Heart Circ. Physiol.</source><year>2018</year><volume>314</volume><fpage>H146</fpage><lpage>H159</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00400.2017</pub-id><?supplied-pmid 29101172?><pub-id pub-id-type="pmid">29101172</pub-id></element-citation></ref><ref id="B158-vaccines-08-00468"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asif</surname><given-names>M.</given-names></name></person-group><article-title>Health effects of omega-3,6,9 fatty acids: <italic>Perilla frutescens</italic> is a good example of plant oils</article-title><source>Orient. Pharm. Exp. Med.</source><year>2011</year><volume>11</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1007/s13596-011-0002-x</pub-id><?supplied-pmid 21909287?><pub-id pub-id-type="pmid">21909287</pub-id></element-citation></ref><ref id="B159-vaccines-08-00468"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guil-Guerrero</surname><given-names>J.L.</given-names></name><name><surname>G&#x000f3;mez-Mercado</surname><given-names>F.</given-names></name><name><surname>Ramos-Bueno</surname><given-names>R.P.</given-names></name><name><surname>Gonz&#x000e1;lez-Fern&#x000e1;ndez</surname><given-names>M.J.</given-names></name><name><surname>Urrestarazu</surname><given-names>M.</given-names></name><name><surname>Jim&#x000e9;nez-Becker</surname><given-names>S.</given-names></name><name><surname>de B&#x000e9;lair</surname><given-names>G.</given-names></name></person-group><article-title>Fatty acid profiles and sn -2 fatty acid distribution of &#x003b3;-linolenic acid-rich <italic>Borago</italic> species</article-title><source>J. Food Compos. Anal.</source><year>2018</year><volume>66</volume><fpage>74</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.jfca.2017.12.005</pub-id></element-citation></ref><ref id="B160-vaccines-08-00468"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timoszuk</surname><given-names>M.</given-names></name><name><surname>Bielawska</surname><given-names>K.</given-names></name><name><surname>Skrzydlewska</surname><given-names>E.</given-names></name></person-group><article-title>Evening Primrose (<italic>Oenothera biennis</italic>) Biological Activity Dependent on Chemical Composition</article-title><source>Antioxidants</source><year>2018</year><volume>7</volume><elocation-id>108</elocation-id><pub-id pub-id-type="doi">10.3390/antiox7080108</pub-id></element-citation></ref><ref id="B161-vaccines-08-00468"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farinon</surname><given-names>B.</given-names></name><name><surname>Molinari</surname><given-names>R.</given-names></name><name><surname>Costantini</surname><given-names>L.</given-names></name><name><surname>Merendino</surname><given-names>N.</given-names></name></person-group><article-title>The Seed of Industrial Hemp (<italic>Cannabis sativa</italic> L.): Nutritional Quality and Potential Functionality for Human Health and Nutrition</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>1935</elocation-id><pub-id pub-id-type="doi">10.3390/nu12071935</pub-id></element-citation></ref><ref id="B162-vaccines-08-00468"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traitler</surname><given-names>H.</given-names></name><name><surname>Winter</surname><given-names>H.</given-names></name><name><surname>Richli</surname><given-names>U.</given-names></name><name><surname>Ingenbleek</surname><given-names>Y.</given-names></name></person-group><article-title>Characterization of gamma-linolenic acid in Ribes seed</article-title><source>Lipids</source><year>1984</year><volume>19</volume><fpage>923</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1007/BF02534727</pub-id><pub-id pub-id-type="pmid">6098796</pub-id></element-citation></ref><ref id="B163-vaccines-08-00468"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.E.</given-names></name><name><surname>Shang</surname><given-names>X.</given-names></name><name><surname>Assefa</surname><given-names>A.D.</given-names></name><name><surname>Keum</surname><given-names>Y.S.</given-names></name><name><surname>Saini</surname><given-names>R.K.</given-names></name></person-group><article-title>Metabolite profiling of green, green/red, and red lettuce cultivars: Variation in health beneficial compounds and antioxidant potential</article-title><source>Food Res. Int.</source><year>2018</year><volume>105</volume><fpage>361</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2017.11.028</pub-id><pub-id pub-id-type="pmid">29433225</pub-id></element-citation></ref><ref id="B164-vaccines-08-00468"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaqoob</surname><given-names>P.</given-names></name></person-group><article-title>Monounsaturated fatty acids and immune function</article-title><source>Eur. J. Clin. Nutr.</source><year>2002</year><volume>56</volume><fpage>S9</fpage><lpage>S13</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1601477</pub-id><pub-id pub-id-type="pmid">12142954</pub-id></element-citation></ref><ref id="B165-vaccines-08-00468"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>N.M.</given-names></name><name><surname>Cortina</surname><given-names>M.</given-names></name><name><surname>Newsholme</surname><given-names>E.A.</given-names></name><name><surname>Calder</surname><given-names>P.C.</given-names></name></person-group><article-title>Effects of variations in the proportions of saturated, monounsaturated and polyunsaturated fatty acids in the rat diet on spleen lymphocyte functions</article-title><source>Br. J. Nutr.</source><year>1997</year><volume>77</volume><fpage>805</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1079/BJN19970077</pub-id><pub-id pub-id-type="pmid">9175999</pub-id></element-citation></ref><ref id="B166-vaccines-08-00468"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mastrangelo</surname><given-names>A.M.</given-names></name><name><surname>Jeitner</surname><given-names>T.M.</given-names></name><name><surname>Eaton</surname><given-names>J.W.</given-names></name></person-group><article-title>Oleic acid increases cell surface expression and activity of CD11b on human neutrophils</article-title><source>J. Immunol.</source><year>1998</year><volume>161</volume><fpage>4268</fpage><lpage>4275</lpage><pub-id pub-id-type="pmid">9780202</pub-id></element-citation></ref><ref id="B167-vaccines-08-00468"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrante</surname><given-names>A.</given-names></name><name><surname>Goh</surname><given-names>D.</given-names></name><name><surname>Harvey</surname><given-names>D.P.</given-names></name><name><surname>Robinson</surname><given-names>B.S.</given-names></name><name><surname>Hii</surname><given-names>C.S.</given-names></name><name><surname>Bates</surname><given-names>E.J.</given-names></name><name><surname>Hardy</surname><given-names>S.J.</given-names></name><name><surname>Johnson</surname><given-names>D.W.</given-names></name><name><surname>Poulos</surname><given-names>A.</given-names></name></person-group><article-title>Neutrophil migration inhibitory properties of polyunsaturated fatty acids. The role of fatty acid structure, metabolism, and possible second messenger systems</article-title><source>J. Clin. Investig.</source><year>1994</year><volume>93</volume><fpage>1063</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1172/JCI117056</pub-id><?supplied-pmid 8132744?><pub-id pub-id-type="pmid">8132744</pub-id></element-citation></ref><ref id="B168-vaccines-08-00468"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llado</surname><given-names>V.</given-names></name><name><surname>Gutierrez</surname><given-names>A.</given-names></name><name><surname>Martinez</surname><given-names>J.</given-names></name><name><surname>Casas</surname><given-names>J.</given-names></name><name><surname>Teres</surname><given-names>S.</given-names></name><name><surname>Higuera</surname><given-names>M.</given-names></name><name><surname>Galm&#x000e9;s</surname><given-names>A.</given-names></name><name><surname>Saus</surname><given-names>C.</given-names></name><name><surname>Besalduch</surname><given-names>J.</given-names></name><name><surname>Busquets</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Minerval induces apoptosis in Jurkat and other cancer cells</article-title><source>J. Cell. Mol. Med.</source><year>2010</year><volume>14</volume><fpage>659</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1111/j.1582-4934.2008.00625.x</pub-id><?supplied-pmid 19413889?><pub-id pub-id-type="pmid">19413889</pub-id></element-citation></ref><ref id="B169-vaccines-08-00468"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cury-Boaventura</surname><given-names>M.F.</given-names></name><name><surname>Pompeia</surname><given-names>C.</given-names></name><name><surname>Curi</surname><given-names>R.</given-names></name></person-group><article-title>Comparative toxicity of oleic acid and linoleic acid on Jurkat cells</article-title><source>Clin. Nutr.</source><year>2004</year><volume>23</volume><fpage>721</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2003.12.004</pub-id><?supplied-pmid 15297111?><pub-id pub-id-type="pmid">15297111</pub-id></element-citation></ref><ref id="B170-vaccines-08-00468"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cury-Boaventura</surname><given-names>M.F.</given-names></name><name><surname>Pompeia</surname><given-names>C.</given-names></name><name><surname>Curi</surname><given-names>R.</given-names></name></person-group><article-title>Comparative toxicity of oleic acid and linoleic acid on Raji cells</article-title><source>Nutrition</source><year>2005</year><volume>21</volume><fpage>395</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2004.07.007</pub-id><pub-id pub-id-type="pmid">15797684</pub-id></element-citation></ref><ref id="B171-vaccines-08-00468"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.H.</given-names></name><name><surname>Cho</surname><given-names>Y.M.</given-names></name><name><surname>Lee</surname><given-names>K.H.</given-names></name><name><surname>Jeong</surname><given-names>S.W.</given-names></name><name><surname>Kwon</surname><given-names>O.J.</given-names></name></person-group><article-title>Oleate protects macrophages from palmitate-induced apoptosis through the downregulation of CD36 expression</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2017</year><volume>488</volume><fpage>477</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2017.05.066</pub-id><pub-id pub-id-type="pmid">28522296</pub-id></element-citation></ref><ref id="B172-vaccines-08-00468"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Weidinger</surname><given-names>C.</given-names></name><name><surname>Schmidt</surname><given-names>F.</given-names></name><name><surname>Keye</surname><given-names>J.</given-names></name><name><surname>Friedrich</surname><given-names>M.</given-names></name><name><surname>Yerinde</surname><given-names>C.</given-names></name><name><surname>Willimsky</surname><given-names>G.</given-names></name><name><surname>Qin</surname><given-names>Z.</given-names></name><name><surname>Siegmund</surname><given-names>B.</given-names></name><name><surname>Glauben</surname><given-names>R.</given-names></name></person-group><article-title>Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>7498</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-07685-9</pub-id><pub-id pub-id-type="pmid">28790345</pub-id></element-citation></ref><ref id="B173-vaccines-08-00468"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>M.T.</given-names></name><name><surname>Hanzelmann</surname><given-names>D.</given-names></name><name><surname>H&#x000e4;rtner</surname><given-names>T.</given-names></name><name><surname>Peschel</surname><given-names>A.</given-names></name><name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name></person-group><article-title>Skin-Specific Unsaturated Fatty Acids Boost the Staphylococcus aureus Innate Immune Response</article-title><source>Infect. Immun.</source><year>2015</year><volume>84</volume><fpage>205</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1128/IAI.00822-15</pub-id><pub-id pub-id-type="pmid">26502910</pub-id></element-citation></ref><ref id="B174-vaccines-08-00468"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viladomiu</surname><given-names>M.</given-names></name><name><surname>Hontecillas</surname><given-names>R.</given-names></name><name><surname>Lu</surname><given-names>P.</given-names></name><name><surname>Bassaganya-Riera</surname><given-names>J.</given-names></name></person-group><article-title>Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents</article-title><source>Evid. Based Complement. Alternat. Med.</source><year>2013</year><volume>2013</volume><fpage>789764</fpage><pub-id pub-id-type="doi">10.1155/2013/789764</pub-id><pub-id pub-id-type="pmid">23737845</pub-id></element-citation></ref><ref id="B175-vaccines-08-00468"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name></person-group><article-title>Modulation of peroxisome proliferator-activated receptor gamma(PPAR &#x003b3;) by conjugated fatty acid in obesity and inflammatory bowel disease</article-title><source>J. Agric. Food Chem.</source><year>2015</year><volume>25</volume><fpage>1883</fpage><lpage>1895</lpage><pub-id pub-id-type="doi">10.1021/jf505050c</pub-id></element-citation></ref><ref id="B176-vaccines-08-00468"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boussetta</surname><given-names>T.</given-names></name><name><surname>Raad</surname><given-names>H.</given-names></name><name><surname>Lett&#x000e9;ron</surname><given-names>P.</given-names></name><name><surname>Gougerot-Pocidalo</surname><given-names>M.A.</given-names></name><name><surname>Marie</surname><given-names>J.C.</given-names></name><name><surname>Driss</surname><given-names>F.</given-names></name><name><surname>El-Benna</surname><given-names>J.</given-names></name></person-group><article-title>Punicic acid a conjugated linolenic acid inhibits TNFalpha-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats</article-title><source>PLoS ONE</source><year>2009</year><volume>4</volume><elocation-id>e6458</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0006458</pub-id><pub-id pub-id-type="pmid">19649246</pub-id></element-citation></ref><ref id="B177-vaccines-08-00468"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorente-Cebri&#x000e1;n</surname><given-names>S.</given-names></name><name><surname>Costa</surname><given-names>A.G.V.</given-names></name><name><surname>Navas-Carretero</surname><given-names>S.</given-names></name><name><surname>Zabala</surname><given-names>M.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>J.A.</given-names></name><name><surname>Moreno-Aliaga</surname><given-names>M.J.</given-names></name></person-group><article-title>Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: A review of the evidence</article-title><source>J. Physiol. Biochem.</source><year>2013</year><volume>69</volume><fpage>633</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1007/s13105-013-0265-4</pub-id><?supplied-pmid 23794360?><pub-id pub-id-type="pmid">23794360</pub-id></element-citation></ref><ref id="B178-vaccines-08-00468"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>P.C.</given-names></name></person-group><article-title>Polyunsaturated fatty acids and inflammation</article-title><source>Biochem. Soc. Trans.</source><year>2005</year><volume>33</volume><fpage>423</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1042/BST0330423</pub-id><?supplied-pmid 15787620?><pub-id pub-id-type="pmid">15787620</pub-id></element-citation></ref><ref id="B179-vaccines-08-00468"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Echeverria</surname><given-names>F.</given-names></name><name><surname>Ortiz</surname><given-names>M.</given-names></name><name><surname>Valenzuela</surname><given-names>R.</given-names></name><name><surname>Videla</surname><given-names>L.A.</given-names></name></person-group><article-title>Long-chain polyunsaturated fatty acids regulation of PPARs, signaling: Relationship to tissue development and aging</article-title><source>Prostaglandins Leukot. Essent. Fat Acids.</source><year>2016</year><volume>114</volume><fpage>28</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.plefa.2016.10.001</pub-id><?supplied-pmid 27926461?><pub-id pub-id-type="pmid">27926461</pub-id></element-citation></ref><ref id="B180-vaccines-08-00468"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>N.G.</given-names></name><name><surname>Contaifer</surname><given-names>D.</given-names></name><name><surname>Madurantakam</surname><given-names>P.</given-names></name><name><surname>Carbone</surname><given-names>S.</given-names></name><name><surname>Price</surname><given-names>E.T.</given-names></name><name><surname>Van Tassell</surname><given-names>B.</given-names></name><name><surname>Brophy</surname><given-names>D.F.</given-names></name><name><surname>Wijesinghe</surname><given-names>D.S.</given-names></name></person-group><article-title>Dietary Bioactive Fatty Acids as Modulators of Immune Function: Implications on Human Health</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>2974</elocation-id><pub-id pub-id-type="doi">10.3390/nu11122974</pub-id><?supplied-pmid 31817430?><pub-id pub-id-type="pmid">31817430</pub-id></element-citation></ref><ref id="B181-vaccines-08-00468"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costantini</surname><given-names>L.</given-names></name><name><surname>Molinari</surname><given-names>R.</given-names></name><name><surname>Farinon</surname><given-names>B.</given-names></name><name><surname>Merendino</surname><given-names>N.</given-names></name></person-group><article-title>Impact of Omega-3 Fatty Acids on the Gut Microbiota</article-title><source>Int. J. Mol. Sci.</source><year>2017</year><volume>18</volume><elocation-id>2645</elocation-id><pub-id pub-id-type="doi">10.3390/ijms18122645</pub-id><?supplied-pmid 29215589?><pub-id pub-id-type="pmid">29215589</pub-id></element-citation></ref><ref id="B182-vaccines-08-00468"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campos</surname><given-names>J.R.</given-names></name><name><surname>Severino</surname><given-names>P.</given-names></name><name><surname>Ferreira</surname><given-names>C.S.</given-names></name><name><surname>Zielinska</surname><given-names>A.</given-names></name><name><surname>Santini</surname><given-names>A.</given-names></name><name><surname>Souto</surname><given-names>S.B.</given-names></name><name><surname>Souto</surname><given-names>E.B.</given-names></name></person-group><article-title>Linseed Essential Oil&#x02014;Source of Lipids as Active Ingredients for Pharmaceuticals and Nutraceuticals</article-title><source>Curr. Med. Chem.</source><year>2019</year><volume>26</volume><fpage>4537</fpage><lpage>4558</lpage><pub-id pub-id-type="doi">10.2174/0929867325666181031105603</pub-id><?supplied-pmid 30378485?><pub-id pub-id-type="pmid">30378485</pub-id></element-citation></ref><ref id="B183-vaccines-08-00468"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asadi-Samani</surname><given-names>M.</given-names></name><name><surname>Bahmani</surname><given-names>M.</given-names></name><name><surname>Rafieian-Kopaei</surname><given-names>M.</given-names></name></person-group><article-title>The chemical composition, botanical characteristic and biological activities of <italic>Borago officinalis</italic>: A review</article-title><source>Asian Pac. J. Trop. Med.</source><year>2014</year><volume>7</volume><fpage>S22</fpage><lpage>S28</lpage><pub-id pub-id-type="doi">10.1016/S1995-7645(14)60199-1</pub-id></element-citation></ref><ref id="B184-vaccines-08-00468"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasote</surname><given-names>D.M.</given-names></name><name><surname>Zanwar</surname><given-names>A.A.</given-names></name><name><surname>Devkar</surname><given-names>S.T.</given-names></name><name><surname>Hegde</surname><given-names>M.V.</given-names></name><name><surname>Deshmukh</surname><given-names>K.K.</given-names></name></person-group><article-title>Immunomodulatory activity of ether insoluble phenolic components of n-butanol fraction (EPC-BF) of flaxseed in rat</article-title><source>Asian Pac. J. Trop. Biomed.</source><year>2012</year><volume>2</volume><fpage>S623</fpage><lpage>S626</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(12)60285-8</pub-id></element-citation></ref><ref id="B185-vaccines-08-00468"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H.J.</given-names></name><name><surname>Park</surname><given-names>J.S.</given-names></name><name><surname>Hayek</surname><given-names>M.G.</given-names></name><name><surname>Reinhart</surname><given-names>G.A.</given-names></name><name><surname>Chew</surname><given-names>B.P.</given-names></name></person-group><article-title>Dietary fish oil and flaxseed oil suppress inflammation and immunity in cats</article-title><source>Vet. Immunol. Immunopathol.</source><year>2011</year><volume>141</volume><fpage>301</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2011.02.024</pub-id><pub-id pub-id-type="pmid">21440312</pub-id></element-citation></ref><ref id="B186-vaccines-08-00468"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Che</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>L.</given-names></name><name><surname>Peng</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>F.</given-names></name><name><surname>Fang</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Flaxseed oil supplementation improves intestinal function and immunity, associated with altered intestinal microbiome and fatty acid profile in pigs with intrauterine growth retardation</article-title><source>Food Funct.</source><year>2019</year><volume>10</volume><fpage>8149</fpage><lpage>8160</lpage><pub-id pub-id-type="doi">10.1039/C9FO01877H</pub-id><pub-id pub-id-type="pmid">31696186</pub-id></element-citation></ref><ref id="B187-vaccines-08-00468"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamburger</surname><given-names>M.</given-names></name><name><surname>Riese</surname><given-names>U.</given-names></name><name><surname>Graf</surname><given-names>H.</given-names></name><name><surname>Melzig</surname><given-names>M.F.</given-names></name><name><surname>Ciesielski</surname><given-names>S.</given-names></name><name><surname>Baumann</surname><given-names>D.</given-names></name><name><surname>Dittmann</surname><given-names>K.</given-names></name><name><surname>Wegner</surname><given-names>C.</given-names></name></person-group><article-title>Constituents in evening primrose oil with radical scavenging, cyclooxygenase, and neutrophil elastase inhibitory activities</article-title><source>J. Agric. Food Chem.</source><year>2002</year><volume>50</volume><fpage>5533</fpage><lpage>5538</lpage><pub-id pub-id-type="doi">10.1021/jf025581l</pub-id><?supplied-pmid 12236675?><pub-id pub-id-type="pmid">12236675</pub-id></element-citation></ref><ref id="B188-vaccines-08-00468"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De La Puerta Vazquez</surname><given-names>R.</given-names></name><name><surname>Martinez-Dominguez</surname><given-names>E.</given-names></name><name><surname>Sanchez Perona</surname><given-names>J.</given-names></name><name><surname>Ruiz-Gutierrez</surname><given-names>V.</given-names></name></person-group><article-title>Effects of different dietary oils on inflammatory mediator generation and fatty acid composition in rat neutrophils</article-title><source>Metabolism</source><year>2004</year><volume>53</volume><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2003.08.010</pub-id><?supplied-pmid 14681843?><pub-id pub-id-type="pmid">14681843</pub-id></element-citation></ref><ref id="B189-vaccines-08-00468"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaqoob</surname><given-names>P.</given-names></name><name><surname>Newsholme</surname><given-names>E.A.</given-names></name><name><surname>Calder</surname><given-names>P.C.</given-names></name></person-group><article-title>Inhibition of natural killer cell activity by dietary lipids</article-title><source>Immunol. Lett.</source><year>1994</year><volume>41</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/0165-2478(94)90140-6</pub-id><pub-id pub-id-type="pmid">8002045</pub-id></element-citation></ref><ref id="B190-vaccines-08-00468"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dirks</surname><given-names>J.</given-names></name><name><surname>van Aswegen</surname><given-names>C.H.</given-names></name><name><surname>du Plessis</surname><given-names>D.J.</given-names></name></person-group><article-title>Cytokine levels affected by gamma-linolenic acid</article-title><source>Prostaglandins Leukot. Essent. Fatty Acids</source><year>1998</year><volume>59</volume><fpage>273</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/S0952-3278(98)90141-7</pub-id><pub-id pub-id-type="pmid">9849654</pub-id></element-citation></ref><ref id="B191-vaccines-08-00468"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>P.C.</given-names></name></person-group><article-title>The effects of fatty acids on lymphocyte functions</article-title><source>Braz. J. Med. Biol. Res.</source><year>1993</year><volume>26</volume><fpage>901</fpage><lpage>917</lpage><?supplied-pmid 8298526?><pub-id pub-id-type="pmid">8298526</pub-id></element-citation></ref><ref id="B192-vaccines-08-00468"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harbige</surname><given-names>L.S.</given-names></name></person-group><article-title>Fatty acids, the immune response, and autoimmunity: A question of n-6 essentiality and the balance between n-6 and n-3</article-title><source>Lipids</source><year>2003</year><volume>38</volume><fpage>323</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1007/s11745-003-1067-z</pub-id><pub-id pub-id-type="pmid">12848277</pub-id></element-citation></ref><ref id="B193-vaccines-08-00468"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vangaveti</surname><given-names>V.N.</given-names></name><name><surname>Jansen</surname><given-names>H.</given-names></name><name><surname>Kennedy</surname><given-names>R.L.</given-names></name><name><surname>Malabu</surname><given-names>U.H.</given-names></name></person-group><article-title>Hydroxyoctadecadienoic acids: Oxidised derivatives of linoleic acid and their role in inflammation associated with metabolic syndrome and cancer</article-title><source>Eur. J. Pharmacol.</source><year>2016</year><volume>785</volume><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2015.03.096</pub-id><pub-id pub-id-type="pmid">25987423</pub-id></element-citation></ref><ref id="B194-vaccines-08-00468"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shewale</surname><given-names>S.V.</given-names></name><name><surname>Boudyguina</surname><given-names>E.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Shen</surname><given-names>L.</given-names></name><name><surname>Hutchins</surname><given-names>P.M.</given-names></name><name><surname>Barkley</surname><given-names>R.M.</given-names></name><name><surname>Murphy</surname><given-names>R.C.</given-names></name><name><surname>Parks</surname><given-names>J.S.</given-names></name></person-group><article-title>Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liver</article-title><source>J. Lipid Res.</source><year>2015</year><volume>56</volume><fpage>1191</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1194/jlr.M059170</pub-id><pub-id pub-id-type="pmid">25921305</pub-id></element-citation></ref><ref id="B195-vaccines-08-00468"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proudman</surname><given-names>S.M.</given-names></name><name><surname>James</surname><given-names>M.J.</given-names></name><name><surname>Spargo</surname><given-names>L.D.</given-names></name><name><surname>Metcalf</surname><given-names>R.G.</given-names></name><name><surname>Sullivan</surname><given-names>T.R.</given-names></name><name><surname>Rischmueller</surname><given-names>M.</given-names></name><name><surname>Flabouris</surname><given-names>K.</given-names></name><name><surname>Wechalekar</surname><given-names>M.D.</given-names></name><name><surname>Lee</surname><given-names>A.T.</given-names></name><name><surname>Cleland</surname><given-names>L.G.</given-names></name></person-group><article-title>Fish oil in recent onset rheumatoid arthritis: A randomised, double-blind controlled trial within algorithm-based drug use</article-title><source>Ann. Rheum. Dis.</source><year>2015</year><volume>74</volume><fpage>89</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2013-204145</pub-id><pub-id pub-id-type="pmid">24081439</pub-id></element-citation></ref><ref id="B196-vaccines-08-00468"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vadell</surname><given-names>A.K.E.</given-names></name><name><surname>B&#x000e4;rebring</surname><given-names>L.</given-names></name><name><surname>Hulander</surname><given-names>E.</given-names></name><name><surname>Gjertsson</surname><given-names>I.</given-names></name><name><surname>Lindqvist</surname><given-names>H.M.</given-names></name><name><surname>Winkvist</surname><given-names>A.</given-names></name></person-group><article-title>Anti-inflammatory Diet In Rheumatoid Arthritis (ADIRA)&#x02014;A randomized, controlled crossover trial indicating effects on disease activity</article-title><source>Am. J. Clin. Nutr.</source><year>2020</year><volume>111</volume><fpage>1203</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.1093/ajcn/nqaa019</pub-id><pub-id pub-id-type="pmid">32055820</pub-id></element-citation></ref><ref id="B197-vaccines-08-00468"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molfino</surname><given-names>A.</given-names></name><name><surname>Amabile</surname><given-names>M.I.</given-names></name><name><surname>Monti</surname><given-names>M.</given-names></name><name><surname>Muscaritoli</surname><given-names>M.</given-names></name></person-group><article-title>Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?</article-title><source>Oxid. Med. Cell. Longev.</source><year>2017</year><volume>2017</volume><pub-id pub-id-type="doi">10.1155/2017/5987082</pub-id><?supplied-pmid 28694914?><pub-id pub-id-type="pmid">28694914</pub-id></element-citation></ref><ref id="B198-vaccines-08-00468"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>A.L.</given-names></name><name><surname>Park</surname><given-names>Y.</given-names></name></person-group><article-title>The association between n-3 polyunsaturated fatty acid levels in erythrocytes and the risk of rheumatoid arthritis in Korean women</article-title><source>Ann. Nutr. Metab.</source><year>2013</year><volume>63</volume><fpage>88</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1159/000353120</pub-id><?supplied-pmid 23949659?><pub-id pub-id-type="pmid">23949659</pub-id></element-citation></ref><ref id="B199-vaccines-08-00468"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sand</surname><given-names>I.K.</given-names></name></person-group><article-title>The role of diet in multiple sclerosis: Mechanistic connections and current evidence</article-title><source>Curr. Nutr. Rep.</source><year>2018</year><volume>7</volume><fpage>150</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1007/s13668-018-0236-z</pub-id><?supplied-pmid 30117071?><pub-id pub-id-type="pmid">30117071</pub-id></element-citation></ref><ref id="B200-vaccines-08-00468"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Innes</surname><given-names>J.K.</given-names></name><name><surname>Calder</surname><given-names>P.C.</given-names></name></person-group><article-title>Omega-6 fatty acids and inflammation</article-title><source>Prostaglandins Leukot. Essent. Fatty Acids</source><year>2018</year><volume>132</volume><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.plefa.2018.03.004</pub-id><?supplied-pmid 29610056?><pub-id pub-id-type="pmid">29610056</pub-id></element-citation></ref><ref id="B201-vaccines-08-00468"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pischon</surname><given-names>T.</given-names></name><name><surname>Hankinson</surname><given-names>S.E.</given-names></name><name><surname>Hotamisligil</surname><given-names>G.S.</given-names></name><name><surname>Rifai</surname><given-names>N.</given-names></name><name><surname>Willett</surname><given-names>W.C.</given-names></name><name><surname>Rimm</surname><given-names>E.B.</given-names></name></person-group><article-title>Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women</article-title><source>Circulation</source><year>2003</year><volume>108</volume><fpage>155</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000079224.46084.C2</pub-id><pub-id pub-id-type="pmid">12821543</pub-id></element-citation></ref><ref id="B202-vaccines-08-00468"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta-Roy</surname><given-names>A.K.</given-names></name><name><surname>Demarco</surname><given-names>A.C.</given-names></name><name><surname>Raha</surname><given-names>S.K.</given-names></name><name><surname>Shay</surname><given-names>J.</given-names></name><name><surname>Garvey</surname><given-names>M.</given-names></name><name><surname>Horrobin</surname><given-names>D.F.</given-names></name></person-group><article-title>Effects of linoleic and gamma-linolenic acids (efamol evening primrose oil) on fatty acid-binding proteins of rat liver</article-title><source>Mol. Cell. Biochem.</source><year>1990</year><volume>98</volume><fpage>177</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1007/BF00231382</pub-id><pub-id pub-id-type="pmid">2176271</pub-id></element-citation></ref><ref id="B203-vaccines-08-00468"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>D.</given-names></name><name><surname>Eng</surname><given-names>P.A.</given-names></name><name><surname>Borelli</surname><given-names>S.</given-names></name><name><surname>K&#x000e4;gi</surname><given-names>R.</given-names></name><name><surname>Zimmermann</surname><given-names>C.</given-names></name><name><surname>Zahner</surname><given-names>C.</given-names></name><name><surname>Drewe</surname><given-names>J.</given-names></name><name><surname>Hess</surname><given-names>L.</given-names></name><name><surname>Ferrari</surname><given-names>G.</given-names></name><name><surname>Lautenschlager</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Gamma-linolenic acid levels correlate with clinical efficacy of evening primrose oil in patients with atopic dermatitis</article-title><source>Adv. Ther.</source><year>2014</year><volume>31</volume><fpage>180</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1007/s12325-014-0093-0</pub-id><pub-id pub-id-type="pmid">24435467</pub-id></element-citation></ref><ref id="B204-vaccines-08-00468"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veale</surname><given-names>D.J.</given-names></name><name><surname>Torley</surname><given-names>H.I.</given-names></name><name><surname>Richards</surname><given-names>I.M.</given-names></name><name><surname>O&#x02019;Dowd</surname><given-names>A.</given-names></name><name><surname>Fitzsimons</surname><given-names>C.</given-names></name><name><surname>Belch</surname><given-names>J.J.</given-names></name><name><surname>Sturrock</surname><given-names>R.D.</given-names></name></person-group><article-title>A double-blind placebo controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritis</article-title><source>Br. J. Rheumatol.</source><year>1994</year><volume>33</volume><fpage>954</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/33.10.954</pub-id><pub-id pub-id-type="pmid">7921757</pub-id></element-citation></ref><ref id="B205-vaccines-08-00468"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomic-Smiljanic</surname><given-names>M.</given-names></name><name><surname>Vasiljevic</surname><given-names>D.</given-names></name><name><surname>Lucic-Tomic</surname><given-names>A.</given-names></name><name><surname>Andjelkovic</surname><given-names>N.</given-names></name><name><surname>Jakovljevic</surname><given-names>V.</given-names></name><name><surname>Bolovich</surname><given-names>S.</given-names></name><name><surname>Veselinovic</surname><given-names>M.</given-names></name></person-group><article-title>Influence of different supplementation on platelet aggregation in patients with rheumatoid arthritis</article-title><source>Clin. Rheumatol.</source><year>2019</year><volume>38</volume><fpage>2443</fpage><lpage>2450</lpage><pub-id pub-id-type="doi">10.1007/s10067-019-04569-3</pub-id><pub-id pub-id-type="pmid">31076942</pub-id></element-citation></ref><ref id="B206-vaccines-08-00468"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>M.</given-names></name><name><surname>Gagnier</surname><given-names>J.J.</given-names></name><name><surname>Chrubasik</surname><given-names>S.</given-names></name></person-group><article-title>Herbal therapy for treating rheumatoid arthritis</article-title><source>Cochrane Database Syst. Rev.</source><year>2011</year><pub-id pub-id-type="doi">10.1002/14651858.CD002948.pub2</pub-id></element-citation></ref><ref id="B207-vaccines-08-00468"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamford</surname><given-names>J.T.</given-names></name><name><surname>Ray</surname><given-names>S.</given-names></name><name><surname>Musekiwa</surname><given-names>A.</given-names></name><name><surname>van Gool</surname><given-names>C.</given-names></name><name><surname>Humphreys</surname><given-names>R.</given-names></name><name><surname>Ernst</surname><given-names>E.</given-names></name></person-group><article-title>Oral evening primrose oil and borage oil for eczema</article-title><source>Cochrane Database Syst. Rev.</source><year>2013</year><pub-id pub-id-type="doi">10.1002/14651858.CD004416.pub2</pub-id><?supplied-pmid 23633319?><pub-id pub-id-type="pmid">23633319</pub-id></element-citation></ref><ref id="B208-vaccines-08-00468"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>R.H.</given-names></name><name><surname>Hardy</surname><given-names>G.</given-names></name><name><surname>Alany</surname><given-names>R.G.</given-names></name></person-group><article-title>Borage oil in the treatment of atopic dermatitis</article-title><source>Nutrition</source><year>2010</year><volume>26</volume><fpage>708</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2009.10.014</pub-id><?supplied-pmid 20579590?><pub-id pub-id-type="pmid">20579590</pub-id></element-citation></ref><ref id="B209-vaccines-08-00468"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ursoniu</surname><given-names>S.</given-names></name><name><surname>Sahebkar</surname><given-names>A.</given-names></name><name><surname>Serban</surname><given-names>M.C.</given-names></name><name><surname>Pinzaru</surname><given-names>I.</given-names></name><name><surname>Dehelean</surname><given-names>C.</given-names></name><name><surname>Noveanu</surname><given-names>L.</given-names></name><name><surname>Rysz</surname><given-names>J.</given-names></name><name><surname>Banach</surname><given-names>M.</given-names></name></person-group><article-title>Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group. A systematic review and meta-analysis of clinical trials investigating the effects of flaxseed supplementation on plasma C-reactive protein concentrations</article-title><source>Arch. Med. Sci.</source><year>2019</year><volume>15</volume><fpage>12</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.5114/aoms.2018.81034</pub-id><?supplied-pmid 30697250?><pub-id pub-id-type="pmid">30697250</pub-id></element-citation></ref><ref id="B210-vaccines-08-00468"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reuben</surname><given-names>J.P.</given-names></name></person-group><article-title>Two rings in them all: The labdane-related diterpenoids</article-title><source>Nat. Prod. Rep.</source><year>2010</year><volume>27</volume><fpage>1521</fpage><lpage>1530</lpage><pub-id pub-id-type="pmid">20890488</pub-id></element-citation></ref><ref id="B211-vaccines-08-00468"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>S.R.</given-names></name><name><surname>Chai</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>Overview of pharmacological activities of <italic>Andrographis paniculata</italic> and its major compound andrographolide</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2018</year><volume>59</volume><fpage>S17</fpage><lpage>S29</lpage><pub-id pub-id-type="doi">10.1080/10408398.2018.1501657</pub-id><pub-id pub-id-type="pmid">30040451</pub-id></element-citation></ref><ref id="B212-vaccines-08-00468"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>J.K.</given-names></name><name><surname>Saikia</surname><given-names>D.</given-names></name><name><surname>Shanker</surname><given-names>K.</given-names></name><name><surname>Thakur</surname><given-names>J.P.</given-names></name><name><surname>Negi</surname><given-names>A.S.</given-names></name><name><surname>Banerjee</surname><given-names>S.</given-names></name></person-group><article-title>A bioactive labdane diterpenoid from <italic>Curcuma amada</italic> and its semisynthetic analogues as antitubercular agents</article-title><source>Eur. J. Med. Chem.</source><year>2010</year><volume>45</volume><fpage>4379</fpage><lpage>4382</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2010.06.006</pub-id><pub-id pub-id-type="pmid">20584563</pub-id></element-citation></ref><ref id="B213-vaccines-08-00468"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Peng</surname><given-names>W.</given-names></name><name><surname>Zhan</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title>A new 12,17-cyclo-labdane diterpenoid from the twigs of <italic>Dacrycarpus imbricatus</italic></article-title><source>Nat Prod Res.</source><year>2018</year><volume>32</volume><fpage>1669</fpage><lpage>1675</lpage><pub-id pub-id-type="doi">10.1080/14786419.2017.1395434</pub-id><pub-id pub-id-type="pmid">29115146</pub-id></element-citation></ref><ref id="B214-vaccines-08-00468"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>J.</given-names></name><name><surname>Sekiguchi</surname><given-names>M.</given-names></name><name><surname>Shigemori</surname><given-names>H.</given-names></name><name><surname>Ohsaki</surname><given-names>A.</given-names></name></person-group><article-title>Chapecoderins A-C, new labdane-derived diterpenoids from <italic>Echinodorus macrophyllus</italic></article-title><source>J. Nat. Prod.</source><year>2000</year><volume>63</volume><fpage>375</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1021/np9905261</pub-id><pub-id pub-id-type="pmid">10757722</pub-id></element-citation></ref><ref id="B215-vaccines-08-00468"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>Y.</given-names></name><name><surname>Khutsishvili</surname><given-names>M.</given-names></name><name><surname>Alizade</surname><given-names>V.</given-names></name><name><surname>Atha</surname><given-names>D.</given-names></name><name><surname>Borris</surname><given-names>R.P.</given-names></name></person-group><article-title>Labdane and Abietane Diterpenoids from Juniperus oblonga and Their Cytotoxic Activity</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1561</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24081561</pub-id></element-citation></ref><ref id="B216-vaccines-08-00468"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R.-H.</given-names></name><name><surname>Liu</surname><given-names>Z.-K.</given-names></name><name><surname>Yang</surname><given-names>D.-S.</given-names></name><name><surname>Zhang</surname><given-names>X.-J.</given-names></name><name><surname>Sun</surname><given-names>H.-D.</given-names></name><name><surname>Xiao</surname><given-names>W.-L.</given-names></name></person-group><article-title>Phytochemistry and pharmacology of the genus Leonurus: The herb to benefit the mothers and more</article-title><source>Phytochemistry</source><year>2018</year><volume>147</volume><fpage>167</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2017.12.016</pub-id><pub-id pub-id-type="pmid">29335190</pub-id></element-citation></ref><ref id="B217-vaccines-08-00468"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>Q.T.N.</given-names></name><name><surname>Wong</surname><given-names>W.S.F.</given-names></name><name><surname>Chai</surname><given-names>C.L.L.</given-names></name></person-group><article-title>Labdane diterpenoids as potential anti-inflammatory agents</article-title><source>Pharmacol. Res.</source><year>2017</year><volume>124</volume><fpage>43</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2017.07.019</pub-id><?supplied-pmid 28751221?><pub-id pub-id-type="pmid">28751221</pub-id></element-citation></ref><ref id="B218-vaccines-08-00468"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ban</surname><given-names>N.K.</given-names></name><name><surname>Thoa</surname><given-names>N.T.K.</given-names></name><name><surname>Linh</surname><given-names>T.M.</given-names></name><name><surname>Trang</surname><given-names>D.T.</given-names></name><name><surname>Van Kiem</surname><given-names>P.</given-names></name><name><surname>Nhiem</surname><given-names>N.X.</given-names></name><name><surname>Tai</surname><given-names>B.H.</given-names></name><name><surname>Van Minh</surname><given-names>C.</given-names></name><name><surname>Song</surname><given-names>J.-H.</given-names></name><name><surname>Ko</surname><given-names>H.-J.</given-names></name><etal/></person-group><article-title>Labdane-type diterpenoids from <italic>Vitex limonifolia</italic> and their antivirus activities</article-title><source>J. Nat. Med.</source><year>2018</year><volume>72</volume><fpage>290</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1007/s11418-017-1125-2</pub-id><?supplied-pmid 28914420?><pub-id pub-id-type="pmid">28914420</pub-id></element-citation></ref><ref id="B219-vaccines-08-00468"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X.Y.</given-names></name><name><surname>Wu</surname><given-names>R.H.</given-names></name><name><surname>Logue</surname><given-names>M.</given-names></name><name><surname>Blondel</surname><given-names>C.</given-names></name><name><surname>Lai</surname><given-names>L.</given-names></name><name><surname>Stuart</surname><given-names>B.</given-names></name><name><surname>Flower</surname><given-names>A.</given-names></name><name><surname>Fei</surname><given-names>Y.T.</given-names></name><name><surname>Moore</surname><given-names>M.</given-names></name><name><surname>Shepherd</surname><given-names>J.</given-names></name><etal/></person-group><article-title><italic>Andrographis paniculata</italic> (Chu&#x00101;n X&#x0012b;n Li&#x000e1;n) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0181780</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0181780</pub-id><?supplied-pmid 28783743?><pub-id pub-id-type="pmid">28783743</pub-id></element-citation></ref><ref id="B220-vaccines-08-00468"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>M.T.</given-names></name><name><surname>Ali</surname><given-names>E.S.</given-names></name><name><surname>Uddin</surname><given-names>S.J.</given-names></name><name><surname>Islam</surname><given-names>M.A.</given-names></name><name><surname>Shaw</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>I.N.</given-names></name><name><surname>Saravi</surname><given-names>S.</given-names></name><name><surname>Ahmad</surname><given-names>S.</given-names></name><name><surname>Rehman</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>V.K.</given-names></name><etal/></person-group><article-title>Andrographolide, a diterpene lactone from <italic>Andrographis paniculata</italic> and its therapeutic promises in cancer</article-title><source>Cancer Lett.</source><year>2018</year><volume>420</volume><fpage>129</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2018.01.074</pub-id><pub-id pub-id-type="pmid">29408515</pub-id></element-citation></ref><ref id="B221-vaccines-08-00468"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaz</surname><given-names>M.S.M.</given-names></name><name><surname>Da Silva</surname><given-names>M.S.V.</given-names></name><name><surname>Oliveira</surname><given-names>R.J.</given-names></name><name><surname>Mota</surname><given-names>J.D.S.</given-names></name><name><surname>Brait</surname><given-names>D.R.H.</given-names></name><name><surname>De Carvalho</surname><given-names>L.N.B.</given-names></name><name><surname>Vani</surname><given-names>J.M.</given-names></name><name><surname>Berno</surname><given-names>C.R.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>F.H.S.</given-names></name><name><surname>De Barros</surname><given-names>M.E.</given-names></name></person-group><article-title>Evaluation of the toxicokinetics and apoptotic potential of ethanol extract from <italic>Echinodorus macrophyllus</italic> leaves <italic>in vivo</italic></article-title><source>Regul. Toxicol. Pharmacol.</source><year>2016</year><volume>82</volume><fpage>32</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.yrtph.2016.10.017</pub-id><pub-id pub-id-type="pmid">27793745</pub-id></element-citation></ref><ref id="B222-vaccines-08-00468"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Silva</surname><given-names>G.P.</given-names></name><name><surname>Fernandes</surname><given-names>D.C.</given-names></name><name><surname>Vigliano</surname><given-names>M.V.</given-names></name><name><surname>da Fonseca</surname><given-names>E.N.</given-names></name><name><surname>Santos</surname><given-names>S.V.</given-names></name><name><surname>Marques</surname><given-names>P.R.</given-names></name><name><surname>Justo</surname><given-names>M.D.</given-names></name><name><surname>Sabino</surname><given-names>K.C.</given-names></name><name><surname>Coelho</surname><given-names>M.G.</given-names></name></person-group><article-title>Flavonoid-enriched fraction from <italic>Echinodorus macrophyllus</italic> aqueous extract exhibits high <italic>in-vitro</italic> and <italic>in-vivo</italic> anti-inflammatory activity</article-title><source>J. Pharm. Pharmacol.</source><year>2016</year><volume>68</volume><fpage>1584</fpage><lpage>1596</lpage><pub-id pub-id-type="doi">10.1111/jphp.12620</pub-id><pub-id pub-id-type="pmid">27726146</pub-id></element-citation></ref><ref id="B223-vaccines-08-00468"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>A.C.</given-names></name><name><surname>Rego</surname><given-names>G.C.G.</given-names></name><name><surname>Siqueira</surname><given-names>A.M.</given-names></name><name><surname>Cardoso</surname><given-names>C.C.</given-names></name><name><surname>Reis</surname><given-names>P.A.</given-names></name><name><surname>Marques</surname><given-names>E.A.</given-names></name><name><surname>Coelho</surname><given-names>M.G.</given-names></name><name><surname>Sabino</surname><given-names>K.G.C.</given-names></name></person-group><article-title>Immunosuppressive effects of <italic>Echinodorus macrophyllus</italic> aqueous extract</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>111</volume><fpage>435</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.11.022</pub-id><pub-id pub-id-type="pmid">17293069</pub-id></element-citation></ref><ref id="B224-vaccines-08-00468"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>M.</given-names></name><name><surname>Appendino</surname><given-names>G.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>F&#x000fc;rst</surname><given-names>R.</given-names></name><name><surname>Izzo</surname><given-names>A.A.</given-names></name><name><surname>Kayser</surname><given-names>O.</given-names></name><name><surname>Pezzuto</surname><given-names>J.M.</given-names></name><name><surname>Viljoen</surname><given-names>A.</given-names></name></person-group><article-title>Best practice in research&#x02014;Overcoming common challenges in phytopharmacological research</article-title><source>J. Ethnopharmacol.</source><year>2020</year><volume>246</volume><fpage>112230</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2019.112230</pub-id><pub-id pub-id-type="pmid">31526860</pub-id></element-citation></ref><ref id="B225-vaccines-08-00468"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izzo</surname><given-names>A.A.</given-names></name><name><surname>Teixeira</surname><given-names>M.</given-names></name><name><surname>Alexander</surname><given-names>S.</given-names></name><name><surname>Cirino</surname><given-names>G.</given-names></name><name><surname>Docherty</surname><given-names>J.R.</given-names></name><name><surname>George</surname><given-names>C.H.</given-names></name><name><surname>Insel</surname><given-names>P.A.</given-names></name><name><surname>Ji</surname><given-names>Y.</given-names></name><name><surname>Kendall</surname><given-names>D.A.</given-names></name><name><surname>Panattieri</surname><given-names>R.A.</given-names></name><etal/></person-group><article-title>A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research</article-title><source>Br. J. Pharmacol.</source><year>2020</year><volume>177</volume><fpage>2169</fpage><lpage>2178</lpage><pub-id pub-id-type="doi">10.1111/bph.15054</pub-id><pub-id pub-id-type="pmid">32298474</pub-id></element-citation></ref><ref id="B226-vaccines-08-00468"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D.</given-names></name><name><surname>Liberati</surname><given-names>A.</given-names></name><name><surname>Tetzlaff</surname><given-names>J.</given-names></name><name><surname>Altman</surname><given-names>D.G.</given-names></name><collab>PRISMA Group</collab></person-group><article-title>Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement</article-title><source>Int. J. Surg.</source><year>2010</year><volume>8</volume><fpage>336</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1016/j.ijsu.2010.02.007</pub-id><pub-id pub-id-type="pmid">20171303</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="vaccines-08-00468-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Responses involved in innate and adaptive immunity. Fast and nonspecific responses, occurring against all factor identified as nonself, are involved in innate immunity; conversely, adaptive immunity is a highly specific, complex and slow response mediated by T and B lymphocytes, which release antigen-specific antibodies and cytokines. Immunomodulators can directly affect innate and adaptive response or the factors involved, thus leading to immunostimulant or immunosuppressive effects.</p></caption><graphic xlink:href="vaccines-08-00468-g001"/></fig><fig id="vaccines-08-00468-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Major groups of plant-derived nutraceuticals able to modulate the immune function.</p></caption><graphic xlink:href="vaccines-08-00468-g002"/></fig><fig id="vaccines-08-00468-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Schematic representantions of the different classes of polysaccharides associated with immune system modulation.</p></caption><graphic xlink:href="vaccines-08-00468-g003"/></fig><fig id="vaccines-08-00468-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Chemical structure examples of the different classes of polysaccharides.</p></caption><graphic xlink:href="vaccines-08-00468-g004"/></fig><fig id="vaccines-08-00468-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Schematic representantions of the direct and inderect effects of polysaccharides on the immune system. SCFA, short-chain fatty acids; NK, natural killer; HDAC, histone deacetylases.</p></caption><graphic xlink:href="vaccines-08-00468-g005"/></fig><fig id="vaccines-08-00468-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Biosynthetic pathways of &#x003c9;-3 and &#x003c9;-6 fatty acids.</p></caption><graphic xlink:href="vaccines-08-00468-g006"/></fig><fig id="vaccines-08-00468-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Role of &#x003c9;-6 and &#x003c9; -3 PUFA in the synthesis of proinflammatory or anti-inflammatory mediators.</p></caption><graphic xlink:href="vaccines-08-00468-g007"/></fig><fig id="vaccines-08-00468-f008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Chemical structure of the skeleton of labdane compound. The figure has been obtained using the ChemSpider<sup>&#x000ae;</sup> chemical structure database.</p></caption><graphic xlink:href="vaccines-08-00468-g008"/></fig><fig id="vaccines-08-00468-f009" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Chemical structure of andrographolide. This has been obtained using ChemSpider<sup>&#x000ae;</sup> chemical structure database.</p></caption><graphic xlink:href="vaccines-08-00468-g009"/></fig><table-wrap id="vaccines-08-00468-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">vaccines-08-00468-t001_Table 1</object-id><label>Table 1</label><caption><p>Some examples of bioactive constituents obtained from immunomodulatory plants, and their effect on immune function.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Medicinal Plants </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Phytochemicals</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effect on Immune Function/Type of Immunomodulation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Acacia catechu</italic> Willd. heartwood</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavonoids, phenolic acids, catechins </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antinflammatory activity/Immunoadjuvant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B21-vaccines-08-00468" ref-type="bibr">21</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Aloe vera</italic> (L.) Burm.f.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acemannan, dihydrocoumarins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adaptive immunity activation/Immunostimulant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-vaccines-08-00468" ref-type="bibr">22</xref>,<xref rid="B23-vaccines-08-00468" ref-type="bibr">23</xref>,<xref rid="B24-vaccines-08-00468" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Andrographis paniculata</italic> (Burm.f.) Nees</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diterpene lactones (andrographolide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Modulation of innate and adaptive immunity/Immunosuppressor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B25-vaccines-08-00468" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Artocarpus tonkinensis</italic> A. Chev. Ex Gagnep</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Auronol glycosides (maesopsin 4-O-glucoside and alphitonin-4-O-glucoside)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of humoral and cellular adaptive immunity/Immunosuppressor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B26-vaccines-08-00468" ref-type="bibr">26</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Astragalus membranaceous</italic> (Fisch.) Bge.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polysaccharides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of cellular immunity/Immunostimulant </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-vaccines-08-00468" ref-type="bibr">27</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Boswellia serrata</italic> Roxb. ex Colebr</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Boswellic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-anaphylactic and mast cell stabilization/Immunosuppressor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B28-vaccines-08-00468" ref-type="bibr">28</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Camellia sinensis</italic> (L.) Kuntze</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polysaccharides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of immunoreactivity through the modulation of gut microbiome/Immunostimulant effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-vaccines-08-00468" ref-type="bibr">20</xref>,<xref rid="B29-vaccines-08-00468" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Centella asiatica</italic> (L.) Urban</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Madecassoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regulation the abnormal humoral and cellular immunity/Immunosuppressor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B30-vaccines-08-00468" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Curcuma longa</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcuminoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-10-mediated anti-inflammatory and immunosuppressive activity/Immunosuppressor </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B31-vaccines-08-00468" ref-type="bibr">31</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Echinacea purpurea</italic> (L.) Moench</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alkylamides, glycoproteins, polysaccharides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of cellular immunity and modulation of gut microbiome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B18-vaccines-08-00468" ref-type="bibr">18</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Glycyrrhiza glabra</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Triterpene saponins (glycyrrhizin)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhanced cellular immunity and antinflammatory activity/Immunostimulant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-vaccines-08-00468" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Hypoxis rooperi</italic> T. Moore</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic glucosides (hypoxoside)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antinflammatory properties/Immunoadjuvant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B33-vaccines-08-00468" ref-type="bibr">33</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ocimum sanctum</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Monoterpenes (eugenol and methyleugenol), sesquiterpenes (&#x003b2;-caryophyllene)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of innate and adaptive immunity/Immunostimulant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B34-vaccines-08-00468" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Panax ginseng</italic> C.A. Meyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Triterpene saponins (ginsenosides)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adaptogen effects, stimulation of immune systems via cytokine activation, modulation of gut microbiome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B19-vaccines-08-00468" ref-type="bibr">19</xref>,<xref rid="B35-vaccines-08-00468" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-08-00468" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Syzigium aromaticum</italic> (L.) Merr. and L.M. Perry</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Monoterpenes (eugenol), sesquiterpenes (&#x003b2;-caryophyllene)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of adaptive humoral immunity/Immunostimulant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-vaccines-08-00468" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Tinospora cordifolia</italic> (Thunb.) Miers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arabinogalactan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of adaptive immunity/Immunostimulant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B38-vaccines-08-00468" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Withania somnifera</italic> (L.) Dunal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Steroidal lactones (withaferin A)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adaptogen effects, stimulation of adaptive humoral and cellular immunity/Immunostimulant </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B39-vaccines-08-00468" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-08-00468" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Zingiber officianalis</italic> Roscoe</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolics (gingerols)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of adaptive humoral immunity/Immunostimulant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-vaccines-08-00468" ref-type="bibr">41</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="vaccines-08-00468-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">vaccines-08-00468-t002_Table 2</object-id><label>Table 2</label><caption><p>Examples of medicinal plants containing polysaccharides with immune system modulation activities.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plants</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Family</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant Part of Biological Interest</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Aconitum carmichaeli</italic> Debx.</td><td align="center" valign="middle" rowspan="1" colspan="1">Ranunculaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Roots</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B76-vaccines-08-00468" ref-type="bibr">76</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Allium sativum</italic> L.</td><td align="center" valign="middle" rowspan="1" colspan="1">Liliaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Bulb</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B77-vaccines-08-00468" ref-type="bibr">77</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Aloe vera</italic> L.</td><td align="center" valign="middle" rowspan="1" colspan="1">Liliaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Leaves</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B78-vaccines-08-00468" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Amorphallus konjac</italic> Koch</td><td align="center" valign="middle" rowspan="1" colspan="1">Araceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Tubers</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B79-vaccines-08-00468" ref-type="bibr">79</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Anadenanthera colubrina</italic> (Vell.) Brenan</td><td align="center" valign="middle" rowspan="1" colspan="1">Fabaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Gum</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B80-vaccines-08-00468" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Astragalus membranaceus</italic> (Fisch.) Bge.</td><td align="center" valign="middle" rowspan="1" colspan="1">Fabacee</td><td align="center" valign="middle" rowspan="1" colspan="1">Root</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B64-vaccines-08-00468" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Carum carvi</italic> L.</td><td align="center" valign="middle" rowspan="1" colspan="1">Apiaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Seeds</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B81-vaccines-08-00468" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Centella asiatica</italic> L. Urb. </td><td align="center" valign="middle" rowspan="1" colspan="1">Apiaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Aerial parts</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B82-vaccines-08-00468" ref-type="bibr">82</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Coffea arabica</italic> L. and <italic>C. robusta</italic> L.</td><td align="center" valign="middle" rowspan="1" colspan="1">Rubiaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Beans</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B83-vaccines-08-00468" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Cyamopsis tetragonolobus</italic> L.</td><td align="center" valign="middle" rowspan="1" colspan="1">Fabaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Seeds</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B84-vaccines-08-00468" ref-type="bibr">84</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Dendrobium huoshanense</italic> C.Z. Tang et S.J. Cheng </td><td align="center" valign="middle" rowspan="1" colspan="1">Orchidaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Stems</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B85-vaccines-08-00468" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Echinacea purpurea</italic> L. (Moench)</td><td align="center" valign="middle" rowspan="1" colspan="1">Asteracee</td><td align="center" valign="middle" rowspan="1" colspan="1">Aerial parts</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B86-vaccines-08-00468" ref-type="bibr">86</xref>,<xref rid="B87-vaccines-08-00468" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Euterpe oleracea</italic> Mart.</td><td align="center" valign="middle" rowspan="1" colspan="1">Arecaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Fruits</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B88-vaccines-08-00468" ref-type="bibr">88</xref>,<xref rid="B89-vaccines-08-00468" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Hordeum vulgare</italic> var. Tyra</td><td align="center" valign="middle" rowspan="1" colspan="1">Poaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Stems</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B90-vaccines-08-00468" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Ipomoea batatas</italic> L.</td><td align="center" valign="middle" rowspan="1" colspan="1">Convolvulaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Roots</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B91-vaccines-08-00468" ref-type="bibr">91</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Juniperus scopolorum</italic> Sarg.</td><td align="center" valign="middle" rowspan="1" colspan="1">Cupressaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Cones</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B92-vaccines-08-00468" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Lycium barbarian</italic> L.</td><td align="center" valign="middle" rowspan="1" colspan="1">Solanaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Fruit</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B93-vaccines-08-00468" ref-type="bibr">93</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Panax ginseng</italic> C.A. Meyer</td><td align="center" valign="middle" rowspan="1" colspan="1">Araliaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Roots</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B94-vaccines-08-00468" ref-type="bibr">94</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Picea abies</italic> L.</td><td align="center" valign="middle" rowspan="1" colspan="1"> Pinaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Softwoods</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B95-vaccines-08-00468" ref-type="bibr">95</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Prunus dulcis</italic> (Miller) D. A. Webb.</td><td align="center" valign="middle" rowspan="1" colspan="1">Rosacee</td><td align="center" valign="middle" rowspan="1" colspan="1">Seeds</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B96-vaccines-08-00468" ref-type="bibr">96</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Sophora alopecuroides</italic> L.</td><td align="center" valign="middle" rowspan="1" colspan="1">Fabaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Seeds</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B97-vaccines-08-00468" ref-type="bibr">97</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Tanacetum vulgare</italic> L.</td><td align="center" valign="middle" rowspan="1" colspan="1">Asteraceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Florets</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B98-vaccines-08-00468" ref-type="bibr">98</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Tinospora cordifolia</italic> (Thunb.) Miers</td><td align="center" valign="middle" rowspan="1" colspan="1">Menispermaceae</td><td align="center" valign="middle" rowspan="1" colspan="1">Aerial parts</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B99-vaccines-08-00468" ref-type="bibr">99</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Trigonella foenum-graecum</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fabaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Seeds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B100-vaccines-08-00468" ref-type="bibr">100</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="vaccines-08-00468-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">vaccines-08-00468-t003_Table 3</object-id><label>Table 3</label><caption><p>Nomenclature and chemical features of some representative long-chain fatty acids.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Fatty Acid </th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Class of Long-Chain Fatty Acid </th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">IUPAC Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Abbreviation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Delta (&#x02206;) Nomenclature</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n- or &#x003c9;-Nomenclature</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Palmitic acid </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hexadecanoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16:0 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16:0 </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stearic acid </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Octadecanoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:0 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:0 </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oleic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MUFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(9E)-Octadec-9-enoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:1&#x02206;9 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:1n-9 or 18:1&#x003c9;-9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Punicic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Conjugated PUFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(9Z,11E,13Z)-9,11,13-Octadecatrienoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:3&#x02206;9,9,11,13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:3n-5 or 18:3 &#x003c9;-5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-Linolenic acid<break/>(ALA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PUFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(9Z,12Z,15Z)-Octadeca-9,12,15-trienoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:3&#x02206;9,12,15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:3n-3 or 18:3&#x003c9;-3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stearidonic acid (SA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PUFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(6Z,9Z,12Z,15Z)-Octadeca-6,9,12,15-tetraenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:4&#x02206;6,9,12,15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:4n-3 or 18:4&#x003c9;-3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eicosatetraenoic acid (ETA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PUFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(2Z,4Z,5Z,8Z)-2,4,6,8-Icosatetraenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20:4&#x02206;2,4,6,8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20:4n-3 or 20:4&#x003c9;-3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eicosapentaenoic acid (EPA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PUFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(2E,4E,6E,8E,10E)-2,4,6,8,10-Icosapentaenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20:5&#x02206;2,4,6,8,10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20:5n-3 or 20:5&#x003c9;-3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Docosahexaenoic acid (DHA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PUFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19-hexaenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22:6&#x02206;4,7,10,13,16,19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22:6n-3 or 20:6&#x003c9;-3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Linoleic acid (LA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PUFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(9Z,12Z)-Octadeca-9,12-dienoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:2&#x02206;9,12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:2n-6 or 18:2&#x003c9;-6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b3;-Linolenic acid (GLA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PUFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(6Z,9Z,12Z)-Octadeca-6,9,12-trienoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:3&#x02206;6,9,12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18:3n-6 or 18:3&#x003c9;-6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dihomo<break/>&#x003b3;-Linolenic acid (DGLA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PUFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(8Z,11Z,14Z)-Icosa-8,11,14-trienoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20:3&#x02206;8,11,14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20:3n-6 or 20:3&#x003c9;-6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arachidonic acid<break/>(AA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PUFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(5E,8E,11E,14E)-Icosa-5,8,11,14-tetraenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20:4&#x02206;5,8,11,14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20:4n-6 or 20:4&#x003c9;-6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Docosapentaenoic acid (DPA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PUFA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22:5&#x02206;7,10,13,16,19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22:5n-6 or 22:5&#x003c9;-6</td></tr></tbody></table><table-wrap-foot><fn><p>SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.</p></fn></table-wrap-foot></table-wrap><table-wrap id="vaccines-08-00468-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">vaccines-08-00468-t004_Table 4</object-id><label>Table 4</label><caption><p>Major natural sources of long-chain monounsaturated (MUFA) and polyunsaturated fatty acids (PUFA) associated with immune system modulating activities and relative amounts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species (Byproduct)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Amount (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>MUFA</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oleic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Olea europea</italic> L.<break/>(fruit oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56&#x02013;84% <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B151-vaccines-08-00468" ref-type="bibr">151</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Vitis vinifera</italic> L.<break/>(grapeseed oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9&#x02013;17%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B154-vaccines-08-00468" ref-type="bibr">154</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Brassica</italic> spp.<break/>(rapeseed oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60&#x02013;80%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B155-vaccines-08-00468" ref-type="bibr">155</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Conjugated PUFA</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Punicic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Punica granatum</italic> L.<break/>(pomegranate seed oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70&#x02013;85%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B150-vaccines-08-00468" ref-type="bibr">150</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Momordica charantia</italic> L. <break/>(bitter gourds seed oils)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5&#x02013;16%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B156-vaccines-08-00468" ref-type="bibr">156</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Essential &#x003c9;3-PUFA</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-Linolenic acid (ALA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Linum usitatissimum</italic> L.<break/>(flaxseed oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55&#x02013;57%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-vaccines-08-00468" ref-type="bibr">153</xref>,<xref rid="B157-vaccines-08-00468" ref-type="bibr">157</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Salvia hispanica</italic> L. <break/>(chia seeds)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.8%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-vaccines-08-00468" ref-type="bibr">153</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Perilla frutescens var. frutescens</italic> L.<break/>(seeds)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54&#x02013;64%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B158-vaccines-08-00468" ref-type="bibr">158</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EPA, DHA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fish oils</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4&#x02013;13%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-vaccines-08-00468" ref-type="bibr">153</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Essential &#x003c9;6-PUFA</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Linoleic acid (LA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Borago</italic> sp. (seed oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.8&#x02013;37.9%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B159-vaccines-08-00468" ref-type="bibr">159</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Oenothera biennis</italic> L.<break/>(seed oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70&#x02013;74%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B160-vaccines-08-00468" ref-type="bibr">160</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cannabis sativa</italic> L.<break/>(hamp seed oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27&#x02013;58%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-vaccines-08-00468" ref-type="bibr">153</xref>,<xref rid="B161-vaccines-08-00468" ref-type="bibr">161</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Glycine max</italic> (L.) Merr. <break/>(soybean)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.4%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-vaccines-08-00468" ref-type="bibr">153</xref>,<xref rid="B161-vaccines-08-00468" ref-type="bibr">161</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Bertholletia excelsa</italic><break/>(Dried brazilnuts)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.8%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-vaccines-08-00468" ref-type="bibr">153</xref>,<xref rid="B161-vaccines-08-00468" ref-type="bibr">161</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Juglans regia</italic> L.<break/>(dried walnuts)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.8%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-vaccines-08-00468" ref-type="bibr">153</xref>,<xref rid="B161-vaccines-08-00468" ref-type="bibr">161</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Zea mays</italic> L.<break/>(corn)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.2%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-vaccines-08-00468" ref-type="bibr">153</xref>,<xref rid="B161-vaccines-08-00468" ref-type="bibr">161</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b3;-Linolenic acid (GLA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Borago</italic> sp. (seed oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.6&#x02013;39.8%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B159-vaccines-08-00468" ref-type="bibr">159</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Oenothera biennis</italic> L.<break/>(seed oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8&#x02013;10%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B160-vaccines-08-00468" ref-type="bibr">160</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ribes nigrum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15&#x02013;19% <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B162-vaccines-08-00468" ref-type="bibr">162</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(seed oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Echium</italic> spp.<break/>(seed oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.2&#x02013;47.1%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B159-vaccines-08-00468" ref-type="bibr">159</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ranunculus</italic> spp.<break/>(seed oil)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.9&#x02013;39.7%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B159-vaccines-08-00468" ref-type="bibr">159</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> referred to the total amount of fatty acids.</p></fn></table-wrap-foot></table-wrap><table-wrap id="vaccines-08-00468-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">vaccines-08-00468-t005_Table 5</object-id><label>Table 5</label><caption><p>Examples of medicinal plants containing labdane diterpenoids, with immune system modulation activities.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plants</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Family</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Part of the Plant of<break/>Biological Interest</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Andrographis paniculata</italic> (Burm.f.) Nees</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acanthaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aerial parts, roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B211-vaccines-08-00468" ref-type="bibr">211</xref>,<xref rid="B219-vaccines-08-00468" ref-type="bibr">219</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Curcuma amada</italic> Roxb</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zingiberaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rizome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B212-vaccines-08-00468" ref-type="bibr">212</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Dacricarpus imbricatus</italic> (Blume) de Laub</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Podocarpaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bark</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B213-vaccines-08-00468" ref-type="bibr">213</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Echinodorus macrophyllus</italic> (Kunth) Micheli</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alismataceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B214-vaccines-08-00468" ref-type="bibr">214</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Juniperus oblonga</italic> M. Bieb</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cupressaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Berries</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B215-vaccines-08-00468" ref-type="bibr">215</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Leonurus japonicas</italic> Houtt </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lamiaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aerial parts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B216-vaccines-08-00468" ref-type="bibr">216</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Marrubium</italic> L. Spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lamiaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aerial parts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B217-vaccines-08-00468" ref-type="bibr">217</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Vitex limonifolia</italic> Wall. ex C.B.Clarke </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lamiaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B218-vaccines-08-00468" ref-type="bibr">218</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>